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ABSTRACT 
One quarter of any community may have normal (normal/high-normal) as 
opposed to optimal or hypertensive blood pressures (BP). These individuals may be 
at risk for a BP-related cardiovascular event, but do not qualify for BP-lowering 
therapy as those at risk are difficult to identify. In the present thesis I sought to 
determine whether aspects of non-invasively determined aortic BP may refine BP-
related cardiovascular risk assessment in those with brachial BP values within 
normotensive ranges. 
In 1169 participants from a community sample of African ancestry, 319 (27%) 
of whom had a normal/high-normal brachial BP, aortic BP was determined from radial 
tonometry and target organ changes assessed from carotid-femoral pulse wave 
velocity (PWV)(n=1025), estimated glomerular filtration rate (eGFR) (n=944), and left 
ventricular mass index (LVMI)(n=690). Normal versus high-normal brachial BP 
categories failed to differentiate between those participants with a BP above optimal 
values with versus without multivariate-adjusted target organ changes. However, in 
those with a normal/high-normal BP with aortic systolic BP (SBP) values that were 
<95% confidence interval of healthy participants with optimal BP values (45% of 
those with a normal/high-normal BP), no unadjusted or multivariate adjusted target 
organ changes were noted. In contrast, those with a normal/high-normal BP with 
aortic SBP values that exceeded optimal thresholds, demonstrated unadjusted and 
multivariate adjusted increases in PWV and LVMI and decreases in eGFR (p<0.05 to 
p<0.005 after multivariate adjustments). Thus, aortic BP measurements may refine 
the ability to detect those with a normal/high-normal BP at risk of BP-related 
cardiovascular damage. 
Although indices of aortic wave reflection could enhance risk prediction in 
normotensives, the extent to which measures of aortic systolic pressure augmentation 
(augmented pressures [Pa] or augmentation index [AIx]) underestimate the effects of 
reflected waves on cardiovascular risk is uncertain. In participants from a community 
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sample I assessed the relative contribution of reflected (backward wave pressures 
[Pb] and the reflection index [RI]) versus augmented (Pa and AIx) pressure wave 
indices to variations in central aortic pulse pressure (PPc) (n=1185), and LVMI 
(n=793). Independent of confounders, RI and Pb contributed more than forward wave 
pressures (Pf), whilst Pa and AIx contributed less than incident wave pressure (Pi) to 
variations in PPc (p<0.0001 for comparison of partial r values). In those <50 years of 
age, while Pb (partial r=0.28, p<0.0001) contributed more than Pf (partial r=0.15, 
p<0.001, p<0.05 for comparison of r values), Pa (partial r=0.13, p<0.005) contributed 
to a similar extent as Pi (partial r=0.22, p<0.0001) to variations in LVMI. Further, in 
those ≥50 years of age, Pb (partial r=0.21, p<0.0001), but not Pf (p=0.98), whilst Pi 
(partial r=0.23, p<0.0001), but not Pa (p=0.80) were associated with LVMI. Thus, as 
compared to relations between indices of aortic pressure augmentation and PPc or 
LVMI, strikingly better relations are noted between aortic wave reflection and PPc or 
LVMI. 
 In 1185 participants of a community-based sample, 27% of whom had 
normal/high-normal BP values, I then determined whether indices of wave reflection 
enhance the ability to detect cardiovascular damage beyond brachial and aortic BP. 
In normotensives aortic SBP was associated with LVMI (g/m1.7) (n=410, partial 
r=0.18, p<0.0005), PWV (n=570, partial r=0.16, p<0.0005) and eGFR (n=605, partial 
r=-0.08, p<0.05) independent of confounders and brachial BP. Similar findings were 
noted for PPc. In contrast, although Pb was independently associated with LVMI 
(partial r=0.22, p<0.0001) and a trend for an effect was noted for eGFR (partial r=-
0.07, p=0.08) independent of confounders and brachial BP, no independent relations 
were noted with PWV (partial r=0.06, p=0.15). Similar relations were noted between 
RI and end-organ changes. The area under the receiver operating curve (AUC) for 
the detection of left ventricular hypertrophy (LVH)(n=168 of 410 normotensives) 
showed a greater ability of PPc (AUC=0.68±0.03) and Pb (AUC=0.67±0.03), but not 
RI (AUC=0.65±0.03) to detect LVH as compared to brachial SBP (AUC=0.60±0.03) 
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and brachial pulse pressure (PPb) (AUC=0.61±0.03) (p<0.05 for comparison of 
AUC). However, the performance for LVH detection was no greater for Pb than for 
PPc. Therefore, in normotensives although Pb is better than brachial BP for the 
detection of end-organ damage, indices of wave reflection do not enhance the ability 
to detect end-organ changes beyond aortic SBP or pulse pressure (PP). 
Although aortic BP may refine the ability to detect normotensives at risk of 
BP-related cardiovascular damage, the cost of measurement devices precludes the 
use of this approach in resource-limited settings. I assessed whether aortic BP 
imputed from simple clinical measures may similarly refine the ability to detect 
normotensives at risk of BP-related cardiovascular damage. An imputation equation 
for PPc, incorporating brachial PP, age, mean arterial pressure and pulse rate was 
identified from multivariate modelling of the factors associated with tonometry-derived 
PPc in 1179 community participants. Imputed PPc values closely approximated 
tonometry-derived PPc in all participants of the community-based sample (r2=0.96, 
slope=1.00±0.006, mean difference (±2xSD)=1.4±6.2 mm Hg) and in 351 patients 
from a clinical sample (r2=0.943, slope=0.96±0.01, mean difference (±2xSD)=-
2.17±7.44 mm Hg). In normotensives imputed PPc was associated with LVMI 
(n=410, partial r=0.17, p<0.01) and eGFR (n=605, partial r=-0.15, p<0.0005) 
independent of confounders and brachial BP. Independent relations with end-organ 
changes were similar for imputed and tonometry-derived aortic BP. The AUC for LVH 
detection (n=168 of 410 normotensives) showed a greater performance of both 
imputed (AUC=0.656±0.027) and tonometry-derived (AUC=0.678±0.027) PPc as 
compared to brachial PP (AUC=0.613±0.028) or brachial systolic BP 
(AUC=0.595±0.029) (p<0.05 for comparisons of AUC). Thus, aortic BP imputed from 
simple clinical measures closely approximates tonometry-derived aortic BP and 
refines the ability to detect normotensives at risk of BP-related cardiovascular 
damage. 
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In conclusion, in the present thesis I provide a possible solution to the 
conundrum of how best to identify normotensives who may be at risk of a BP-related 
cardiovascular event. In this regard I show that tonometry-derived aortic BP may 
refine the ability to detect cardiovascular damage in normotensives; that although 
aortic wave reflection largely accounts for the ability of aortic BP to detect end-organ 
damage better than brachial BP in normotensives, that these effects are no better 
than aortic BP per se; and that aortic BP imputed from simple clinical measures 
closely approximates tonometry-derived aortic BP and performs as well as tonometry-
derived aortic BP in the detection of cardiovascular damage in normotensives. 
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PREFACE 
 
 At a global level, cardiovascular disease (CVD) accounts for 30% of all 
deaths worldwide. In the next two decades, the burden of death from CVD across 
the globe is predicted to occur in low and middle-income countries such as South-
Africa. In groups of African ancestry living in Africa, hypertension is the leading 
cause of CVD. Although most guidelines use a blood pressure (BP) threshold of 
140/90 mm Hg for the diagnosis and treatment of hypertension, there is 
considerable evidence that BP effects on CVD occur at levels well below this 
threshold. Indeed BP values in the pre-hypertensive range (120-129 systolic 
BP/80-85 diastolic BP), which occurs in a quarter of any adult population, have 
repeatedly been demonstrated to predict outcomes. However, as BP lowering to 
values well below 140/90 mm Hg have failed to consistently improve outcomes, 
further antihypertensive therapy is not advocated for those with BP values in this 
range. However, inconsistencies in the ability of antihypertensive therapy to 
reduce CV outcomes in this BP range may be explained by the marked 
heterogeneity in CV risk associated with pre-hypertension.     
 The present thesis was therefore prompted by a need to better identify 
those of African descent living in Africa with BP values in the pre-hypertensive 
range at risk of BP-related CV damage. Central aortic BP may be considerably 
different from brachial BP. Moreover, aortic BP predicts risk independent of 
brachial BP. Because marked overlap in aortic BP values have been noted across 
optimal, pre-hypertensive and hypertensive BP ranges, in the present thesis I 
explored whether various aspects of aortic BP measurement may better detect 
pre-hypertensives with cardiovascular end-organ changes. In the present thesis I 
evaluated whether aortic pulse pressure, systolic BP and/or aortic backward wave 
pressures enhance the ability to detect end-organ changes in a community  
 
 xxxii
sample of black African ancestry living in the South West Township (SOWETO) of 
Johannesburg, South Africa. I explored with non-invasive measurements of aortic 
BP derived from applanation tonometry, as well as aortic BP determined using an 
imputation equation that I identified and applied at no additional cost, may 
enhance the ability to detect end-organ changes. In support of the value of the 
findings described in the present thesis, the data presented in chapters 2 and 3 
have been published in the Journal of Hypertension  31(6), 1124-1130 (Chapter 
2)(Booysen et al 2013) and Hypertension 65(3), 540-546 (Chapter 3)(Booysen et 
al 2015) respectively. The data provided in the other chapters are currently in 
preparation for submission to international journals for review (Chapter 4) or 
currently under-review (Chapter 5). 
The present thesis is written as a series of semi-independent chapters, 
each with its own introduction, methods, results and discussion section. The thesis 
begins with a review chapter which highlights the current understanding and 
controversies in the field and leads the reader through a series of arguments in 
support of conducting the studies described in the present thesis. Furthermore, 
the present thesis concludes with a summary chapter which consolidates the 
findings of each chapter and underscores the novelty of the findings by placing the 
studies in the context of our present understanding of the field.  
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Chapter 1  
 
Introduction 
 
           Current Understanding and Controversies in Pre-hypertension 
and Central Aortic Haemodynamics 
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1.0 Introduction 
 
 
Cardiovascular disease (CVD) includes a wide variety of clinical conditions such as 
myocardial infarction (MI) (ne coronary heart disease [CHD] or coronary artery disease 
[CAD]), stroke, heart failure, peripheral vascular disease and renal failure, which often 
share common risk factors. In 2005, 17.5 million deaths worldwide were attributed to CVD 
(Mendis et al 2007) and current estimates are that CVD will account for 25 million deaths 
per year by the year 2020 (Yusuf et al 2001). At a global level, CVD by far exceeds other 
causes of death, contributing overall to 30% of deaths and this contribution is thought to 
be increasing every year (Mendis et al 2007). Urbanisation, globalisation and ageing 
populations are the major causes of the increasing prevalence of CVD. Whilst in the 
previous century, CVD was mainly a disease of the developed world, presently, of all 
deaths caused by CVD, 80% occur in low-to-middle income countries (Mendis et al 2007) 
such as South Africa. What is our current understanding of the contribution of CVD to 
death rates in South Africa and is there a prevalent risk factor? 
In South Africa, CVD is the leading cause of death in the elderly; and the third most 
common cause of death in younger age groups in rural communities of African ancestry 
(Tollman et al 2008). Cardiovascular disease probably accounts for substantially more 
deaths in black African communities in urban areas in South Africa. Current estimates are 
that hypertensive heart disease is the 2nd, and cerebrovascular disease is the 5th most 
common cause of death in South Africa (South African Medical Research Council Causes 
of Death Report, 2014). Hypertension is the most important risk factor for CVD in groups 
of black African ancestry in South Africa (Rayner 2010). In urban communities of African 
ancestry in South Africa, hypertension may account for up to a third of heart failure cases 
(Stewart et al 2008), hypertension is strongly associated with MI (Steyn et al 2005), and 
hypertension is the major risk factor for strokes (Conner et al 2009, O’Donnell et al 2010). 
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Hence, a critical target for CVD prevention and consequently prevention of overall death 
rates in black South African communities is control of blood pressure (BP). 
Presently, the diagnosis of hypertension is based on brachial BP thresholds that 
best predict cardiovascular outcomes and which, when BP is treated to below these 
targets produce significant decreases in CVD. These thresholds are 140/90 mm Hg, and 
whilst some recent guidelines advocate higher thresholds for the elderly (Kjeldsen et al 
2014), and lower thresholds for many patients with co-morbidities such as diabetes 
mellitus or renal disease (Kjeldsen et al 2014), these thresholds have been adopted by 
more recent guidelines and for most patient populations (Kjeldsen et al 2014). However, 
BP is a continuous trait and several studies have demonstrated that independent of 
confounders CVD occurs well below these thresholds and that a significant proportion of 
cardiovascular deaths may occur in the normal (BP=120-129/80-84 mm Hg) or high-
normal (BP=130-139/85-89 mm Hg) BP ranges (Hsia et al 2007, Conen et al 2007, 
Dorjgochoo et al 2009, Qureshi et al 2005, Vasan et al 2001, Blake et al 2003, Liszka et al 
2005, Gu et al 2009, Zhang et al 2006, Butler et al 2011, Kshirsagar et al 2006, Lewington 
et al 2002), that is in the pre-hypertensive BP range. However, intervention studies 
evaluating the effect of antihypertensive treatment to lower than currently accepted 
thresholds (140/90 mm Hg) have produced contrasting outcomes (Law et al 2009, 
Cushman et al 2010, Nissen et al 2004, McMurray et al 2010, Remme et al 2009, 
Staessen and Jiguang 2001, Yusuf et al 2008, Schrier et al 2002, Trialists Collaboration 
2003, Patel 2007, Cooper-DeHoff et al 2010). Hence the current thresholds of 140/90 mm 
Hg for the diagnosis and treatment of hypertension have remained in recent guidelines 
(Kjeldsen et al 2014). The consequence is that there may be a considerable number of 
individuals (one quarter of any community may have BP values in the normal/high-normal 
range) at risk of a BP-related cardiovascular event whom would not receive 
antihypertensive therapy. One possible explanation for discrepant results obtained from 
intervention studies evaluating the effect of antihypertensive treatment to lower than 
currently accepted thresholds (Law et al 2009, Cushman et al 2010, Nissen et al 2004, 
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McMurray et al 2010, Remme et al 2009, Staessen and Jiguang 2001, Yusuf et al 2008, 
Schrier et al 2002, Trialists Collaboration 2003, Patel 2007, Cooper-DeHoff et al 2010), is 
that not all with a BP below 140/90 and above 120/80 mm Hg (pre-hypertensives) are at 
risk of a cardiovascular event. The question that obviously arises is whether there is an 
approach that may be adopted which may identify those who have brachial BP values 
below 140/90 mm Hg who are at risk of a BP-related cardiovascular event? 
Aortic BP is weIl-recognised as being lower than brachial BP, and because of the 
proximity of the aorta to cardiovascular target organs it has been hypothesised that aortic 
BP is more closely associated with cardiovascular damage than brachial BP. Indeed, 
several studies have shown that aortic BP is associated with end-organ changes 
(reviewed by Roman and Devereux 2014, Boutouyrie et al 1999, Covic et al 2000, Wang 
et al 2009, Roman et al 2010, Neisius et al 2012, Norton et al 2012, Wohlfahrt et al 2011) 
and cardiovascular outcomes (Safar et al 2002, Williams et al 2006, Wang et al 2009, 
Benetos et al 2010, Benetos et al 2012, Regnault et al 2012, Jankowski et al 2008, Pini et 
al 2008, Roman et al 2007, Roman et al 2009) better than or independent of brachial BP. 
In the present thesis I therefore hypothesised that aortic BP may better identify pre-
hypertensives at risk of cardiovascular damage (end-organ changes) than brachial BP 
thresholds (high-normal vs normal). As aortic reflected waves, which contribute to aortic 
BP, may also be associated with end-organ changes and cardiovascular outcomes 
independent of brachial BP (Hashimoto et al 2007, Hashimoto et al 2006, Weber et al 
2006, Westerbacka et al 2005, Sibiya et al 2014, London et al 2001, Ueda et al 2004, 
Weber et al 2005, Chirinos et al 2005a & b, Wang et al 2010, Chirinos et al 2012, Weber 
et al 2012, Zamani et al 2014), I also assessed whether aortic reflected waves may 
improve on the ability to identify pre-hypertensives at risk of cardiovascular damage (end-
organ changes). Prior to conducting the research necessary to evaluate this aim of in the 
present thesis, I first addressed the question of whether aortic reflected wave function, 
determined from aortic pressure augmentation or from the magnitude of backward wave 
pressures is more closely associated with age-related increases in aortic BP and end-
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organ damage across the adult lifespan. This question was evaluated as part of the 
present thesis as there is currently little clarity as to whether aortic augmentation indices 
do indeed closely approximate aortic reflected wave effects. As the cost of performing 
aortic BP measurements is presently too high to advocate for routine use in countries such 
as South Africa, I further evaluated whether aortic BP can be estimated using simple 
clinical measures and whether imputed aortic BP thresholds also better identify pre-
hypertensives at risk of cardiovascular damage (end-organ changes) than brachial BP 
thresholds (high-normal vs normal). 
As the present thesis is designed to answer the question as to whether current 
approaches to risk prediction can be enhanced in those with a BP in the normotensive 
range, in the first part of the present chapter I will review the evidence to show that pre-
hypertension predicts cardiovascular outcomes, and the evidence from intervention 
studies evaluating the effect of antihypertensive treatment to lower than currently 
accepted thresholds (140/90 mm Hg) that have produced discrepant outcomes. I will also 
discuss the arguments posed to suggest that pre-hypertension may be associated with 
CVD through mechanisms unrelated to BP or through increases in aortic BP. 
As I subsequently addressed the issue of whether aortic BP rather than brachial 
BP thresholds in pre-hypertension enhance the ability to detect end-organ changes, in the 
second part of the present chapter I will then review the evidence that aortic BP is 
associated with end-organ changes and cardiovascular outcomes better than or 
independent of brachial BP and provide reasons for these possible differences. In this 
section of the chapter I will highlight the factors that contribute to aortic BP that may not 
be detected by brachial BP measurements and suggest possible methods of estimating 
aortic BP that may be cost-effective in low-to-intermediate income countries. In this regard 
I will highlight the problems with previous studies that have employed these approaches 
and indicate how in the present thesis I addressed these problems. Importantly the 
present chapter is designed as a critical review that will lead the reader through a series 
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of arguments in favour of performing the studies described in the present thesis and will 
end with a summary of the problem statements and aims of the thesis. 
 
1.2.0 Pre-hypertension and cardiovascular disease 
 
As BP is a continuous trait and BP values as low as 115/75 mm Hg are positively 
related to cardiovascular outcomes (Lewington et al 2002), the concept of thresholds of 
BP that define the presence of hypertension and hence an increased risk for 
cardiovascular events, although necessary for clinical practice, is largely artificial. Indeed, 
over the past 3-4 decades the definition of hypertension has changed from threshold 
levels of 160/100 mmHg or even higher to values of 140/90 mm Hg or even lower 
(Ventura et al 2001). In 2003, the 7th Joint National Committee guidelines on the 
Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) 
acknowledged that those with a BP>120 mm Hg and <140 mm Hg systolic BP (SBP); or 
>80 mm Hg<90 mm Hg diastolic BP (DBP) were at an increased risk of CVD (Chobanian 
et al 2003). The JNC 7 called this BP category ‘pre-hypertension’ (Chobanian et al 2003) 
largely because it is well-recognized that those with pre-hypertension are more likely to 
develop BP values within hypertensive ranges (Moreira et al 2008) and that the early 
lowering of BP reduces the chances of progressing to hypertension (Julius et al 2006, 
Luders et al 2008). However, more recently, the terms normal BP (SBP≥120 mm Hg<130 
mm Hg; DBP≥80 mm Hg<85 mm) and high-normal BP (SBP≥130 mm Hg<140 mm Hg; 
DBP≥85 mm Hg<90 mm) have been employed to replace the term pre-hypertension 
(Mancia et al 2007). 
The classification of normal and high-normal BP categories (pre-hypertension) was 
specifically designed to increase awareness of those individuals with a BP within this 
range who should receive advice to adopt a healthier lifestyle, in order to decrease their 
risk for a cardiovascular event, attenuate the rate of progression to hypertension or 
prevent hypertension completely and in turn decrease the risk of CVD (Chobanian et al 
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2003, Mancia et al 2007). However, JNC 7 did not recommend that antihypertensive 
therapy should be employed in those whose BP lies within the pre-hypertensive range 
(Chobanian et al 2003). However, the European Society of Hypertension (ESH) 
recommended antihypertensive therapy even within these BP ranges if overall risk is 
sufficiently high to warrant even further lowering of BP (Mancia et al 2007). In this respect, 
the presence of CVD, diabetes mellitus, renal disease, the metabolic syndrome or end-
organ changes together with the presence of pre-hypertension was regarded as sufficient 
reason to initiate antihypertensive therapy (Mancia et al 2007). However, there is still 
considerable uncertainty as to whether pre-hypertension even in those at a high risk 
warrants antihypertensive therapy. Indeed, most recent guidelines recognise that drug 
therapy should only be initiated at or above BP levels of 140/90 mm Hg (Kjeldsen et al 
2014). What is the evidence that pre-hypertension is associated with an increased 
cardiovascular risk and why is there still ongoing debate and uncertainty as to whether 
pre-hypertension warrants BP lowering with antihypertensive medication? 
 
1.2.1 Pre-hypertension is associated with cardiovascular events 
 
As previously alluded to, evidence derived from large longitudinal studies indicates 
that a linear relationship exists between BP and cardiovascular (CV) risk (Lewington et al 
2002). In this regard, a 2-fold increase in mortality occurs with each 20 mm Hg SBP or 10 
mm Hg DBP, or both, increase above BP values of 115/75 mm Hg (Lewington et al 2002). 
Hence, there is significant evidence that CV risk increases from optimal BP levels 
(<120/80 mm Hg) to pre-hypertensive ranges. Indeed, several large prospective, 
observational studies have demonstrated the risk for CVD and death in normal and high-
normal BP ranges as compared to optimal BP ranges (Table 1.1) (Vasan et al 2001, 
Liszka et al 2005, Qureshi et al 2005, Hsia et al 2007, Conen et al 2007, Gu et al 2009, 
Blake et al 2003, Dorjgochoo et al 2009, Kshirsagar et al 2006, Butler et al 2011,  
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Table 1.1. Summary of important characteristics of prospective, observational studies evaluating the impact of normal-high normal blood pressures (BP) on 
cardiovascular outcomes and mortality. 
Reference  Blood Pressure      N  Median  N of events  Outcomes  Result   Adjustments 
   Range     Follow-up        HR / RR (95% CI) 
Hsia et al 2007 Normal & High Normal  21 187# 7.7 years 219   CD   HR 1.58(1.12-2.21) Age, BMI, diabetes 
          407   Strokes   HR 1.93(1.49-2.50) Smoking, High Chol  
          351   CHF   HR 1.36(1.05-1.77) 
          442   MI   HR 1.76(1.40-2.22) 
Conen et al 2007 Normal   11 326# 10.2 years 176   CVE   HR 0.61(0.48-0.76) Age, smoking, drinking,  
           85   Stroke   HR 0.74(0.53-1.03) diabetes, HCL, exercise,  
           70   MI   HR 0.50(0.36-0.71) education, BMI   
           37   CD   HR 0.65(0.39-1.06 Treatment regime 
           123   CR   HR 0.49(0.38-0.64) 
    High Normal  4 988#    159   CVE   HR 1.0    
           63   Stroke   HR 1.0      
           77   MI   HR 1.0     
           32   CD   HR 1.0      
           140   CR   HR 1.0                                                                          
Dorjgochoo et al 2009 Normal & High Normal 26 689  5 years  527   All-Cause Mortality HR 0.86(0.75-0.99) Education, waist-to-hip ratio, 
            64   Stroke Mortality  HR 1.65(0.98-2.78) smoking, history of CVD, 
          19   CHD Mortality  HR 0.74(0.35-1.57)         history of diabetes 
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Table 1.1 Continued 
Reference  Blood Pressure      N  Median  N of events  Outcomes  Result   Adjustments 
   Range     Follow-up        HR / RR (95% CI) 
Qureshi et al 2005 Normal & High Normal 2 127  9.9 years 24   ABI   RR 2.2(0.5-9.3)  Age, sex, smoking, obesity, 
            56   Strokes   RR 2.3(0.8-6.3)  diabetes, HChol, Study   
         138   MI   RR 3.5(1.6-7.5)  period    
          285   CAD   RR 1.7(1.2-2.4) 
Mainous III et al 2004 Normal    9 087  12.8 years -   All-cause Mortality      HR 0.82(0.60-1.13) Age, Race, sex, smoking, 
            -   CVD mortality  HR 0.99(0.66-1.50) BMI, activity, TChol,  
      High Normal      -   All-cause Mortality      HR 0.97(0.74-1.27) diabetes, HF. HA, Stroke  
          -    CVD mortality                HR 1.19(0.82-1.71)                                                                                                                  
Vasan et al 2001 Normal   3 979  11.1 years 40#   CVE#   HR 1.1(0.6-2.0)  Age, BMI, smoking, TChol, 
             96+   CVE+   HR 1.3(1.1-2.3)  Diabetes 
   High Normal      72#   CVE#   HR 1.8(1.0-3.1)    
          108+   CVE+   HR 1.6(1.1-2.3) 
Blake et al 2003 Normal   15 215# 8.1 years -   CVE   HR 1.39(-)  Asprin, Vitamin E, Age,  
     High Normal      -   CVE   HR 2.45(-)  BMI, smoking, LDL, HDL, 
        diabetes 
Liszka et al 2005 Normal    2 708  18 years -   MI, Stroke, CHF HR 1.24(0.96-1.59) Age, race, sex, smoking,  
    High Normal      -   MI, Stroke, CHF HR 1.42(1.09-1.84) BMI, exercise, TChol, 
                    diabetes, CHF, MI, stroke 
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Table 1.1 Continued 
Reference  Blood Pressure     N  Median  N of events  Outcomes  Result   Adjustments 
   Range     Follow-up        HR / RR (95% CI) 
Pednekar et al 2009 Normal    56 996   5.5 years 1 921+   Mortality+           HR 0.91(0.84-0.98) Age, education, religion, 
            521+   Circ Sys death+  HR 1.11(0.95-1.29) Smoking, BMI 
          41+   HYP disease death+ HR 0.91(0.55-1.53) Mother Tongue    
          338+   IHD death+  HR 1.19(0.97-1.45) 
          78+   Cerebrovascular death+ HR 1.16(0.78-1.74) 
          392#   Mortality#  HR 0.74(0.65-0.85)     
          80#   Circ Sys death#  HR 0.70(0.52-0.95)    
          12#   HYP disease death# HR 0.69(0.32-1.47)     
          39#   IHD death#  HR 0.73(0.47-1.14) 
          10#   Cerebrovascular death# HR 0.51(0.23-1.13)     
   High Normal      1 135+   Mortality+           HR 0.99(0.91-1.07)    
            333+   Circ Sys death+  HR 1.18(0.99-1.39)    
          36+   HYP disease death+ HR 1.26(0.74-2.15)     
          189+   IHD death+  HR 1.11(0.89-1.38) 
          70+   Cerebrovascular death+ HR 1.73(1.15-2.61) 
          337#   Mortality#  HR 0.98(0.85-1.13)     
          87#   Circ Sys death#  HR 1.08(0.80-1.45)     
          14#   HYP disease death# HR 1.06(0.51-2.21)     
          44#   IHD death#  HR 1.15(0.75-1.78) 
          16#   Cerebrovascular death# HR 1.19(0.59-2.41) 
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Table 1.1 Continued 
Reference  Blood Pressure      N  Median  N of events  Outcomes  Result   Adjustments 
   Range     Follow-up        HR / RR (95% CI) 
 
Gu et al 2009  Normal & High Normal 58 569   10 years 3556   CVD   RR 1.34(1.27-1.42) Age, sex, education, 
                2316   CVD mortality  RR 1.22(1.15-1.30) smoking, Alcohol, activity, 
               634   CHD   RR 1.32(1.16-1.50)  HYP, BMI, history of CVD,  
            384   CHD mortality  RR 1.47(1.23-1.75) diabetes, geographic region, 
          2021   Stroke   RR 1.72(1.59-1.86) Urbanization, anti- 
          971   Stroke mortality  RR 1.67(1.50-1.86) Hypertensive treatment 
Zhang et al 2006 Normal & High Normal 2 629  12 years 97   CVD   HR 1.80(1.28-2.54) Age, Sex, gender, BMI, 
                   Waist circumference, LDL 
                   Chol, HDL Chol, Trig, activity 
                   Smoking, alcohol use 
Butler et al 2011 Normal & High Normal 1 765  10 years -   HF   HR 1.63(1.23-2.16) Cohort, sex, race, age, BMI 
                   History of CAD, smoking 
                   Diabetes, LVH, Hr, fasting 
                   Glucose, creatinine, albumin,  
                   TChol, LDL Chol, HDL Chol, 
                   Trig 
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Table 1.1 Continued 
Reference  Blood Pressure      N  Median  N of events  Outcomes  Result   Adjustments 
   Range     Follow-up        HR / RR (95% CI) 
Kshirsagar et al 2006 Normal   2 059  11.6 years 221   CVD   HR 1.69(1.37-2.02) Center, age, race, sex, BMI, 
          192   CHD   HR 1.70(1.35-2.13) diabetes, smoking, LDL,  
          38   Stroke   HR 1.53(0.92-2.54) education, sport index, Chol 
   High Normal  1 279    158   CVD   HR 2.33(1.85-2.92) medication, fibrinogen, HDL, 
          136   CHD   HR 2.44(1.92-3.12) von Willebrand factor, WBC 
          25   Stroke   HR 1.31(0.70-2.45)  
 
CVE; Cardiovascular event, CR; coronary revascularisation, CD; Cardiovascular death, Chol; Cholesterol, BMI; body mass index, HChol; Hypercholesterolemia, LDL; low-density 
lipoprotein; HDL; high-density lipoprotein, Trig; Triglycerides, CVD; cardiovascular disease, CHF; congestive heart failure, MI; Myocardial infarction, HYP; hypertensive, ABI; 
Atherothrombotic brain infarction, CAD; coronary artery disease, HF; Heart failure, HA; Heart attack,  TChol; Total cholesterol, CHD; Coronary heart disease,  #; Female, +; Male, Circ 
Sys; Circulatory system, IHD; Ischemic heart disease, HR; Hazard Ratio, RR; Relative risk, Hr; Heart rate, LVH; Left ventricular hypertrophy, WBC; White blood cell count.  
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Zhang et al 2006). In this regard, in 23 706 women, pre-hypertension predicted CVD 
including MI, stroke, heart failure and CV death and these relations were noted 
independent of age, body mass index (BMI), diabetes, high cholesterol concentrations, 
smoking, drinking and activity level (Hsia et al 2007). Further, in the Framingham Heart 
Study pre-hypertension predicted an increased incidence of CAD, MI, atherothrombotic 
brain infarction, cardiovascular death, and congestive heart failure, but not strokes, 
independent of age, BMI, smoking, diabetes, sex, cholesterol and obesity (Qureshi et al 
2005). In the Atherosclerosis Risk in Communities (ARIC) study both normal and high-
normal BP predicted an increased risk of CVD, CHD, and strokes independent of many 
confounding variables (Kshirsagar et al 2006). Moreover, in 38 322 woman free of 
cardiovascular disease, cancer or other major illness, a high-normal BP was associated 
with an increased cardiovascular risk (Conen et al 2007). In the 1991 China National 
Hypertension Survey, after 10 years of follow-up, pre-hypertension was related to an 
increased risk of CVD (MI, stroke, cardiovascular death) independent from age, sex, 
education, alcohol, activity, treatment for hypertension, BMI, diabetes, geographic region 
and urbanization (Gu et al 2009). In the Strong Heart Study, after 12 years of follow-up, 
pre-hypertensive participants free from CVD at baseline had an 80% increased risk of 
incident CVD (Zhang et al 2006). Participants with pre-hypertension have also been 
reported to have a 63% increased risk of incident heart failure as compared to those with 
an optimal BP (Butler et al 2011). Pre-hypertension in a United States cohort was similarly 
associated with major cardiovascular events independent of any other cardiovascular risk 
factor (Liszka et al 2005). Importantly, the risk for CVD appears to be stronger in the high-
normal as compared to the normal BP range (Vasan et al 2001). Indeed, in Chinese 
woman, after a five year follow-up period, a high-normal, but not a normal BP was 
associated with stroke mortality (Dorjgochoo et al 2010). Moreover, the predictive value of 
pre-hypertension for cardiovascular events is additive to that of inflammation as assessed 
from C-reactive protein concentrations (Blake et al 2003). 
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Have all studies demonstrated that pre-hypertension is associated with the risk of 
CVD? In the NHANES II (National Health and Nutrition Examination Survey) and NHANES 
II Mortality Study, pre-hypertension was not associated with an increased risk of all-cause 
mortality or cardiovascular disease (Mainous III et al 2004). Furthermore, in a study 
conducted in Mumbai, India in 56 996 participants, although hypertension was, a normal 
and high normal BP were not associated with all-cause mortality, circulatory system 
related death, death caused by hypertension, or ischemic heart disease (Pednekar et al 
2009). However, in this study a high normal but not normal BP was related to an increased 
risk of deaths caused by cerebrovascular disease (Pednekar et al 2009). 
 
1.2.2 Does the treatment of pre-hypertension with antihypertensive therapy reduce 
cardiovascular event rates? 
 
A higher level of evidence to support a role for pre-hypertension as a cause of CVD 
would come from intervention studies where the impact on CVD is assessed when BP is 
decreased to values considered to be lower than what would normally be achieved if the target 
was 140/90 mm Hg. These studies have been summarised in Table 1.2 (Law et al 2009, 
Cushman et al 2010, Nissen et al 2004, McMurray et al 2010, Remme et al 2009, Staessen 
and Jiguang 2001, Yusuf et al 2008, Schrier et al 2002, Trialists Collaboration 2003, Patel 
2007, Cooper-DeHoff et al 2010). 
Several studies have reported on the impact of BP lowering in hypertensives to values 
considered far lower than current thresholds. In this regard, in a meta-analysis of 29 
randomised clinical trials consisting of 162 341 participants, the authors noted that irrespective 
of baseline BP the greater the reduction of BP to values far below current BP thresholds of 
140/90 mm Hg, the greater the decrease in the risk of all major cardiovascular events (Trialists 
Collaboration 2003). Moreover, in a further randomised, controlled trial, a significant reduction 
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Table 1.2. Characteristics of intervention studies where the impact of blood pressure BP lowering to values well below current thresholds for the diagnosis of 
hypertension on cardiovascular outcomes and mortality were assessed. 
Authors    Sample size Study design Duration Average  BP Achieved  Result   Outcome  Adjustors 
(Population Group)      Follow-up drop in BP (mm Hg)    evaluated 
               (Sys/Dia mm Hg) 
Law et al 2009   464 000 Rand trials -  6/3  <120 Sys Reduced risk  CHD, Stroke  BP reduction 
(No CVD, Normotensive)          <80 Dia       
Cushman et al 2010  4 733  Rand trial 5 years  19.9 Sys <120 Sys No effect on risk MI, Stroke, Death Unadjusted 
(Type 2 diabetics, normotensive) 
Nissen et al 2004   1991  Double blind 2 years  4.85/2.45 <125 Sys Reduced risk  CD, MI, CR, HAn Unadjusted 
(With CAD, normotensive)    Rand con trial     <80 Dia     HCHF, Stroke, PVD 
McMurray et al 2010  9 306  Double blind 5 years  6.3 Sys  <130 Sys No effect on risk CD, MI, Stroke, HCHF Unadjusted 
(Impaired Glucose Tolerance   Rand trial     <80 Dia     CR, Han 
& one CV risk factor, normotensive)    
Remme et al 2009   12 218  Double blind 4.2 years 5/2  <120 Sys Reduced risk  CD, MI, RCA  Start SBP, age,  
(With CAD, normotensive)    Rand trial     <80 Dia        sex, diabetes 
                     Treatment  
                        Regime 
Staessen and Jiguang 2001 1 587  Double blind 4 years  9/4  <130 Sys Reduced risk  Stroke, VE, Mortality Unadjusted 
(History of Stroke or TIA, normotensive)  Rand trial     <80 Dia 
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Table 1.2. Continued 
Authors    Sample size Study design Duration Average  BP Achieved  Result   Outcome  Adjustors 
(Population Group)      Follow-up drop in BP (mm Hg)    evaluated 
        (Average)    (Sys/Dia mm Hg) 
 
Yusuf et al 2008   3 413  Two-by-two 2.5 years 8.3 Sys  <130 Sys No effect on risk Stroke, CVE  Age, diabetes 
(Ischemic Stroke, normotensive)   Factorial             Treatment 
                     Rankin scale  
Schrier et al 2002   480  Rand con 5.3 years 10 Dia  <130 Sys Reduced risk  Stroke   Unadjusted 
(Normotensive diabetics)    trial      <80 Dia  
 
Trialists Collaboration 2003  162 341 Rand con 700 000 $ various  various  Reduced risk  Stroke, CHD, HF, CVE Unadjusted 
(Hypertensive)     Trial           CD, Total mortality 
Patel 2007    4 567 NT Rand con 4.3 years 5.6/2.2  various  Reduced risk  CVE, Deaths  Unadjusted 
(Type II Diabetics, hypertensive &   Trial  24 005 $    
Normotensive) 
Cooper-DeHoff et al 2010  6400  Prospective, 16 893 $ 22.5 Sys <130 Sys Reduced risk  All-cause mortality Age, race, sex,  
(With diabetes & CAD,     Rand trial        below 110 mm Hg MI & Stroke  history of MI, HF 
Hypertensive)       
   
  
 
Rand; Randomised, $; Patient years, con; Controlled, Sys; Systolic, Dia; Diastolic, MI; Myocardial Infarct, CD; Cardiovascular death, HAn; Hospitalisation for Angina, HCHF; 
Hospitalisation for congestive heart failure, PVD; Peripheral vascular disease, CHD; Coronary heart disease, RCA; Resuscitated cardiac arrest, SBP; Systolic blood pressure, VC; 
Vascular event, LVH; Left ventricular hypertrophy, HF; Heart failure, CVE; Cardiovascular events, TIA; Transient ischaemic attack. NT; Normotensive    
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in mortality was only evident among patients with a SBP below 110 mm Hg (Cooper-
DeHoff et al 2010). 
With respect to studies specifically reporting on the impact of antihypertensive 
therapy in normotensive participants, in the largest meta-analysis conducted to-date, a 10 
mm Hg drop in SBP and a 5 mm Hg drop in DBP reduced the risk of CHD and stroke 
across all BP ranges including NT ranges (Law et al 2009). In the “Perindopril Protection 
Against Recurrent Stroke Study” (PROGRESS), antihypertensive treatment reduced the 
risk of stroke in hypertensive and non-hypertensive participants (Staessen and Jiguang 
2001). In a small study conducted in 480 diabetic pre-hypertensive participants, where 
DBP was decreased by more than 10 mm Hg, therapy reduced the incidence of stroke, 
but not MI, congestive heart failure (CHF), CHD, or all-cause mortality (Schrier et al 2002). 
Furthermore, in normotensives, perindopril in the “European Trial on Reduction of Cardiac 
Events with Perindopril in Stable Coronary Artery Disease’’ (EUROPA) study reduced the 
risk of cardiovascular death, non-fatal MI and cardiac arrest in patients with a history of 
CHD (Remme et al 2009). In the EUROPA study, the greatest risk reduction in 
cardiovascular events from anti-hypertensive treatment was noted in patients with BP 
values in the optimal range (<120/80 mm Hg) (Nissen et al 2004). In addition, in pre-
hypertensive participants, a BP reduction of ±5/2.5 mm Hg was reported to reduce all 
cardiovascular events (angina, strokes, CHF, MI) (Nissen et al 2004). Moreover, in 
normotensive and hypertensive type 2 diabetic participants, treatment with anti-
hypertensive agents for an average of 4.3 years resulted in a reduction in major vascular 
events (coronary events, cerebrovascular events, renal events, eye events) and 
cardiovascular deaths irrespective of baseline BP (Patel 2007). 
In contrast to the evidence to suggest that lowering BP well below 140/90 mm Hg 
produces benefits, several studies nevertheless show a lack of risk reduction with 
antihypertensive therapy in the pre-hypertensive range (McMurray et al 2010, Yusuf et al 
2008, Cushman et al 2010). In this regard, in pre-hypertensives, BP lowering for 5 years 
showed no risk reduction for MI, cardiovascular death, strokes, angina, heart failure and 
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arterial revascularization (McMurray et al 2010). Further, in a relatively short follow-up 
study of 2.5 years, antihypertensive treatment failed to reduce recurrent strokes or major 
cardiovascular events in the normotensive BP range (Yusuf et al 2008). Moreover, in 
those in whom BP was reduced to below 120/80 mm Hg, the same risk for major 
cardiovascular events was noted as compared to participants in whom BP was lowered to 
below 140/90 mm Hg (Cushman et al 2010).  
Thus, meta-analyses of several clinical studies provide evidence that there may be 
significant benefits derived from decreasing BP no matter what the initial BP category and 
that the benefit may occur in those where the initial BP values are well within the pre-
hypertensive range. However, although some randomised, controlled, clinical trials 
support the notion that decreasing BP to values that would be considered well below 
current BP thresholds provide benefits (Nissen et al 2004, Remme et al 2009, Staessen 
and Jiguang 2001, Schrier et al 2002, Patel 2007, Trialists Collaboration 2003, Law et al 
2009, Cooper-DeHoff et al 2010), not all intervention studies show the same benefit. 
Indeed, several trials do not support a role for BP as a cause of CVD in pre-hypertension 
(Yusuf et al 2008, Cushman et al 2010, McMurray et al 2010). Thus, several intervention 
studies suggest that brachial BP in the pre-hypertensive range may not be a factor 
involved in contributing significantly to overall CV risk in these individuals. However, one 
must consider that intervention studies in pre-hypertension have been conducted over 
relatively short periods and hence there still remains the possibility that longer periods of 
BP reduction may have uncovered beneficial effects on CVD in those studies that failed to 
show benefit. 
 
1.2.3 Impact of lifestyle modification on pre-hypertension and cardiovascular disease in 
pre-hypertension. 
 
 Several studies show that modifying lifestyle with exercise, weight loss and dietary 
changes lowers BP in pre-hypertension. In this regard, the Dietary Approaches to Stop 
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Hypertension (DASH) trial showed that a healthy diet of fruits, vegetables and dairy 
products lowered BP by 5.5/3.0 (SBP/DBP) mm Hg overall and 3.5/2.1 mm Hg in pre-
hypertensives (Appel et al 1997). Further, in 2082 ethnically diverse pre-hypertensives, 
therapeutic lifestyle changes including exercise, nutritional changes, weight management, 
stress management and smoking cessation decreased SBP by 7 mm Hg and DBP by 6 
mm Hg (Bavikati et al 2008). Importantly however, do lifestyle-related BP changes 
translate into a decreased CVD in pre-hypertension? In this regard, in a 10-15 year follow-
up study, decreasing sodium intake reduced the risk of CVD including MI, stroke and CV 
related death in middle-aged pre-hypertensives (Cook et al 2007). Whether these benefits 
of salt reduction could be attributed to a decrease in BP is nevertheless uncertain (Cook et 
al 2007). Considering that the benefits of salt reduction on CVD are thought to be largely 
attributed to BP effects, we assume that BP did indeed explain the benefits of salt 
reduction on BP. However, why BP lowering with a reduced salt intake reduces CV risk in 
pre-hypertensives (Cook et al 2007), whereas BP lowering with antihypertensive therapy 
is unable to achieve risk reduction in some studies (Yusuf et al 2008, Cushman et al 2010, 
McMurray et al 2010) remains unexplained. 
 
1.2.4 Other non-blood pressure-related factors could account for an increased 
cardiovascular risk in pre-hypertension? 
 
If brachial BP indeed does not account for CV risk in pre-hypertension, what then 
may contribute toward the well-described increased CV risk in the normal-high normal BP 
range? Several studies provide consistent evidence that pre-hypertension is associated 
with CV risk factors other than BP levels above optimal values. These risk factors include 
obesity, dyslipidaemia and diabetes mellitus. In this regard, the National Health and 
Nutrition Examination Survey (NHANES) 1999-2000 study demonstrated that 64% of 
individuals with pre-hypertension had at least one other concomitant CV risk factor 
(Greenlund et al 2004). In the same study in those older than 60 years of age with pre-
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hypertension, 94% of participants had at least one other concomitant CV risk factor 
(Greenlund et al 2004). In the NHANES II mortality study, 90% of pre-hypertensives had at 
least one other CV risk factor (Mainous III et al 2004). In 36 424 participants, in whom 
51% males and 36% females had pre-hypertension the pre-hypertensives had higher 
blood concentrations of glucose, low-density lipoprotein (LDL) cholesterol, total 
cholesterol, and triglycerides, lower high-density lipoprotein (HDL) cholesterol 
concentrations, and a higher BMI (Grotto et al 2006). Moreover, after 12 years of follow-
up, participants with pre-hypertension developed more diabetes mellitus as compared to 
participants with optimal BP levels (Zhang et al 2006). 
Inflammatory markers associated with an enhanced risk of CVD also increase in 
pre-hypertension (King et al 2004, Chrysohoou et al 2004). Indeed, in the NHANES III and 
ATTICA epidemiological studies, (in the ATTICA study participants were enrolled from the 
Attica area of Greece), higher blood concentrations of C-reactive protein (King et al 2004, 
Chrysohoou et al 2004), tumour necrosis factor-α, amyloid-α, and homocysteine and 
higher white blood cell counts (Chrysohoou et al 2004) were noted in pre-hypertensives as 
compared to those with optimal BP levels. Thus, there is considerable evidence to suggest 
that the association between pre-hypertension and CVD may be through other risk factors. 
Is there evidence to show that pre-hypertension is indeed associated with cardiovascular 
damage or CVD through associations with risk factors other than BP? 
 
1.2.5 Associations between pre-hypertension and cardiovascular damage may be 
accounted for by risk factors other than blood pressure. 
 
 Work from our group was the first to show that although marked cardiovascular 
end-organ changes are noted in pre-hypertension, that these changes do not persist when 
adjustments for risk factors other than BP are made in multivariate regression models 
(Norton et al 2008). Although subsequent studies suggest that risk factors other than BP 
do not fully account for end-organ changes in pre-hypertension, the quality of office BP 
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measurements was not reported in that study (Kim et al 2011). In contrast, we have 
reported high quality office BP measurements employed to define pre-hypertension 
(Norton et al 2008, Woodiwiss et al 2009). Our laboratories data (Norton et al 2008) 
therefore provided a possible explanation as to relationships between pre-hypertension 
and cardiovascular damage that may not be modified by BP lowering therapy. However, 
evidence to suggest that relationships between pre-hypertension and CVD can be 
explained by associated risk factors is missing. Previously described relationships 
between pre-hypertension and CVD have largely been adjusted for confounding variables 
including associated risk factors (Table 1.1), but only one study adjusted for the increases 
in inflammatory markers that may be noted in pre-hypertension. Further, as discussed in 
section 2.3 why BP lowering with a reduced salt intake reduces CV risk in pre-
hypertensives (Cook et al 2007), whereas BP lowering with antihypertensive therapy is 
unable to achieve risk reduction in some studies (Yusuf et al 2008, Cushman et al 2010, 
McMurray et al 2010) remains unexplained. 
 
1.2.6 Pre-hypertensives have aortic blood pressures that lie within hypertensive or 
optimal BP ranges. 
 
 An alternative explanation for the relationship between pre-hypertension and CVD 
which cannot consistently be modified through BP lowering therapy is that considerable 
overlap occurs in aortic BP across categories of optimal, pre-hypertensive (normal or high-
normal) and hypertensive BP ranges (McEniery et al 2008). In this regard, as shall be 
discussed in the following sections of the present chapter, aortic SBP may be considerably 
lower than brachial SBP and possibly because of the closer proximity of the aorta as 
opposed to the brachial artery to cardiovascular target organs, aortic BP has been 
demonstrated in several populations to predict outcomes better than brachial BP (Safar et 
al 2002, Roman et al 2007, Roman et al 2009, Jankowski et al 2008, Pini et al 2008, 
Wang et al 2010, Benetos et al 2010, Regnault et al 2012, Benetos et al 2012). As a 
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significant proportion of pre-hypertensives may have aortic SBP values within the range 
normally found in hypertensives (McEniery et al 2008), these individuals may be at a high 
risk of CVD. In contrast, as a significant proportion of pre-hypertensives may have aortic 
SBP values within the range normally found in individuals with optimal BP levels 
(McEniery et al 2008), these individuals may be at a low risk of CVD. Hence, the use of 
brachial BP to risk stratify in pre-hypertensives may be inaccurate. Further, the impact of 
antihypertensive therapy on aortic as compared to brachial BP may differ (Agabiti-Rosei et 
al 2007). Thus when lowering brachial BP in pre-hypertensives with antihypertensive 
therapy, the effect on those BP values that may be responsible for cardiovascular end-
organ changes (aortic BP) may not be accurately predicted from brachial BP changes. 
 As considerable overlap occurs in aortic BP across categories of optimal, pre-
hypertensive (normal or high-normal) and hypertensive BP ranges (McEniery et al 2008) 
and because aortic rather than brachial BP may be more representative of BP values 
responsible for cardiovascular damage (Safar et al 2002, Roman et al 2007, Roman et al 
2009, Jankowski et al 2008, Pini et al 2008, Benetos et al 2010, Wang et al 2009, 
Regnault et al 2012, Benetos et al 2012), in the present thesis I first hypothesised that 
aortic BP values may better identify pre-hypertensives with cardiovascular damage. In this 
regard, in chapter 2 I describe these data which have been published in the Journal of 
Hypertension (Booysen et al 2013). As I was able to show that aortic BP best identified 
pre-hypertensives with end-organ changes, I subsequently evaluated whether these 
effects are attributed to aortic reflected waves (Chapter 4). This question was addressed 
in order to try and identify whether aortic reflective wave indices may further refine the 
ability to identify end-organ changes and hence possibly cardiovascular risk in pre-
hypertension. 
As a consequence of the aforementioned questions that have been addressed in 
the present thesis, in the following section of this chapter I will subsequently review the 
evidence to show that aortic BP may be more closely associated with, or a better predictor 
of cardiovascular damage than brachial BP, or may be associated with or predict 
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cardiovascular damage independent of brachial BP. Furthermore, I will then review the 
evidence to suggest that aortic reflected wave indices may further risk stratify and the 
evidence to indicate whether antihypertensive therapy reduces forward or reflected wave 
pressures. In the process of reviewing this evidence I will highlight current controversies 
as to the role of forward and reflected waves in contributing to aortic BP and 
cardiovascular damage and describe how, in the present thesis, I addressed these issues 
prior to assessing whether the use of reflected wave indices further refine the ability to 
identify end-organ changes in pre-hypertension (Chapter 3). In this regard, this work has 
resulted in the acceptance of a paper in the journal Hypertension (Booysen et al 2015), to 
be published in March 2015 (see reprint in appendix 3). Finally, as the devices for non-
invasive aortic BP measurement are presently far too expensive for routine use at a 
primary healthcare level in most African countries including South Africa, I also evaluated 
whether an equation that employs simple clinical measurements can be derived that may 
closely approximate aortic BP (Chapter 5) and whether this imputation equation may be 
applied to pre-hypertensives to better identify end-organ damage (Chapter 5). In this 
regard, data on the derivation of the imputation equation for aortic BP are presently under 
review for consideration of publication in the journal PLoS One. Hence, in the following 
section of this chapter I will also review the evidence to suggest that an equation that 
employs simple clinical measurements can be derived that may closely approximate aortic 
BP, and the evidence to show that such equations may be useful in cardiovascular risk 
prediction.  
 
1.3.0 Aortic versus brachial blood pressure. 
 
 Several large population-based studies have demonstrated that the most important 
risk factor for hypertension, that is advancing age, is associated with linear increases in 
SBP across the adult lifespan (Franklin et al 1997, US National Health Survey 1977, Burt 
et al 1995). In contrast, DBP increases until 50 years of age and then begins to decline 
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thereafter (Franklin et al 1997, US National Health Survey 1977, Burt et al 1995). These 
data (Franklin et al 1997, US National Health Survey 1977, Burt et al 1995) raise the 
question of whether SBP or DBP are more important in risk prediction. In comparison to 
DBP, the Framingham Heart Study showed in 5127 participants with a follow-up duration 
of 14 years, that SBP is a stronger predictor of cardiovascular risk than DBP (Kannel et al 
1971). In this regard, consistent with age-related changes in SBP and DBP most evidence 
points toward SBP being more important than DBP in cardiovascular risk prediction in the 
middle-aged to elderly, whilst DBP tends to be more important than SBP in young adults 
(Chobanian et al 2003, Mancia et al 2007). However, the only reason why in young adults 
DBP may be more important than SBP when risk predicting is because brachial SBP in 
young adults considerably overestimates aortic SBP (McEniery et al 2008), the BP which 
is thought to be responsible for cardiovascular damage. Indeed there is substantial 
evidence that aortic SBP may be markedly lower than brachial SBP, but that with ageing, 
aortic SBP may begin to approximate brachial SBP (McEniery et al 2008). Therefore, 
there is generally a consensus that SBP rather than DBP is the BP that is responsible for 
cardiovascular damage and that aortic SBP may be more important than brachial SBP 
when risk predicting. 
In contrast to SBP which increases from the aorta to the brachial artery, neither 
DBP nor mean arterial pressure (MAP) differ to any substantial degree across this large 
artery bed (Nichols et al 2011). As SBP, but not DBP increases from the aorta to the 
brachial artery, the main change in BP from the aorta to the brachial artery is an increase 
in pulse pressure (PP)(PP=SBP-DBP). Hence BP or PP is amplified from the aorta to the 
brachial artery (PP amplification)(Nichols et al 2011). The question that arises is what 
evidence supports a closer or independent relationship between aortic as compared to 
brachial BP with cardiovascular damage? Furthermore, why is aortic SBP lower than 
brachial SBP and what determines increases in aortic, but not brachial BP and hence a 
decrease in PP amplification with ageing? 
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1.3.1 What evidence supports a closer or independent relationship between aortic as 
compared to brachial blood pressure and cardiovascular damage? 
  
 Several studies provide the evidence to support the view that aortic BP is 
associated with cardiovascular end-organ changes better than or independent of brachial 
BP (Boutouyrie et al 1999, Covic et al 2000, Wang et al 2009, Roman et al 2010, Neisius 
et al 2012, Norton et al 2012, Wohlfahrt et al 2011) and this topic has been extensively 
reviewed by Roman and Devereux (2014). Furthermore, a number of studies have 
demonstrated that aortic BP predicts cardiovascular outcomes better than or independent 
of brachial BP (Safar et al 2002, Williams et al 2006, Wang et al 2009, Benetos et al 2010, 
Benetos et al 2012, Regnault et al 2012, Jankowski et al 2008, Pini et al 2008, Roman et 
al 2007, Roman et al 2009)(Table 1.3). 
Most of the earlier studies provided the evidence that beyond brachial BP, central 
aortic PP or SBP or PP amplification were predictors of CV events. These findings were 
reported in patients with end-stage renal disease (Safar et al 2002), in patients undergoing 
coronary angiography (Jankowski et al 2008), in the elderly (Pini et al 2008), and in the 
general population (Roman et al 2007 & 2009)(Table 1.3). In contrast however, in female 
hypertensives, brachial, but not central aortic BP predicted CV outcomes (Dart et al 
2006)(Table 1.3). This study (Dart et al 2006) has nevertheless been criticised for the use 
of inaccurate mean arterial pressures as applied to central pressures. In a meta-analysis 
of these studies published at that time (Table 1.3)(Vlachopoulos et al 2010), the 
comparative ability of aortic versus brachial BP to cardiovascular risk predict did not 
achieve significance, although a trend for a better effect was noted (p=0.057). This meta-
analysis however, included the study by Dart et al (2006) which, as mentioned, employed 
inaccurate mean arterial pressures, and excluded data from the The Conduit Artery 
Function Evaluation (CAFE) study (and obviously other later studies) which also reported 
on relations between aortic versus brachial BP and cardiovascular outcomes (Williams et  
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Table 1.3. Characteristics of studies comparing the impact of central aortic to brachial blood pressures on cardiovascular outcomes or mortality. 
 
Authors   Sample size Study design      Duration  Outcomes          Result  Adjustors 
            (median follow-up) evaluated                
Safar et al 2002   180  Prospective  52 months  All-cause mortality  PPamp is an I-P Age, Time on dialysis, previous  
                    CVE 
Williams et al 2006  2 073  Prospective  3 years   CVE and CV procedures  PPc is an I-P Age, baseline risk factors 
Wang et al 2009   1 272  Longitudinal   10 years   All-cause mortality & CD  PPc is an I-P Age, sex, Hr, BMI, smoking,  
                  Glucose, Chol:HDL ratio, 
                  PWV, LVM, IMT, eGFR 
Mitchell et al 2010a  2 232  Prospective  7.8 years  MI, Angina, HF, Stroke  Aortic BP is N-P Age, sex, SBPb, treatment, TChol,  
                PPamp is N-P HDL, smoking, diabetes 
Benetos et al 2010  125 151  Epidemilogical  12 years   All-cause mortality and CD  PPamp is an I-P Age, sex, smoking, activity, 
                   Cholesterol, diabetes, pulse rate 
Benetos et al 2012  1 126  Prospective  2 years   Mortality, CVE   PPamp is an I-P Age, activity, BMI, sex, Charlson 
comorbidity index, previous CVD, 
treatment, MAP, Hr 
Regnault et al 2012  125 121  Prospective  12 years   All-cause mortality & CD  PPamp is an I-P Age, Height, weight, smoking, 
                    Activity, cholesterol, diabetes, 
                   Heart rate, sex 
Chirinos et al 2012  5 960  Prospective  7.61 years  CVE, CHF   PPamp is N-P Race, treatment, TChol, HDL, 
                   Smoking, heart rate, eGFR, sex, 
                  SBP, DBP, diabetes, BH, BW, 
             `      treatment 
Jankowski et al 2008   1 109  Prospective  4.5 years  CR, MI, HF, CD, Stroke,  PPc is an I-P Age, sex, EF, CAS, HF, Hr, 
            CA, Heart Transplant    risk factors, CV history, GFR 
                  Drug Treatment  
Pini et al 2008   864  Prospective  8 years   Fatal & Non -fatal CVE  PPc is an I-P Age, sex 
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Table 1.3. Continued. 
Authors   Sample size Study design      Duration  Outcomes          Result  Adjustors 
            (median follow-up) evaluated      
____________________________________________________________________________________________________________________________ 
Roman et al 2007   3 520  Longitudinal  4.8 years  MI, Stroke, CHF, CHD, CD  PPc is an I-P Age, sex, smoking, BMI,  
                  TChol:HDL, serum creatinine 
                  Fibrinogen, diabetes, HR 
Roman et al 2009   2 405   Longitudinal   5.6 years  MI, Stroke, CHF, CHD  PPc is an I-P Age, sex, smoking, BMI, 
                  TChol:HDL, serum creatinine 
                  Fibrinogen, diabetes, Hr 
Dart et al 2006   484  Prospective  4.1 years  MI, CR, HF, cerebral or coronary PPc is N-P Age, Chol, smoking  
            Occlusion, stroke, TIA 
Vlachopoulos et al 2010  5 648  Longitudinal  3.75 years  MI, Stroke, CR, CD, All-cause PPc is N-P Meta-Analysis 
            mortality     
________________________________________________________________________________________________________________________________ 
PPc; Central aortic pulse pressure, CVE; Cardiovascular events, I-P; Independent predictor, N-P; Not an independent predictor, CV; Cardiovascular, BP; Blood pressure, PPamp; 
Pulse Pressure Amplification, Pb; reflected wave magnitude, SBPb; Brachial Systolic Blood Pressure, MI; Myocardial infarction, HF; Heart failure, CR; Cardiac revascularization, 
TChol; Total cholesterol, HDL; High-density lipoprotein, CD; Cardiovascular death, BMI; Body mass index, CVD; Cardiovascular disease, MAP; Mean arterial pressure, CHF; 
Congestive heart failire, eGFR; Estimated Glomerular Filtration Rate, BH; Body height, BW; Body weight, CA; Cardiac arrest, EF; Ejection fraction, CAS; Coronary artery 
stenosis, Hr; Heart rate, GFR; Glomerular Filtration Rate, TIA; Transient ischemic event, Chol; Cholesterol, PWV; Pulse wave velocity, LVM; Left ventricular mass, IMT; Intima-
media thickness       
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al 2006) as well as a study conducted in Taiwan which had not as yet been published at 
the time of the meta-analysis (Wang et al 2009) which similarly demonstrated an 
enhanced ability of aortic as compared to brachial BP in risk prediction. When excluding 
the study by Dart et al (2006), the meta-analysis did indeed show that central aortic BP 
predicted CV events beyond brachial BP. Nevertheless, the Framingham Heart Study, 
which was similarly not published at the time of the meta-analysis, demonstrated that 
neither aortic BP, nor PP amplification offered an ability to risk predict beyond brachial BP 
(Mitchell et al 2010a)(Table 1.3). However, in the Framingham Heart Study, in contrast to 
the expected 5-15 mm Hg difference between aortic and brachial BP (PP amplification), 
little difference was noted across the adult lifespan (Mitchell et al 2010b). This has been 
explained on the basis of the application of tonometry at a site where the principles of 
tonometry cannot be achieved (brachial artery to calibrate the carotid artery pulse) and 
the use of an inaccurate mean pressure for calibrating carotid artery pressures (O’Rourke 
et al 2010). In this regard, the brachial artery, with tendon aponeurosis superficial to it, 
and with no bone to support it, cannot be reliably applanated, so that the theory of 
Drzewiecki et al (1983), cannot be relied upon. This error resulted in an assumption that 
little carotid to brachial amplification occurs, but that marked brachial-to-radial 
amplification occurs. In contrast, several additional studies have demonstrated that a 
decreased PP amplification provides strong prognostic information beyond brachial BP 
(Benetos et al 2010, Regnault et al 2012, Benetos et al 2012)(Table 1.3). However, in 
these studies aortic BP itself failed to show an ability to risk predict beyond brachial BP 
(Benetos et al 2010, Regnault et al 2012, Benetos et al 2012)(Table 1.3). Nevertheless, a 
further recent study (Chirinos et al 2012), although demonstrating a strong relationship 
between aortic reflected waves and cardiovascular outcomes, failed to show a stronger 
relationship between PP amplification and cardiovascular outcomes (Table 1.3). 
In order to understand how increases in aortic SBP or PP, or decreases in PP 
amplification could enhance cardiovascular risk prediction beyond brachial SBP, and why 
some but not other studies may show an ability to enhance risk prediction, It is essential 
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that an understanding of the factors that result in variations in aortic, but not brachial SBP 
and hence the determinants of decreases in PP amplification is gained. The critical 
question is what are the factors which determine variations in these differences? 
 
1.3.2 What explains the variability in the difference between aortic and brachial systolic 
blood pressures? 
 
The evolution of arterial pulse wave analysis has largely driven our understanding 
of differences between aortic and brachial BP. In this regard an excellent historical 
context has been provided by Nichols et al (2011) in McDonald’s textbook. Briefly, the 
first paper to establish many of the properties of propagated and reflected waves was 
published in a monograph entitled ‘Wellenlehre’ in 1825 by the Weber brothers (WE and 
EH Weber, physicist and physician respectively) (Nichols et al 2011). The first recording 
of the human pulse occurred in 1855 and involved a lever placed over the radial artery, 
which was attached to a pencil dipped in Indian ink (Nichols et al 2011). Changes in the 
contour of the arterial pressure pulse wave with age and in hypertension were first 
described by the physicians Marcy (1863) and Mahomed (1872) (Nichols et al 2011). This 
was followed by the publication of experimental work on wave propagation by Moens in a 
monograph in 1878 (Nichols et al 2011). Unfortunately, with the introduction of the cuff 
sphygmomanometer in 1896, the changes observed in the characteristics of arterial 
pressure waves with age and elevated blood pressure, were largely forgotten. 
Nevertheless, in the early 1900’s manometers measuring pulsatile pressure were 
developed and principles that underpin these technique are still used today as standard 
clinical measurement tools (Nichols et al 2011). Luminaries such as Carl Wiggers and 
William Hamilton together with Otto Frank developed improved manometers with an 
increased sensitivity and these early manometers again sparked interest in wave 
reflection throughout the arterial tree (Nichols et al 2011). Indeed, in 1899, Frank held the 
view that the arterial pressure pulse has a basic pattern on which was superimposed a 
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damped oscillation which was created by wave travel and reflection hence generating a 
type of resonance (Nichols et al 2011). Despite the focus on systolic and diastolic blood 
pressure values, as a consequence of the introduction of the cuff sphygmomanometer, 
and hence the failure to take into account the characteristics of pressure waves, during 
the 1950’s, McDonald took interest in the pulsatile pressure-flow relations, which at the 
time were largely based on the Windkessel theory (Nichols et al 2011). In this regard the 
Windkessel theory states that pressure rises as blood is pumped into the vessels (Nichols 
et al 2011). The Windkessel theory has caused much controversy as this theory, 
although useful for calculating stroke volume, is inadequate to predict instantaneous flow 
rate (Nichols et al 2011). In comparison, arterial input impedance better describes the 
relationship between aortic pressures and flow (Nichols et al 2011). By the 1960’s the 
arterial pulse was accurately measured and by the mid-1960’s the principles were 
incorporated in physiology textbooks (Nichols et al 2011). Based on the principles of 
arterial pulse wave analysis, the mechanisms explaining differences in aortic and brachial 
blood pressure soon began to emerge. What is the current state of knowledge with 
respect to the understanding variations in these differences? 
As the aorta stiffens through structural alterations, a change largely explained by 
ageing effects, but which may also be produced by the chronic effects of hypertension, 
smoking, diabetes mellitus, dyslipidaemia and chronic inflammation, aortic pressures are 
enhanced during aortic ejection when blood is pumped into a stiffer conduit. Increasing 
stiffness of the aorta with age and cardiovascular risk factors is a complex process that is 
thought to involve destruction of elastic tissue, increases in aortic collagen content and 
changes in the properties of collagen (e.g. increased collagen cross-linking as may occur 
with enhanced glycosylation of collagen in diabetes mellitus) (Nichols et al 2011). 
Importantly, the magnitude of the pressure waveform generated when blood is ejected 
into a stiffer aorta (the aortic forward pressure wave, Figure 1.1), which is determined by 
stroke volume and hence left ventricular contractility as well as aortic impedance, 
increases as the aorta stiffens. Whilst aortic stiffness may increase, especially with the  
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Aortic Pressure Wave 
A: Augmentation Pressure (Pa)   D: First Systolic Shoulder 
B: Incident Wave Pressure (Pi)   E: Second Systolic Shoulder 
C: Central Aortic Pulse Pressure (PPc)  Ratio of A/C: Augmentation Index (AIx) 
 
 
 
 
 
 
 
 
 
 
 
                          Corresponding Forward (Pf) and Backward (Pb) Pressure Waves 
 
 
 
 
 
 
 
Wave reflection index (RI) = Pb/[Pf+diastolic BP) 
 
Figure 1.1 Aortic pressure wave (upper panel) as determined by the combined effect of 
the aortic forward (Pf) and aortic backward (Pb) pressure waves (lower panel). Definitions 
of various measures of arterial pulse wave analysis are also shown. The figure shows 
actual data obtained from SphygmoCor recordings. 
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ageing process, the stiffness of peripheral arteries in the upper limb increases to a lesser 
degree across the adult lifespan (Nichols et al 2011). The stiffer aorta causes a shift of 
peripheral/central pressure amplification curves to higher frequencies (decreased 
distensibility increases characteristic impedance in the ascending aorta and through its 
effects on wave velocity causes a shift of the impedance curves to a higher velocity) 
(O’Rourke 1970). Hence, with ageing and disease, it is proposed that as aortic BP 
increases, BP in peripheral arteries increases far less and hence brachial BP begins to 
approximate aortic BP (Nichols et al 2011, McEniery et al 2008). Indeed, on average, 
brachial BP increases by 25 mm Hg between the ages of 20–80 years, whilst central 
aortic BP increases by 40 mm Hg between the ages of 20–80 years (Vlachopoulos & 
O’Rourke 2000). Thus, with increasing age, and with more cardiovascular risk factors, 
aortic BP increases far more than brachial BP and PP amplification decreases. Hence, 
increases in aortic BP in excess of brachial BP and a reduced PP amplification may be 
surrogate indices of an increased aortic stiffness that occurs with advancing age and the 
presence of cardiovascular risk factors. Consequently, either aortic BP or PP 
amplification may be better indices than brachial BP, or indices that add to the ability of 
brachial BP to predict CVD. 
Variability in the difference between aortic and brachial BP is attributed to 
variations in aortic backward wave pressure (Figure 1.1). In this regard, pressure waves 
travelling down arteries encounter reflection points which may occur at innumerable sites 
in the arterial bed (Nichols et al 2011)(discontinuities in the arterial tree produced by 
branch points, changes in wall structure and tapering). At these sites pressure waves are 
reflected back and return to the ascending aorta. Summation of the numerous reflected 
waves derived from multiple arterial reflection points is thought to occur on wave return 
and this results in largely a single backward wave reaching the aorta. The backward 
wave in most adults returns sufficiently early that the pressure generated by this wave 
(Pb) may add to the pressure generated by the forward wave (Pf) and this augments 
aortic SBP (see Figure 1.1). However, differences in the timing of the generation of Pf 
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and Pb in the aorta translate into differences in the brachial as compared to the aortic 
pulse waveform. How do these differences in the timing of Pf and Pb in the aorta 
translate into the generation of a brachial artery waveform that may differ markedly from 
the aortic waveform? 
Because aortic Pb usually occurs later than aortic Pf, subsequent transmission of 
Pb outward to the brachial artery occurs after the transmission of Pf. Hence, in the 
brachial artery two pressure waves are generated, a percussion wave (first systolic 
shoulder), which largely reflects the effect of blood flow generated by aortic Pf, and a 
later tidal wave (second systolic shoulder), which largely reflects the effect of late 
transmission of aortic Pb (Figure 1.2). As the forward wave is larger than the backward 
wave, the percussion wave is similarly larger than the tidal wave. Because SBP is 
considered to be the maximum pressure generated in the brachial artery, the pressure 
generated by the forward wave (percussion wave) is therefore recorded as SBP 
(Figure1.2). Hence, although aortic pressures are lower than brachial pressures because 
of differences in stiffness between these vascular beds, peak brachial BP in most adults, 
especially the young and in middle-aged adults, largely ignores the impact of Pb on aortic 
BP (tidal wave) and only assesses the impact of Pf (percussion wave)(Figure 1.2). With 
age and in the presence of cardiovascular risk factors, as Pb increases, brachial BP 
increases less than aortic BP. This is because brachial BP only detects the peak of the 
percussion wave which is driven by Pf (Figure 1.3). In contrast, aortic BP increases more 
than brachial BP as aortic BP is determined by both Pf and Pb (Figure 1.3). With 
advanced age and with the effects of cardiovascular risk factors, Pb may be generated 
sufficiently early that its transmission outward to the brachial artery coincides with Pf and 
hence peak brachial BP is a summation of Pf and Pb effects (Figure 1.3)(Nichols et al 
2011). Under these circumstances brachial BP closely approximates the combined 
effects of Pf and Pb and PP amplification is close to 0. Hence, variations in differences 
between aortic and brachial BP and in PP amplification may be attributed to variations in 
aortic stiffness and hence in the impact of stiffness on wave reflection (O’Rourke 1970).  
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Figure 1.2. The contribution of aortic forward and aortic backward waves to aortic and 
radial (approximate of brachial) pulse waves. The dashed lines show temporal alignment 
(left panels) and alignment of the magnitude (left versus right panels) of pressure waves. 
The figure shows actual data obtained from SphygmoCor recordings. 
Percussion Wave  
Tidal Wave 
Aortic Wave 
Radial Wave 
Forward and 
Backward Wave 
35 
 
 
Young participant      Old participant 
 
 
 
 
 
 
 
 
         
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3. Age effects on aortic and radial artery pressure waves (which approximate 
brachial pressure waves). The figure shows changes in the combined effect of the aortic 
forward and aortic backward waves on pressure waveforms with age. The dashed line 
show how the forward and backward pressure waves contribute to radial and aortic 
pressure waves. The figure shows actual data obtained from SphygmoCor recordings.   
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The question that arises is whether it is variations in forward or reflected (backward) wave 
pressures or both that determine age- and cardiovascular risk factor-related increases in 
aortic BP, end-organ damage and cardiovascular outcomes? As alluded to in the 
aforementioned discussion, prior to assessing whether the use of forward or backward 
wave pressure measurements further refine the ability to identify end-organ changes in 
pre-hypertension, I first addressed some of the  controversies as to the role of forward 
and backward wave pressures in contributing to aortic BP and cardiovascular damage 
(Chapter 3). Hence, in the following section I will highlight these disputes and indicate 
how, in the present thesis I addressed some of these issues. Many of these controversies 
are related to how best to identify forward and backward wave effects. In the next section 
I will therefore review the role of forward and backward wave pressures in contributing to 
aortic BP and cardiovascular damage in the light of the of these controversies are related 
to how best to identify forward and backward wave effects. 
 
1.3.3 What is the role of forward and backward waves in contributing to variations in 
aortic BP and cardiovascular damage? 
 
A number of earlier studies indicate that across the adult age range, reflected 
waves, assessed from indices of pressure augmentation, dominate age-related increases 
in aortic pressure (McEniery et al 2008, Namasivayam et al 2009, Cecelja et al 2009) and 
that reflected waves account for increases in aortic pressure in hypertension (Mitchell et 
al 2003). Aortic pressure augmentation is the extent to which aortic pressure is enhanced 
by wave reflection and is identified as the difference between peak systolic pressure and 
the pressure at the first systolic shoulder of the aortic pressure wave (Figure 1.1). Several 
earlier studies also demonstrate that reflected waves, determined from indices of 
pressure augmentation, predict cardiovascular damage (Hashimoto et al 2007, 
Hashimoto et al 2006, Weber et al 2006, Westerbacka et al 2005, Sibiya et al 2014), and 
cardiovascular outcomes (Chirinos et al 2005b, London et al 2001, Ueda et al 2004, 
Weber et al 2005) beyond brachial BP. In this regard, a meta-analysis of these and other 
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outcome studies provided clear evidence that indices of pressure augmentation predict 
outcomes beyond brachial BP (Vlachopoulos et al 2010). Hence, based on measures of 
aortic pressure augmentation, aortic reflected waves were considered to be an important 
determinant of aortic pressure effects on cardiovascular damage independent or beyond 
brachial BP. However, several lines of evidence subsequently cast doubt on the use of 
pressure augmentation as a useful surrogate index for the impact of wave reflection on 
CVD. What is this evidence? 
The Framingham Heart Study failed to show that indices of aortic pressure 
augmentation predict outcomes independent of brachial BP (Mitchell et al 2010a). 
However, as previously pointed out, in the Framingham Heart Study, in contrast to the 
expected 5-15 mm Hg difference between aortic and brachial BP (PP amplification), little 
difference was noted across the adult lifespan (Mitchell et al 2010b). This has been 
explained on the basis of the application of tonometry at a site where the principles of 
tonometry cannot be achieved (brachial artery to calibrate the carotid artery pulse) and 
the use of an inaccurate mean pressure for calibrating carotid artery pressures (O’Rourke 
et al 2010). In this regard, the brachial artery, with tendon aponeurosis superficial to it, 
and with no bone to support it, cannot be reliably applanated, so that the theory of 
Drzewiecki et al (1983), cannot be relied upon. This error resulted in an assumption that 
little carotid to brachial amplification occurs, but that marked brachial-to-radial 
amplification occurs. Nevertheless, as shown in Figure 1.1, Pa is calculated as the 
difference between peak systolic aortic pressure and the first systolic shoulder of the 
aortic pressure wave. Aortic augmentation index is calculated as either Pa/aortic PP x 
100 or, to avoid negative values in younger persons, aortic SBP/pressure at the first 
systolic shoulder of the aortic pressure wave x 100 (Figure 1.1). The obvious error which 
may be introduced when assessing wave reflection with indices of pressure 
augmentation is that the point where the forward wave ends and the reflected wave 
begins is obscure (Figure 1.1). What is the evidence that indices of aortic pressure 
augmentation are inaccurate assessments of wave reflection? 
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The use of Pa or AIx as measures of aortic wave reflection have recently been 
criticised (Davies et al 2010, Cheng et al 2012, Hughes et al 2013, Fok et al 2014, 
Torjesen et al 2014, Schultz et al 2013). Although in several of these studies (Davies et al 
2010, Hughes et al 2013, Fok et al 2014), the method of wave intensity analysis has 
been seriously questioned on methodological and theoretical grounds (Segers et al 
2015), and Fok et al (2014) report an impossible flow-frequency response, apparently 
hand-drawn representative waves are shown, and control impedance values are given 
that differ markedly from Yaginuma et al (1985), these and several other studies 
nevertheless suggest that marked overlap between aortic forward and reflected waves 
may confound Pa and AIx (Cheng et al 2012, Fok et al 2014, Torjesen et al 2014, Schultz 
et al 2013). Hence these measures may be poor indices of wave reflection. Indeed, there 
is a weak relationship between the magnitude of the reflected wave and Pa or AIx with 
the timing or magnitude of the Pf or incident (Pi) wave pressures (aortic PP- [Pressure at 
the first systolic shoulder of the aortic pressure wave-DBP]) (Figure 1.1), and left 
ventricular systolic function playing a more important role than wave reflection in 
contributing to variations in Pa and AIx (Cheng et al 2012, Hughes et al 2013, Fok et al 
2014, Torjesen et al 2014, Schultz et al 2013). In this regard, to avoid the confounding 
influence of these factors on wave reflection, aortic pressure waveforms may be 
separated using simultaneous aortic flow measurements or with an assumed aortic flow 
waveform (Westerhof et al 2006). How are aortic pressure waves separated using aortic 
flow waveforms? In essence to assess the magnitude of Pf and Pb, one requires 
pressure and flow waveforms. The following formula is used to calculate Pf and Pb:  
 
Pf(t)=[P(t) + Zc • F(t)]/2 
Pb(t)=[P(t) – Zc • F(t)]/2 
 
where P(t) is the measured pressured wave, F(t) is the flow wave, and Zc is characteristic 
impedance of the proximal aorta (Westerhof et al 2006). Characteristic impedance (Zc) is 
derived from the 4th to 7th harmonic (Westerhof et al 2006). In the calculation of Pb and 
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Pf, Zc • F appears, where Zc is a ratio of (P/F). Therefore the product of Zc • F is 
independent of flow calibration (Westerhof et al 2006). 
The assumed aortic flow waves that have been employed for wave separation 
analysis include a triangular aortic waveform or a “physiological” waveform (Kips et al 
2009, Westerhof et al 2006). From actual flow and pressure measurements, it was noted 
that one can approximate a flow waveform using a triangulation technique (Westerhof et 
al 2006), To apply a triangular flow waveform, all that is required is the identification of 
the start, peak and end of aortic flow (Westerhof et al 2006). As indicated in Figure 1.4, 
the start is at the beginning of the ejection period, the peak occurs at the inflection point 
of the first systolic shoulder or at 30% of the ejection time, and the end of flow is at the 
dicrotic notch where the aortic valve closes. The three points of the triangle are simply 
placed at these points (Figure 1.4) and the forward and backward waves are calculated 
as shown in Figure 1.4. As the aortic flow wave is not exactly a triangular waveform, a 
better approach to wave separation analysis may be the use of a “physiological 
waveform”, which represents the average aortic flow waveform for a particular community 
(Kips et al 2009). 
What is the evidence derived from wave separation analysis to indicate whether 
aortic reflected waves play an important role in contributing to CVD? Importantly, to 
address this point, the first question to consider is whether current evidence supports an 
important role for reflected waves, derived from wave separation analysis, in determining 
age-related increases in aortic pressures? 
In the only study conducted at the time, which employed wave separation analysis 
to identify Pb (Segers et al 2007), in contrast to studies demonstrating that Pa dominates 
age-related increases in aortic pressure (McEniery et al 2005, Namasivayam et al 2009, 
Cecelja et al 2009) and variations in aortic BP (Cecelja et al 2009), Pb was noted to  
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Figure 1.4. Approach to separating aortic forward and backward pressure waves using 
an assumed triangular aortic flow wave. (Modified from Mitchell 2006). 
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make a small contribution to variations in aortic pressure (Segers et al 2007). However, 
this study (Segers et al 2007) was conducted in participants evaluated over a very narrow 
age- range (average 15 year age range) and hence is unlikely to reflect what occurs 
overthe full adult age-range. Nevertheless, subsequent studies employing wave 
separation analysis provided discrepant data. In this regard, notwithstanding the finding 
that little difference in aortic and brachial BP was noted across the adult lifespan (Mitchell 
et al 2010b), data explained on the basis of the application of tonometry at a site where 
the principles of tonometry cannot be achieved (brachial artery to calibrate the carotid 
artery pulse) and the use of an inaccurate mean pressure for calibrating carotid artery 
pressures (O’Rourke et al 2010), the Framingham Heart Study nevertheless 
demonstrated only modest contributions of wave reflection (backward wave pressures or 
Pb), derived from wave separation analysis to variations in aortic pressure across the 
adult age range (Mitchell et al 2010b). In contrast, in an alternative large community-
based study where the community had a high prevalence of uncontrolled hypertension, 
Pb derived from aortic wave separation analysis was strongly and linearly related to age 
(Wang et al 2010). However, whether in that study (Wang et al 2010) Pb contributed 
more, less or the same amount as forward wave pressures (Pf) to variations in aortic 
pressure across the adult lifespan was not described. Hence, in the present thesis, 
before I evaluated whether the ability of aortic reflected waves better identify pre-
hypertensives with end-organ changes (Chapter 4), I first assessed whether indices of 
pressure augmentation are sufficient to determine the impact of wave reflection on age-
related increases in aortic pressure across the adult lifespan or whether Pb should be 
assessed from wave separation analysis (Chapter 3). As previously alluded to, these 
data have been accepted for publication in the journal Hypertension (Booysen et al 
2015). More importantly however, what is the evidence derived from wave separation 
analysis to indicate whether aortic reflected waves play an important role in contributing 
to cardiovascular damage or CVD? 
 As previously indicated, earlier studies evaluating the impact of reflected waves 
on cardiovascular end-organ changes (Hashimoto et al 2007, Hashimoto et al 2006, 
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Weber et al 2006, Westerbacka et al 2005, Sibiya et al 2014), and cardiovascular 
outcomes (Chirinos et al 2005b, London et al 2001, Ueda et al 2004, Weber et al 2005) 
beyond brachial BP did not employ wave separation analysis to identify reflected or 
backward wave pressure effects. In the last few years however, several studies have 
described an association of reflected waves (Pb or the reflected wave index [RI]) derived 
from wave separation analysis with end-organ changes (Wang et al 2010, Weber et al 
2012) or an ability of Pb or RI (or reflected wave magnitude) to risk predict beyond 
brachial BP (Wang et al 2010, Weber et al 2012, Chirinos et al 2012, Zamani et al 2014). 
These studies are summarised in Table 1.4. However, neither Pb nor RI were 
independently associated with outcomes in the Framingham study (Cooper et al 2014) 
(Table 1.4), a finding that may be explained by the fact that application of tonometry was 
at a site where the principles of tonometry cannot be achieved (brachial artery to calibrate 
the carotid artery pulse) and the use of an inaccurate mean pressure for calibrating 
carotid artery pressures (O’Rourke et al 2010). What are the outstanding issues in these 
studies which prompted me, as part of the present thesis, to further pursue the role of 
wave reflection as a possible determinant of cardiovascular damage beyond brachial BP? 
Importantly, in these studies, relations with end-organ damage were not adjusted 
for confounders (Wang et al 2010, Weber et al 2012), discrepancies in the index of wave 
reflection that was better associated with end-organ damage beyond forward wave 
pressures were noted (Wang et al 2010, Weber et al 2012); and whether the increase in 
forward wave pressures at 50 years of age (McEniery et al 2008, Mitchell et al 2010b) 
impacts on these relations was not considered (Wang et al 2010, Weber et al 2012, 
Chirinos et al 2012, Zamani et al 2014) (Table 1.4). Hence, in the present thesis, before 
I evaluated whether the ability of aortic pressure to better identify pre-hypertensives with 
end-organ changes are attributed to aortic reflected waves (Chapter 4), I first evaluated 
whether indices of pressure augmentation are sufficient to assess the impact of wave 
reflection on end-organ changes (as indexed by left ventricular mass index) across the 
adult lifespan, or whether Pb should be assessed from wave separation analysis  
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Table 1.4. Characteristics of studies assessing the impact of aortic reflected (backward) wave effects on cardiovascular damage and outcomes. 
Authors  Sample Study design      Duration      Outcomes          Result   Adjustors 
   Size       Evaluated 
Wang et al 2010 1 272  Community based 15 years LVMI, IMT, eGFR, PWV  Correlated  None  
     Survey 
Wang et al 2010 1 272  Community based 15 years All-cause mortality & CVE I-P   None 
     Survey 
Weber et al 2012 725  Prospective  1 399 days GFR, LA Diameter, LVM Correlated  None 
          E/É, Aortic PWV      
Weber et al 2012 725  Prospective  1 399 days Mortality, MI, Stroke, CR I-P   Sex, age, systolic function, Statin use 
            Peripheral & Cerebrovascular    MAP, LA Diameter, GFR, CAD, Aortic PWV  
           Revascularization     angioscore, diabetes, smoking, NT-proBNP 
                    hypertension, E/É, Hr, previous MI,  
                    treatment, LV end-diastolic pressure 
Chirinos et al 2012 5 960  Prospective  7.61 years Heart Failure   I-P   Race, Treatment, TChol, HDL-Chol, 
                  Smoking, HR, eGFR 
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Table 1.4. Continued 
Authors  Sample Study design      Duration      Outcomes          Result   Adjustors 
   Size       Evaluated 
 
Zamani et al 2014  5 984  Prospective  9.8 years All-cause mortality, CD  I-P   Hr, age, sex, race, SBP, Urinary 
                 Albumin/creatinine ratio, Tchol, LDL- 
                  Chol, HDL-Chol, treatment, smoking,  
                  BMI, previous MI, diabetes, C-reactive 
                   protein, education, family income, 
                  alcohol, calorie intake, calories from fat, 
                  physical activity, ankle-brachial index, 
                  maximum IMT, NT-proBNP, eGFR,                            
                  score, Aortic Agatson calcium score,  
                  Agaston coronary calcium  
Cooper et al 2014 2 492  Longitudinal   6.8 years MI, Angina, HF, Ischemic  N-P   Age, sex, antihypertensive therapy 
          & hemorrhagic stroke, CVD    BMI, Hr, TChol, HDL, smoking 
                 Diabetes     
 
LVMI; Left Ventricular Mass Index, IMT; Intima Media Thickness, eGFR; Estimated Glomerular Filtration Rate, PWV; Pulse Wave Velocity, CVE; Cardiovascular Events, I-P; 
Independent predictor; GFR; Glomerular Filtration Rate, LA; Left Atrium, LVM; Left Ventricular Mass, MI; Myocardial Infarction, CR; Coronary Revascularization, Hr; Heart Rate, 
CAD; Coronary Artery Disease, TChol; Total Cholesterol, HDL; High-density Lipoprotein, CD; Cardiovascular Death, SBP; Systolic Blood Pressure, NT-proBNP; NT-probrain 
Natriuretic peptide, Chol; Cholesterol, LDL; Low-density lipoprotein, BMI; Body Mass Index, N-P; Not an independent predictor 
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(Chapter 3). In doing so I describe the relative contribution of wave reflection (assessed 
with or without wave separation analysis) versus forward wave pressures to end-organ 
changes independent of confounders, and in those less than or more than 50 years of age. 
As indicated in aforementioned discussion, these data have been accepted for publication 
in the journal Hypertension (Booysen et al 2015) and provided the evidence that prompted 
me to further pursue whether aortic reflected waves may further refine the ability to identify 
pre-hypertensives with end-organ changes. 
 
1.3.4 Additional determinants of aortic forward and backward wave pressures. 
  
Although to a large extent the determinants of aortic forward (Pf) and backward (Pb) wave 
pressures have already been discussed in section 1.3.2, there are several additional 
factors which require consideration to place the present thesis in context. To summarise 
previous discussion, the aortic forward wave pressure (Pf) is determined by stroke volume 
and aortic impedance or stiffness and the aortic backward wave pressure (Pb) is 
determined by wave reflection. What are the factors that determine stroke volume, aortic 
stiffness and wave reflection? 
 Stroke volume is determined by cardiac contractility and ventricular filling volumes 
(Frank-Starling effect). However, stroke volume does not increase with age or account for 
age-related increases in aortic pressure (Segers et al 2007). Although there is some 
recent evidence that increases in left ventricular contractility may determine increases in Pf 
and hence aortic pressure in hypertension (Fok et al 2014), this study was conducted in a 
small sample of patients (n=20) and controls (n=20)(Fok et al 2014) and as previously 
indicated, Fok et al (2014) report an impossible flow-frequency response, apparently hand-
drawn representative waves are shown, and control impedance values are given that differ 
markedly from Yaginuma et al (1985). Hence, stroke volume may not be a major 
determinant of increases in aortic Pf. 
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As previously described in section 1.3.2, aortic impedance or stiffness is 
determined by the structural characteristics of the aorta which change with age and the 
presence of cardiovascular risk factors. When structural aortic changes occur, the 
relationship between aortic pressure and volume shifts to a steeper curve (Figure 1.5) and 
these changes are thought to make a major contribution to variations in Pf with age and in 
hypertension. However, importantly, because of the exponential relationship between 
aortic volume and pressure, distension of the aorta (increased volume) may also change 
aortic stiffness through passive mechanisms, where wall tension is transferred from 
distensible elastin fibres to stiff collagen fibres as the volume in the aorta increases (Figure  
1.5). In this regard, the main determinant of aortic distension is mean arterial pressure 
(MAP) and hence any factor that augments MAP will produce marked increases in Pf 
through passive mechanisms (Nichols et al 2011). 
As previously discussed, aortic Pb is determined by wave reflection. However, the 
mechanisms responsible for increases in wave reflection are less well understood. In this 
regard, although not a strong relationship, Pb is associated with aortic stiffness as 
determined by aortic pulse wave velocity (PWV)(Nichols et al 2011), the current ‘gold- 
standard’ non-invasive assessment of aortic stiffness. This may be explained by 
impedance mismatching at arterial reflection points, and hence in alterations in the 
magnitude of wave reflection (Nichols et al 2011). As MAP is an important determinant of 
aortic stiffness, any factor that influences MAP (through effects on either total peripheral 
resistance [TPR] or cardiac output [CO]) will obviously also increase wave reflection and 
Pb. Importantly however, there is also the possibility that alterations in vascular smooth 
muscle tone at various reflection sites may produce an increased magnitude of wave 
reflection. In this regard, the ability of nitrates to decrease Pa and AIx, as well as aortic 
pressure, without producing much change in brachial pressure and at doses which do not 
influence TPR (Simkus and Fitchett 1990, Takazawa et al 1995), was previously thought to 
be through an impact on medium sized-artery smooth muscle tone and consequently 
reflected waves. However, more recent evidence suggests that the impact of nitrates on  
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A: Produced by structural aortic changes 
B: Produced by aortic distension  
 
 
 
Figure 1.5. Aortic pressure-volume relations and the impact of structural aortic changes 
(destruction of elastin fibres, increased collagen or changes in collagen phenotypes) in the 
aorta or aortic distension (e.g. as may occur with increases in mean arterial pressure) on 
these relations. 
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aortic pressure is through changes in cardiac function and hence Pf, rather than Pb (Fok et 
al 2014). The previously described benefits of nitrates on Pa and AIx (Simkus and Fitchett 
1990, Takazawa et al 1995) may therefore be attributed to an impact on forward rather 
than reflected waves. However, as previously indicated, Fok et al (2014) report an 
impossible flow-frequency response, apparently hand-drawn representative waves are 
shown, and control impedance values are given that differ markedly from Yaginuma et al 
(1985). As indicated in the aforementioned discussion, as aortic SBP is likely to be the 
principal BP responsible for cardiovascular damage and adverse outcomes, it is important 
to consider how antihypertensive therapy may produce the well-described benefits of 
these agents in risk prevention. In this regard, the crucial question is how does 
antihypertensive therapy influence Pf, Pb and hence aortic pressure? 
 
 1.3.5 Effects of antihypertensive therapy on aortic pressures and the component waves.  
 
 Although in the present thesis I did not assess the impact of antihypertensive 
therapy on aortic pressures or the component waveforms, if aortic BP or specific 
component waveforms better identify pre-hypertensives with cardiovascular end-organ 
changes, it is important to understand whether current approaches to BP lowering are 
effective in reducing these pressures in pre-hypertension. 
It is well-recognised that current antihypertensive agents were designed to target 
CO and TPR (MAP=CO x TPR). Indeed, current therapy largely influences resistance 
arteries (arterioles and pre-capillary sphincters) and/or stroke volume, heart rate or cardiac 
contractility. In this regard, thiazide and thiazide-like diuretics, renin-angiotensin-
aldosterone system (RAAS) blockers, calcium channel blockers (CCB), non-specific 
vasodilators, α1-adrenergic receptor blockers, centrally acting α2-adrenergic receptor 
agonists, and neutral endopeptidase inhibitors, all decrease TPR. Moreover, thiazide and 
thiazide-like diuretics, RAAS blockers, and β1-adrenoreceptor blockers will decrease CO 
through effects on heart rate, blood volume and hence cardiac filling volumes, or cardiac 
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contractility. If one is to understand how antihypertensives produce benefits to 
cardiovascular risk, the essential question however is whether these agents are able to 
decrease Pf and Pb and hence aortic BP? 
 As Pf and Pb are both influenced by MAP, there is no question that all 
antihypertensive agents, because they decrease MAP through effects on either TPR 
and/or CO will decrease both Pf and Pb. However, what has attracted considerable 
attention over the years is whether antihypertensive agents are able to target aortic 
forward and reflected waves independent of effects on MAP. In this regard, to the best of 
my knowledge most studies that have evaluated the impact of antihypertensive therapy on 
aortic BP and the component waves of aortic PP, have assessed the effects on forward 
and reflected wave effects without separating the waveforms. In this regard, a number of 
studies have reported that antihypertensive therapy decreases Pa, AIx and aortic pressure 
and hence the authors of these studies have concluded that most classes of agents 
reduce wave reflection and hence aortic pressure (Agabiti-Rosei et al 2007). The 
exception to this rule is that it appears that diuretics and β-adrenoreceptor blockers may 
not produce the same benefits, with less of a reduction in Pa and AIx and hence aortic 
pressures with these agents than with more modern classes of agents including RAAS 
blockers and CCBs (Williams et al 2006, Agabiti-Rosei et al 2007). These findings have 
been employed to explain differential benefits of older agents (diuretics or β-
adrenoreceptor blockers) as compared to newer agents (RAAS blockers and CCBs) on 
cardiovascular outcomes independent of brachial BP, with newer agents showing 
superiority over older agents (Dahlof et al 2002, Williams et al 2006). However, whether 
these differential benefits are attributed to the magnitude of reflected wave effects on 
aortic pressure or through other effects on aortic pressures (impact on Pf or the timing of 
wave reflection) is uncertain as to the best of my knowledge no study has evaluated 
whether RAAS blockers and CCBs are better at decreasing Pb derived from wave 
separation analysis than older agents. What is nevertheless generally accepted is that the 
MAP-independent benefits of antihypertensive therapy on the structural aortic changes 
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that determine aortic stiffness and hence stiffness-induced increases in Pf over short-term 
periods is minimal (Agabiti-Rosei et al 2007). However, diuretics and β-adrenoreceptor 
blockers may produce MAP-independent effects on stroke volume and hence Pf and 
therefore may have benefits on Pf and thus aortic pressure that go beyond MAP. 
 
1.4.0 Deriving aortic pressures: Cost implications and possible alternative 
approaches 
 
Assuming that central aortic pressure measurement does indeed improve on 
cardiovascular risk prediction, the question arises as to how it should be measured? In 
this regard, central aortic BP should ideally be measured invasively with a non-fluid-filled 
(transducer-tipped) catheter placed in the proximal aorta. However, for obvious reasons 
invasive measurements are impractical for general clinical use. Are there reasonable 
alternatives? More than 100 years ago, premature arteriosclerotic changes were 
measured from the pulse waveform in the radial artery by sphygmography (Osler 1898, 
Mackenzie 1902). The first graphic recordings of the arterial pulse revealed differences in 
waveform shape between young and old (Marey 1863). These early studies set the scene 
for the development of devices to derive central aortic pressures from non-invasive 
measurements, measurements from which most current knowledge of the role of aortic 
haemodynamics in CVD has been derived. 
One method is based on applanation tonometry of the radial artery to derive an 
accurate arterial pulse waveform (pulse wave analysis or PWA), which, coupled with the 
use of a validated population-based generalized transfer function (GTF), converts the 
radial pulse wave into an aortic pulse wave. This technique has previously been criticised 
for the use of a population-based transfer function which may not apply to all clinical 
populations (Hope et al 2008, Khoshdel et al 2007, Hope et al 2004, Hope et al 2002). 
However, this approach produces aortic pressures which closely approximate aortic 
pressures derived from the second systolic shoulder of the radial waveform (which does 
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not require a population-based transfer function to derive aortic pressures) and is as 
closely associated with end-organ damage as aortic pressures derived from the second 
systolic shoulder (Norton et al 2012). More recently however, this approach has been 
criticised for using brachial pressures to calibrate the waveform as BP amplification has 
been suggested to be significant from the brachial to the radial artery (Mahieu et al 2010, 
Verbecke et al 2005). However, high radial amplification (Mahieu et al 2010, Verbecke et 
al 2005) has never been shown in invasive studies of the brachial and radial pulse wave 
and non-invasively determined brachial-to-radial amplification has been attributed to 
inappropriate use of applanation tonometry at the brachial artery. In this regard, the 
brachial artery, with tendon aponeurosis superficial to it, and with no bone to support it, 
cannot be reliably applanated, so that the theory of Drzewiecki et al (1983), cannot be 
relied upon. 
An alternative method of deriving aortic pressures non-invasively employs carotid 
applanation tonometry calibrated against the brachial artery. Although this approach has 
the benefit of not requiring a population-based transfer function to derive an aortic 
waveform, it suffers from inaccuracies in deriving the waveform in obese individuals (there 
is no bony structure to compress the carotid artery against to perform the measurement) 
and the concern of a potential risk of emboli if complicated plaque exists in advanced 
atheroma. This is in contrast to radial PWA where the artery can be flattened against a 
bony structure and hence where obesity does not limit the ability to obtain an accurate 
pulse wave, and where the risk of emboli to essential organs does not exist in patients 
with complicated plaque. Criticism of carotid tonometry derived central haemodynamic 
values obtained in some studies includes the use of inaccurate brachial tonometry to 
calibrate carotid pressure traces (O’Rourke et al 2010). In this regard, as previously 
indicated, in contrast to the expected 5-15 mm Hg difference between aortic and brachial 
BP (PP amplification), in one study little difference was noted across the adult lifespan 
(Mitchell et al 2010b). This has been explained on the basis of the application of 
tonometry at a site where the principles of tonometry cannot be achieved (brachial artery 
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to calibrate the carotid artery pulse) and the use of an inaccurate mean pressure for 
calibrating carotid artery pressures (O’Rourke et al 2010). In this regard, the brachial 
artery, with tendon aponeurosis superficial to it, and with no bone to support it, cannot be 
reliably applanated, so that the theory of Drzewiecki et al (1983), cannot be relied upon. 
This error resulted in an assumption that little carotid to brachial amplification occurs, but 
that marked brachial-to-radial amplification occurs (Mitchell et al 2010b). 
An essential criticism of the use of any form of PWA is that the instruments that 
have been developed are costly in comparison to current oscillometric devices validated 
for BP measurement. In relative terms, in South Africa, validated oscillometric devices are 
available for a few thousand rands (South African currency), whilst devices for PWA are a 
few hundred thousand rands (100 times the price). Furthermore, in resource-limited 
settings in Africa, even oscillometric devices are out of the price range and BP 
measurements may require much simpler approaches which do not rely on electronic 
devices. Although finger photoplethysmography may also allow for PWA, and these 
devices may be considerably cheaper than present devices available for PWA, these 
devices have not as yet been made commercially available. Moreover, although discarded 
manometers used for cardiac catheterisation may also be used for PWA, the recording 
devices available that these manometers are coupled to, are considerably more 
expensive than devices employed for the simple measurement of brachial BP. Hence, the 
question which arises is whether simple clinical tools, which do not rely on electronic 
devices for their measurement, may allow for an approximation of aortic pressure that can 
improve on risk prediction? 
 
1.4.1 Imputing aortic blood pressure from simple clinical measures. 
 
The major determinants of central aortic BP (Wilkinson et al 2000 & 2001, 
McEniery et al 2008) are normally acquired as part of routine cardiovascular risk 
prediction. It has therefore been suggested that aortic BP may be imputed (or calculated) 
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from simple clinical measures derived from multivariate regression modelling (Camacho et 
al 2004). In this regard, although brachial pressure may considerably underestimate aortic 
pressures, a close correlation exists between brachial PP and aortic PP (Benetos et al 
2010). Hence, brachial PP may account for more than 80% of the variability of aortic PP 
(Benetos et al 2010) and is an essential component of an equation employed to derive 
aortic PP and SBP.  To adequately account for differences in aortic and brachial BP, the 
impact of backward wave pressures may in-part be accounted for by age, as age is 
linearly associated with Pb (Wang et al 2010). Furthermore, the impact of forward wave 
pressures may also in-part be accounted for by age, as age is the strongest recognized 
determinant of aortic stiffness. Hence, age may be an essential component of an equation 
derived from multivariate regression modelling that is employed to impute aortic BP. As 
indicated in previous discussion, MAP, through passive effects on aortic stiffness 
increases both Pf and Pb and hence aortic pressures. Therefore, MAP may also be an 
essential component of an equation derived from multivariate regression modelling that is 
employed to impute aortic BP. Heart rate is a well-recognized determinant of aortic 
pressure augmentation, not because it changes the magnitude of the backward pressure 
wave, but because it influences the extent to which the forward and backward pressure 
waves overlap (Wilkinson et al 2000, Wilkinson et al 2001). In this regard, a slower heart 
rate is thought to prolong the forward pressure wave and hence increase the chances that 
the backward wave arrives at a similar time as the forward wave (Wilkinson et al 2000, 
Wilkinson et al 2001). Therefore, heart rate may also be an essential component of an 
equation derived from multivariate regression modelling that is employed to impute aortic 
BP. A shorter stature, as occurs in women, may result in a reduced distance required by 
the backward wave to travel, the consequence being that the backward wave arrives 
earlier and coincides with the forward wave thus augmenting aortic SBP (Hughes et al 
2013, Wilkinson et al 2000, Wilkinson et al 2001). Therefore, height and sex may also be 
essential components of an equation derived from multivariate regression modelling that 
is employed to impute aortic BP. As indicated in previous discussion, recognized 
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cardiovascular risk factors, including smoking, diabetes mellitus, hypertension, and 
dyslipidaemia are all causes of structural changes in the aorta and hence aortic stiffness. 
Thus, these risk factors may also be associated with Pf and Pb and hence aortic pressure. 
Therefore, a number of cardiovascular risk factors may also be essential components of 
an equation derived from multivariate regression modelling that is employed to impute 
aortic BP. Is there evidence that aortic BP determined from an imputation equation 
derived from simple clinical assessments predicts cardiovascular damage beyond brachial 
BP? 
 
 
1.4.2 Relationships between imputed aortic blood pressure and cardiovascular damage. 
 
Recent studies have demonstrated an ability of PP amplification, determined from 
aortic PP imputed from an equation derived from multivariate regression modelling of 
simple clinical parameters, to predict cardiovascular outcomes, independent from brachial 
BP (Benetos et al 2010, Regnault et al 2012). However, in these studies imputed aortic 
PP per se failed to predict outcomes beyond brachial BP (Benetos et al 2010, Regnault et 
al 2012). Nevertheless, in these studies (Benetos et al 2010, Regnault et al 2012), only 
brachial PP, age and diabetes mellitus were employed in the imputation equation and the 
relationship between imputed aortic PP and measured aortic PP (r2=0.888) was only 
marginally improved on the relationship between brachial PP and aortic PP (r2=0.835). In 
neither of these studies was MAP or heart rate, two strong determinants of aortic PP 
included in the multivariate model (Benetos et al 2010, Regnault et al 2012). Further, 
although the imputation equation produced mean differences (Bland Altman analysis) 
between imputed aortic PP and measured aortic PP (-0.50 mm Hg for men and -6.45 mm 
Hg for woman) that improved on the mean difference (Bland Altman analysis) between 
brachial PP and measured aortic PP, whether any intrinsic bias in the slope of the brachial 
PP versus aortic PP relationship occurred and whether the imputation model improved on 
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this intrinsic bias was not reported on (Benetos et al 2010, Regnault et al 2012). In 
addition, the imputation equation derived by Benetos et al (2010), failed to predict 
outcomes in alternative populations (unpublished data). Thus further work is required to 
evaluate whether an imputation equation employing simple clinical measures closely 
approximates aortic BP and whether this imputation equation produces aortic BP values 
which may enhance the ability to identify cardiovascular damage in pre-hypertensives 
beyond brachial BP. In the present thesis in Chapter 5 I therefore identified an 
imputation equation employing simple clinical measures that closely approximates aortic 
BP. In chapter 5 I further assessed whether imputed aortic BP values may better identify 
pre-hypertensives with cardiovascular damage and whether this effect is similar to the 
ability of aortic BP derived from PWA to identify pre-hypertensives with cardiovascular 
damage. 
 
1.5 Problem statement 
 
 In summary therefore, individuals with normal/high-normal BP values are at risk of 
cardiovascular events, but the risk attributed to BP within this BP category may be highly 
heterogeneous. As aortic BP may enhance risk prediction beyond brachial BP and 
considerable overlap in aortic BP occurs across optimal, normal, high-normal and 
hypertensive BP categories, I hypothesized that aortic BP may refine the ability to identify 
those with a normal-high normal BP whom are at risk for BP-related sub-clinical 
cardiovascular disease (end-organ changes). As variations in the difference between 
aortic and brachial BP are attributed largely to aortic reflected waves, I also hypothesized 
that aortic reflected waves may enhance the ability to identify sub-clinical cardiovascular 
disease in normotensives. However, before addressing this question, whether the use of 
aortic augmentation indices adequately evaluates the impact of aortic reflected waves on 
aortic pressure and cardiovascular damage required clarification. Although the 
assessment of aortic BP may enhance the ability to identify cardiovascular damage in 
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those with BP values within normal-high normal BP ranges, the devices designed to 
measure aortic BP non-invasively are cost-prohibitive for routine use at a primary 
healthcare level in low-to-middle income countries, such as South Africa. As aortic BP is 
closely associated with a number of routinely determined clinical measures, I also 
hypothesized that an imputation equation derived from these routine clinical measures 
may closely approximate aortic BP and that imputed aortic BP would improve on the ability 
of brachial BP to detect sub-clinical cardiovascular disease as well as actual aortic BP. 
 
1.6 Aims 
 
Hence, as part of the present thesis I aimed: 
 
1) To determine whether aortic BP enhances the ability of brachial BP to identify end-
organ changes in a community sample of participants with normal/high-normal BP 
values. These data are described in chapter 2 and have been published in the 
Journal of Hypertension (Booysen et al 2013). 
2) To determine whether aortic augmentation indices closely reflect the impact of 
backward waves on aortic BP and end-organ changes. These data are described in 
chapter 3 and have been accepted for publication in the journal Hypertension 
(Booysen et al 2015)(scheduled for publication in March 2015). 
3)  To determine whether aortic reflected (backward) waves explain the capacity of 
aortic BP to enhance the identification of end-organ changes in normotensives and 
to assess whether reflected (backward) waves improve on the ability of aortic BP to 
identify end-organ changes. These data are described in chapter 4. 
4) To determine whether an imputation equation derived from routine clinical 
measures closely approximates aortic BP and whether imputed aortic BP improves 
on the ability of brachial BP to detect end-organ changes as well as actual aortic 
BP. These data are described in chapter 5. 
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Chapter 2 
 
 
Aortic, but Not Brachial Blood Pressure Category Enhances the Ability 
to Identify Target Organ Changes in Normotensive. 
 
The data in this chapter have been published in the Journal of Hypertension: 
Booysen, H. L., Norton, G. R., Maseko, M. J., Libhaber, C. D., Majane, O. H., Sareli, P., & 
Woodiwiss, A. J. (2013). Aortic, but not brachial blood pressure category enhances the 
ability to identify target organ changes in normotensives. Journal of Hypertension 31(6), 
1124-1130. (reprint provided in appendix 2) 
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2.1  Abstract 
 
As those at risk of blood pressure (BP)-related cardiovascular damage in pre-
hypertension are difficult to identify, I sought to determine whether within normal/high-
normal BP ranges (120-139/80-89 mm Hg), aortic BP may further refine BP-related 
cardiovascular risk assessment, as determined from target organ changes. In 1169 
participants from a community sample of African ancestry, 319 (27%) of whom had a 
normal/high-normal BP, aortic BP was determined using radial applanation tonometry and 
SphygmoCor software, and target organ changes assessed from carotid-femoral pulse 
wave velocity (PWV)(n=1025), estimated glomerular filtration rate (eGFR) (n=944), and 
left ventricular mass indexed to height2.7 (LVMI)(n=690). Normal versus high-normal BP 
categories failed to differentiate between those participants with a BP above optimal 
values with versus without multivariate-adjusted target organ changes. However, in those 
with a normal/high-normal BP with aortic systolic BP values that were <95% confidence 
interval of healthy participants with optimal BP values (45% of those with a normal/high-
normal BP), no unadjusted or multivariate adjusted target organ changes were noted. In 
contrast, those with a normal/high-normal BP with aortic systolic BP values that exceeded 
optimal thresholds, demonstrated unadjusted and multivariate adjusted increases in PWV 
and LVMI and decreases in eGFR (p<0.05 to p<0.005 after multivariate adjustments). In 
conclusion, in contrast to normal versus high-normal BP categories which do not clearly 
distinguish normotensives with from those without end-organ changes, non-invasively 
determined aortic BP measurements may refine the ability to detect those with a 
normal/high-normal BP at risk of BP-related end-organ changes. 
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2.2 Introduction 
 
Although guidelines recommend threshold blood pressure (BP) values of 140/90 
mm Hg for the diagnosis of hypertension, BP is continuously associated with 
cardiovascular outcomes from values as low as 115/75 mm Hg (Lewington et al 2002). 
Prospective, observational studies indicate that those with BP values in the normal/high-
normal range (120-139/80-89 mm Hg) are at an increased risk for cardiovascular events 
(Hsia et al 2007, Conen et al 2007, Dorjgochoo et al 2009, Qureshi et al 2005, Vasan et al 
2001, Blake et al 2003, Liszka et al 2005, Gu et al 2009, Zhang et al 2006, Butler et al 
2011, Kshirsagar et al 2006). In addition, some randomised, controlled trials (Nissen et al 
2004, Remme et al 2009, Staessen and Jiguang 2001, Schrier et al 2002, Patel 2007) and 
meta-analyses of BP lowering trials (Trialists Collaboration 2003, Law et al 2009) in high 
risk patients support a view that treatment of those with a normal/high-normal BP has 
benefits for outcomes. In contrast, several more recent intervention studies suggest that 
antihypertensive treatment to thresholds lower than 140/90 mm Hg has no added benefit 
(Yusuf et al 2008, Cushman et al 2010, McMurray et al 2010). Contrasting results of 
intervention studies in normal/high-normal BP ranges (Law et al 2009, Cushman et al 
2010, Nissen et al 2004, McMurray et al 2010, Remme et al 2009, Staessen and Jiguang 
2001, Yusuf et al 2008, Schrier et al 2002, Trialists Collaboration 2003, Patel 2007, 
Cooper-DeHoff et al 2010) highlight the markedly variable BP-related risk conferred by a 
normal/high-normal BP. Strategies are therefore required to better identify those with a 
normal/high-normal BP at risk for BP-related cardiovascular outcomes. 
 One possible reason for the variable BP-related cardiovascular risk in those with a 
normal/high-normal BP is that brachial BP measurements may be insufficiently accurate 
for risk determination. In this regard, prior studies indicate that a number of those with a 
normal/high-normal BP may have aortic BP values that are more consistent with either an 
optimal or hypertensive BP range (McEniery et al 2008). As aortic BP as assessed using 
easy and reproducible non-invasive measurements is more closely associated with 
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cardiovascular outcomes than brachial BP (Safar et al 2002, Wang et al 2009, Benetos et 
al 2010, Benetos et al 2012, Regnault et al 2012, Jankowski et al 2008, Pini et al 2008, 
Roman et al 2007, Roman et al 2009), non-invasive aortic BP measurement may further 
refine cardiovascular risk in those with a normal/high-normal BP. To test this hypothesis, 
in the present study I therefore assessed whether aortic BP enhances the ability to identify 
independent relationships between BP and target organ changes in the normotensive 
range and whether “optimal” aortic BP thresholds may refine the ability to identify end-
organ changes in the normal/high-normal BP range. 
 
2.3 Methods 
 
The study protocol was approved by the University of the Witwatersrand 
Committee for Research in Human Subjects (approval numbers: M02-04-72 renewed as 
M07-04-69 and M12-04-108). Participants gave informed, written consent. The study 
design has previously been described (Norton et al 2008, Redelinghuys et al 2010, Norton 
et al 2012). Briefly, nuclear families of black African ancestry consisting of siblings with a 
minimum age of 16 years were randomly recruited from the South West Township 
(SOWETO) of Johannesburg, South Africa. Of the 1191 participants enrolled, 1169 had 
central aortic BP measurements and in these participants, carotid-femoral pulse wave 
velocity (PWV) was available in 1025 participants, estimated glomerular filtration rate 
(eGFR) in 944 participants, and in a substudy, echocardiographic data in 690 participants. 
782 participants had ambulatory BP recordings that met with pre-specified quality control 
criteria (longer than 20 hours and more than 10 and 5 readings for the computation of 
daytime and night-time means, respectively). 
 
 
 
 
61 
 
2.3.1 Clinical, demographic and anthropometric measurements.  
 
A standardized questionnaire was administered to obtain demographic data and 
information on each participant’s medical history, smoking habits, intake of alcohol, use of 
medication, and menopausal status (Norton et al 2008, Redelinghuys et al 2010, Norton 
et al 2012). Height and weight were measured with participants standing, wearing indoor 
clothing and no shoes. Body mass index (BMI) was calculated as weight in kilograms 
divided by height in meters squared. Participants were identified as being overweight if 
their body mass index (BMI) was ≥25 kg/m2 and obese if their BMI was ≥30 kg/m2. Waist 
circumference was measured using standard approaches. Laboratory blood tests of renal 
function, liver function, blood glucose, haematological parameters, lipid profiles and 
percentage glycated haemoglobin (HbA1C)(Roche Diagnostics, Mannheim, Germany) 
were performed. Diabetes mellitus was defined as the use of insulin or oral hypoglycaemic 
agents and an impaired blood glucose control was identified from an HbA1C>6.1% 
(Bennett et al 2007). 
 
2.3.2 Conventional and 24-hour BP.  
 
Nurse-derived conventional BP and 24-hour BP measurements were obtained as 
previously described (Norton et al 2008, Redelinghuys et al 2010). A trained nurse-
technician measured conventional (brachial) blood pressure (BP) using a standard 
mercury sphygmomanometer. After participants had rested in a seated position for five 
minutes brachial BP was measured five consecutive times, 30 to 60 seconds apart. The 
cuff was deflated at approximately 2 mm Hg per second and Korotkov phases I and V 
were employed to identify systolic and diastolic BP respectively. Care was taken to avoid 
auscultatory gaps. Standard cuffs were used with an inflatable bladder with a length of 
22 cm and a width of 12 cm except when arm circumference exceeded 31 cm, when 
larger cuffs with a 31 x 15 cm bladder were employed. The five readings were averaged to 
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obtain a single systolic and diastolic BP reading. Hypertension was defined as the 
presence of antihypertensive treatment or a mean conventional BP≥140/90 mm Hg; a 
high-normal BP as a conventional BP ≥130/85 and <140/90 mm Hg; a normal BP as a 
conventional BP ≥120/80 and <130/85 mm Hg; and an optimal BP as <120/80 mm Hg.  
 
2.3.3 Aortic BP and target organ changes.  
 
Aortic BP and carotid-femoral PWV were determined using applanation tonometry 
and SphygmoCor software as previously described (Norton et al 2008, Redelinghuys et al 
2010, Norton et al 2012, Shiburi et al 2006). After participants had rested for 15 minutes in 
the supine position, arterial waveforms were determined at the radial (dominant arm) 
pulse by applanation tonometry during an 8-second period using a high-fidelity SPC-301 
micromanometer (Millar Instrument, Inc., Houston, Texas) interfaced with a computer 
employing SphygmoCor, version 6.21 software (AtCor Medical Pty. Ltd., West Ryde, New 
South Wales, Australia) (Figure 2.1). Recordings where the systolic or diastolic variability 
of consecutive waveforms exceeded 5% or the amplitude of the pulse wave signal was 
less than 80 mV were discarded. The pulse wave was calibrated by manual measurement 
(auscultation) of BP taken immediately before the recordings. From a validated inbuilt 
transfer function an aortic waveform was generated from which central systolic, diastolic 
and mean arterial BP were derived (Figure 2.2). Central PP (PPc) was determined from 
SphygmoCor software and mean arterial pressure (MAP) was calculated as [central 
diastolic BP + 1/3(central PP)]. Although applanation tonometry at the carotid artery is the 
most accurate non-invasive assessment of the forward and augmented pressures, carotid 
tonometry cannot be reliably applied in obesity (Laurent et al 2006). Considering the high 
prevalence of obesity in the study participants (≈43%) I therefore assessed the pressure 
components of PPc using radial tonometry. 
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A Applanation tonometer. 
  B Electrocardiograph electrodes. 
  C SphygmoCor device. 
D Image of radial artery and aortic pressure waves recorded from a 
participant (see Figure 2.2 for further details).   
 
 
Figure 2.1 SphygmoCor device coupled to an applanation tonometer used to determine 
central (aortic) haemodynamics and aortic pulse wave velocity. 
A 
B 
C 
D 
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Second shoulder 
Second shoulder 
First shoulder 
First shoulder 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2. Example of a pulse wave recording obtained to determine central haemodynamics. The figure shows the radial artery pulse wave 
obtained from applanation tonometry (lower left panel) and the aortic pulse wave derived from a population-based transfer function built into the 
software (lower right panel). The first and second systolic shoulders are identified. See text for a further description. Quality control assessments 
are shown in the top panel. Sp, systolic blood pressure (BP); Dp, diastolic BP; MP, mean arterial pressure; PP, pulse pressure. 
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Aortic PWV was measured from sequential waveform measurements at carotid 
and femoral sites as previously described (Shiburi et al 2006) (Figure 2.3). The distance 
which the pulse wave travels was determined as the difference between the distance from 
the femoral sampling site to the suprasternal notch, and the distance from the carotid 
sampling site to the suprasternal notch. 
Estimated glomerular filtration rate (eGFR) was determined using the abbreviated 
Modification of Diet in Renal Disease (MDRD) study group equation: 186.3 x (serum 
creatinine in mg/decilitre-1.154) x (age in years-0.203) x 1.212 x 0.742 (if female) (Levey et al 
1999). 
Echocardiographic measurements of left ventricular (LV) diastolic dimensions were 
performed using previously described methods (Norton et al 2008, Woodiwiss et al 2009, 
Norton et al 2012) (Figure 2.4). Left ventricular end diastolic internal diameter and septal 
(anterior wall) and posterior wall thickness were determined from transthoracic two-
dimensional targeted M-mode echocardiographic images obtained in the parasternal long-
axis as previously described. Variables were analysed according to the American Society 
of Echocardiography convention (Sahn et al 1978). All measurements were recorded and 
analysed off-line by experienced investigators (Carlos D Libhaber and Angela J 
Woodiwiss) who were unaware of the clinical data of the participants and whom had a low 
degree of inter- and intra-observer variability (Norton et al 2008, Woodiwiss et al 2009, 
Norton et al 2012). Only M-mode images of acceptable quality were analysed. In this 
regard, acceptable quality was considered to exist when appropriate visualization of both 
the right and the left septal surfaces occurred and where the endocardial surface of the 
septal and posterior wall were clearly visible when imaging at the optimal angle of 
incidence (perpendicular to the posterior wall) and close to the mitral leaflets. Left 
ventricular mass was derived according to an anatomically validated formula (Devereux et 
al 1986) and indexed to height2.7 (LVMI). 
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Figure 2.3 Representative example of simultaneous carotid pulse wave and electrocardiogram (ECG) recording and simultaneous femoral pulse 
wave and electrocardiogram recording. The speed of aortic wave travel is determined from difference between time A and time B. 
Femoral Pulse  
 
 
ECG 
Carotid Pulse 
 
 
ECG 
A 
B 
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Figure 2.4. Representative example of a two-dimensional directed M-mode 
echocardiogram recording showing the dimension measurements employed to calculate 
left ventricular mass index. Note the position of the cursor in the long axis view of the left 
ventricle. SEPED = Septal wall thickness in end diastole. PWED = Posterior wall 
thickness in end diastole. SEPES = Septal wall thickness in systole. PWES = Posterior 
wall thickness in systole. LVEDD = Left ventricle internal diameter in end diastole. LVESD 
= Left ventricle internal diameter in end systole. 
LVEDD 
SEPED 
PWED 
SEPES 
LVESD 
PWES 
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2.3.4 Data analysis.  
 
For database management and statistical analysis, SAS software, version 9.1 
(SAS Institute Inc., Cary, NC) was employed. Unadjusted means and proportions were 
compared by the large-sample z-test and the χ2-statistic, respectively. Optimal thresholds 
for aortic and 24-hour BP were identified from upper 95% confidence intervals obtained in 
311 participants with optimal conventional BP values and without diabetes mellitus, 212 of 
whom had 24-hour BP measurements that met with pre-specified quality control criteria. 
The aortic systolic BP threshold was identified as 112 mm Hg and the 24-hour systolic 
and diastolic BP thresholds as 123 and 78 mm Hg respectively. Differences in indices of 
organ changes between participants in categories of BP and independent relations 
between BP and target organ changes were determined using multivariate regression 
analysis with adjustments for age, sex, BMI, diabetes mellitus and/or an HbA1c>6.1%, 
regular tobacco use, regular alcohol intake and pulse rate in the models. To determine 
probability values, further adjustments for non-independence of family members was 
performed using non-linear regression analysis (mixed procedure as defined in the SAS 
package). 
 
2.4 Results 
 
2.4.1 Characteristics of participants in categories of BP.  
 
Of the total sample 27.3% of participants had either normal or high-normal BP. 
16.5% had a normal BP and 10.8% had high-normal BP values. Age, BMI, waist 
circumference, and the frequency of participants who were overweight or obese were 
intermediate in those with a normal or high-normal BP between values noted in persons 
with an optimal BP and in hypertensives (Table 2.1). Hypertensives, but not those with a 
69 
 
Table 2.1 Characteristics of study participants. 
BP categories      Optimal         Normal            High-normal          Hypertensives 
BP range (mm Hg)     <120/80          ≥120/80 and            ≥130/85 and      ≥140/90 or 
              <130/85  <140/90   Treatment 
_________________________________________________________________________________ 
Sample size (% female)    311 (69.1)       193 (62.7)             126 (61.1)             539 (64.9)  
Age (years)      30.7±12.4       34.0±13.6              40.2±16.8***††            55.1±15.0***†††## 
Body mass index (kg/m2)   25.3±6.3        28.0±8.1**  29.6±8.0***†             32.4±7.9***†††##      
Waist circumference (cm)   80.6±13.9         86.2±15.5**  89.2±15.1***             97.6±15.4***†††## 
% Overweight/obese    21.2/22.5         22.8/32.6*   22.2/43.7**  23.9/57.9***†††#  
Regular tobacco intake (%)      13.8           18.7      16.7    14.3 
Regular alcohol intake (%)      18.7            21.8      25.4   21.9       
% with DM or HbA1C>6.1%      10.0           15.0  10.3              41.4***†††## 
Pulse rate (beats/min)  69.5±11.3        69.5±10.9   69.0±11.0  69.4±10.3 
total/HDL cholesterol   3.13±1.17        3.22±1.06   3.60±1.53  3.84±1.26***†† 
_________________________________________________________________________________ 
BP, blood pressure; DM, diabetes mellitus; HbA1C, glycosylated haemoglobin; HDL:, high density lipoprotein. *p<0.05, **p<0.005, ***p<0.0001 
vs optimal; †p<0.05, ††p<0.005, †††p<0.0005 vs normal; #p<0.005, ##p<0.0001 vs high-normal.
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normal or high-normal BP, had more diabetes mellitus and/or an impaired blood glucose 
control, and an increased total/HDL cholesterol (Table 2.1). No differences were noted 
between BP categories in regular alcohol and tobacco intake or pulse rate (Table 2.1). 
 
2.4.2 Blood pressures and proportions with elevated aortic or ambulatory BP within BP 
categories.  
 
Conventional, 24-hour and central aortic BP values were intermediate in those with 
a normal or high-normal BP between values noted in persons with an optimal BP and in 
hypertensives (Table 2.2). A greater proportion of hypertensives as well as those with a 
normal or high-normal BP had aortic systolic BP values that exceeded that of the upper 
95% confidence intervals of healthy participants with an optimal BP (Table 2.2). Of those 
with a normal/high-normal BP, 45% had an aortic systolic BP that did not exceed the 
upper 95% confidence intervals of healthy participants with an optimal BP. A greater 
proportion of hypertensives and those with high-normal BP values, but not those with 
normal BP values had 24-hour systolic and diastolic BP values that exceeded that of the 
upper 95% confidence intervals of healthy participants with an optimal BP (Table 2.2). 
  
2.4.3 Continuous relationships between various measures of BP and target organ 
changes in normotensive participants.  
 
In normotensive participants (BP<140/90 mm Hg and no antihypertensive 
treatment), with adjustments for confounders, conventional and central aortic BP were 
correlated with target organ changes (Table 2.3). After further adjustments for aortic BP, 
the relationship between conventional BP and target organ changes in normotensives was 
abolished. In contrast, with further adjustments for conventional BP, aortic BP retained 
independent relationships with target organ changes in normotensives (Table 2.3). In 
addition, with further adjustments for 24-hour systolic BP, aortic BP also retained  
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Table 2.2. Blood pressures (BP) of study participants. 
BP categories           Optimal                  Normal            High-normal           Hypertensives 
BP range (mm Hg)       <120/80             ≥120/80 and           ≥130/85 and             ≥140/90 or 
                      <130/85    <140/90  Treatment 
________________________________________________________________________________________ 
Sample size        311           193           126       539  
Conventional SBP/DBP (mm Hg) 108±7/72±6   119±7/80±4***        128±8/86±4***†††       146±22/92±13***†††### 
Aortic SBP (mm Hg)   100±13     110±7***            119±8***†††                  136±22***†††### 
Aortic pulse pressure (mm Hg)         26.6±11.0     29.1±7.5           33.6±8.8*           43.5±16.7***†††### 
24-hour SBP (mm Hg)(n)             109±9(212)   113±9*(134)         117±11***†††(84)        127±16***†††###(352) 
24-hour DBP (mm Hg)(n)   67±7(212)    69±7(134)               72±7*(84)        78±11***†††###(352) 
n (%) with aortic SBP>threshold‡    16 (5)      75 (39)***           99 (80)***†††           471 (88)***†††# 
n (%) with 24-hour SBP>threshold‡‡    12 (6)      16 (12)                  21 (25)*†          201 (57)***†††###  
n (%) with 24-hour DBP>threshold‡‡    11 (5)       10 (8)                   18 (21)**††           147 (42) ***†††##  
___________________________________________________________________________________________     
SBP, systolic BP; DBP, diastolic BP. ‡Upper threshold for aortic SBP in those with an optimal conventional BP=112 mm Hg; ‡‡Upper threshold 
for 24-hour SBP/DBP in those with an optimal conventional BP=123/78 mm Hg. *p<0.05, **p<0.005, ***p<0.0001 vs optimal; †p<0.05, 
††p<0.005, †††p<0.0005 vs normal; #p<0.05, ##p<0.005, ###p<0.0001 vs high-normal. 
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Table 2.3. Multivariate adjusted relationships between systolic blood pressure (SBP) and 
target organ changes in normotensive participants (conventional BP<140/90 mm Hg). 
      
BP vs               n     partial r      CI         p-value partial r       CI           p-value             
______________________________________________________________________ 
                                                 SBPc adjusted for*           SBPc adjusted for aortic SBP+*        
Pulse wave velocity  568    0.24   0.16 to 0.32   <0.0001      0.05    -0.03 to 0.13     =0.24  
Estimated GFR         501   -0.10   -0.19 to -0.01 <0.05  0.06    -0.03 to 0.14    =0.22 
LV mass index           372   0.20   0.10 to 0.30   <0.0001     -0.05    -0.15 to 0.06    =0.36 
 
                                              Aortic SBP adjusted for*      Aortic SBP adjusted for SBPc+*     
Pulse wave velocity  568    0.26   0.18 to 0.34   <0.0001  0.12   0.04 to 0.20     <0.005 
Estimated GFR         501   -0.17  -0.25 to -0.08 <0.0005 -0.15  -0.23 to -0.06    =0.001 
LV mass index          372    0.28   0.18 to 0.37   <0.0001  0.20   0.10 to  0.30    =0.0001 
______________________________________________________________________ 
CI, confidence intervals; SBPc, conventional systolic BP; GFR, glomerular filtration rate; 
LV, left ventricle. *Adjustments are for age, sex, BMI, diabetes mellitus and/or an 
HbA1c>6.1%, regular tobacco intake, regular alcohol intake and pulse rate. 
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independent relationships with target organ changes in normotensives (PWV; partial 
r=0.18, confidence intervals=0.08 to 0.28, p<0.0005, n=389; eGFR; partial r= -0.15, 
confidence intervals= -0.25 to -0.04, p<0.01, n=342; LVMI; partial r=0.22, confidence 
intervals=0.10 to 0.33, p<0.0005, n=265). 
 
2.4.4 Target organ changes in those with a normal or high-normal BP irrespective of 
aortic BP.  
 
Before adjustments for confounders, as compared to participants with optimal BP 
values, hypertensives and those with either normal or high-normal BP values had a 
markedly increased PWV and LVMI and decreased eGFR (Table 2.4). However, after 
adjustments for confounders, only modest target organ changes were noted in those with 
a normal or high-normal BP (Table 2.4). Moreover, normal versus high-normal BP 
categories failed to distinguish between those with and without target organ changes 
(Table 2.4). 
 
2.4.5 Aortic BP distinguishes target organ changes in those with a normal/high-normal 
BP.  
 
As compared to those with an optimal BP, both unadjusted and multivariate 
adjusted target organ changes were consistently noted in those with a normal/high-normal 
BP with, but not in those without aortic systolic BP values≥upper 95% confidence interval 
for healthy participants with optimal BP values (Table 2.5). Importantly, even those with a 
normal as opposed to high-normal conventional BP values, but whom had an aortic BP 
that exceeded “optimal” values had multivariate adjusted decreases in eGFR  
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Table 2.4. Unadjusted and multivariate adjusted indices of target organ changes of study participants. 
 
 BP categories         Optimal                Normal          High-normal            Hypertensives 
BP range (mm Hg)        <120/80               ≥120/80 and             ≥130/85 and          ≥140/90 or 
                <130/85              <140/90                Treatment 
______________________________________________________________________________________ 
Unadjusted values 
PWV (m/sec)(n)               4.83±1.24(289)     5.36±1.55*(172)      6.09±1.97**(107)     7.90±2.99***†††###(457)  
eGFR (mls/min/1.73 m2)(n)   128±32(244)          122±29*(153)      111±28**(104)         103±28***†††#(443) 
LV mass index (g/m2.7)(n)   35.5±10.2(181)      41.1±11.2**(117)      42.2±13.3**(74)      47.5±15.8***†††##(318) 
 
Multivariate adjusted values 
PWV (m/sec)(n)    5.89±2.21(289)       6.15±1.97(172)      6.34±1.97(107)     6.87±2.35***†††#(457)   
eGFR (mls/min/1.73 m2)(n)     117±31(244)          113±28(153)      108±27*(104)          113±31(443) 
LV mass index (g/m2.7)(n)   40.3±14.4(181)      43.6±13.0*(117)      42.4±12.6(74)       43.8±14.6*(318) 
_______________________________________________________________________________________ 
BP, blood pressure; PWV, aortic pulse wave velocity; eGFR, estimated glomerular filtration rate; LV, left ventricle. Adjustments are for age, sex, 
BMI, diabetes mellitus and/or an HbA1c>6.1%, regular tobacco use, regular alcohol intake and pulse rate. *p<0.05, **p<0.005, ***p<0.0001 vs 
optimal; †p<0.05, ††p<0.005, †††p<0.0005 vs normal; #p<0.05, ##p<0.005, ###p<0.0001 vs high-normal. 
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Table 2.5. Unadjusted and multivariate adjusted indices of target organ changes of prehypertensives with (Yes) or without (No) aortic 
systolic blood pressures (SBP) greater than thresholds (112 mm Hg) defined in those with optimal conventional BP values.  
 
Blood pressure categories         Optimal                        Normal/high-normal         Hypertensives 
Blood pressure range (mm Hg)     <120/80                  ≥120/80 and <140/90            ≥140/90 or        
    with aortic SBP≥112 mm Hg                   Treatment 
                      No         Yes 
_________________________________________________________________________________________________________ 
Unadjusted values 
Pulse wave velocity (m/sec)(n)      4.83±1.24(289)      5.07±1.30 (128)    6.12±1.94***†††(151)   7.90±2.99***†††###(457)    
Estimated GFR (mls/min/1.73 m2)(n)      128±32(244)          126±32(108)        111±26***†††(149)     103±28***†††##(443) 
LV mass index (g/m2.7)(n)       35.5±10.2(181)      38.2±11.0(82)        44.0±12.1***†††(109)  47.5±15.8***†††#(318) 
 
Multivariate adjusted values 
Pulse wave velocity (m/sec)(n)      5.89±2.21(289)      6.09±2.05(128)      6.30±1.95*(151)      6.87±2.29***†††##(457)    
Estimated GFR (mls/min/1.73 m2)(n)     118±29(244)           115±27(108)        108±26**†(104)      112±30*(443) 
LV mass index (g/m2.7)(n)      40.0±14.3(181)       40.7±13.2(82)        44.5±12.6**†(109)     44.0±14.6*(318) 
_________________________________________________________________________________________________________ 
eGFR, estimated glomerular filtration rate LV, left ventricle. Adjustments are for age, sex, BMI, diabetes mellitus and/or an HbA1c>6.1%, 
regular tobacco use, regular alcohol intake and pulse rate. *p<0.05, **p<0.005, ***p<0.0001 vs optimal; †p<0.05, ††p<0.005, †††p<0.0005 vs 
aortic BP<112 mm Hg; #p<0.05, ##p<0.005, ###p<0.0001 vs aortic BP≥112 mm Hg. 
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(mls/min/1.73 m2)(108±4 vs 116±2, p<0.05) and increases in LVMI (g/m2.7)(46.7±1.8 vs 
40.8±1.2, p<0.005). 
 
2.5 Discussion 
  
The main findings of the present study are as follows: First, in a randomly selected 
community sample, although a normal/high-normal BP was noted in 27% of the sample, 
45% of these participants had central aortic BP values that did not exceed the upper 95% 
confidence interval of aortic BP values in healthy participants with optimal BP values. 
Second, normal and high-normal BP categories failed to identify those with target organ 
changes. In contrast, in those with either a normal or high-normal BP, aortic BP values 
above “optimal” thresholds clearly identified those with target organ changes. 
Persons with a BP in the normal/high-normal range are considered at sufficient 
risk to warrant antihypertensive therapy if in-part they have diabetes mellitus, or 
established cardiovascular or renal disease (Mancia et al 2007). However, intervention 
studies targeting high risk patients with pre-existing cardiovascular disease or diabetes 
mellitus have produced discrepant outcomes (Law et al 2009, Cushman et al 2010, 
Nissen et al 2004, McMurray et al 2010, Remme et al 2009, Staessen and Jiguang 2001, 
Yusuf et al 2008, Schrier et al 2002, Trialists Collaboration 2003, Patel 2007, Cooper-
DeHoff et al 2010). This approach nevertheless assumes that most high risk patients with 
normal/high-normal conventional BP values would benefit from BP lowering therapy. In 
contrast, as indicated in the present study, in those participants with normal/high-normal 
BP values whom also had “optimal” aortic BP values (45% of participants), no evidence of 
target organ changes were noted. Thus, a high proportion of persons with a normal/high-
normal BP are not at risk for BP-related sub-clinical cardiovascular disease. 
As suggested by guidelines (Mancia et al 2007), the presence of organ damage 
may identify persons with a BP in the high-normal range at sufficient risk to warrant 
antihypertensive therapy. Indeed, two recent studies indicate that by adding markers of 
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sub-clinical cardiovascular disease to traditional risk assessment, risk prediction may be 
considerably improved (Sehestedt et al 2009, Sehestedt et al 2010). However, the mean 
BP values in those experiencing a cardiovascular event in the one study (Sehestedt et al 
2010) suggest that almost half of these participants were hypertensive. Moreover, in the 
other study (Sehestedt et al 2009), 42% were hypertensives. Thus, in neither of these 
studies (Sehestedt et al 2009, Sehestedt et al 2010) can conclusions be drawn from data 
obtained only in the normotensive range. Moreover, in these studies (Sehestedt et al 
2009, Sehestedt et al 2010), the presence of sub-clinical cardiovascular disease identified 
using one measure of target organ change, did not necessarily imply the presence of sub-
clinical cardiovascular disease using another measure. Thus, the benefit of target organ 
assessment would require the evaluation of sub-clinical cardiovascular disease in multiple 
organs (Sehestedt et al 2009, Sehestedt et al 2010). This combined approach would incur 
considerable costs, necessitate the use of trained technicians, and not necessarily identify 
organ damage attributed to BP effects as opposed to alternative risk factors. In contrast, 
aortic BP measurements are simple, reliable and reproducible, are likely to incur 
considerably lower costs, and reflect the impact of BP rather than alternative risk factors. 
 In the present study 39% of those with a BP in the normal conventional BP range 
as compared to 80% in the high-normal BP range had aortic BP values that exceeded 
“optimal” values. Rather than measure aortic BP, a more cost-effective approach could 
therefore be to treat those with a high-normal, but not a normal BP. However, 75 of the 
total sample of 319 participants with a normal or high-normal conventional BP had a 
normal conventional, but an increased aortic BP. Importantly, these individuals had 
multivariate adjusted decreases in eGFR and increases in LVMI. Hence, approximately 
one quarter of all those with a normal/high-normal BP at risk of sub-clinical cardiovascular 
disease would be excluded from potentially necessary antihypertensive therapy if 
treatment were withheld from those with a normal BP. Clearly, this dilemma would be 
avoided if aortic BP rather than normal versus high-normal conventional BP categories 
were employed to identify at-risk persons. 
78 
 
 In the present study, in those with normal/high-normal BP values, aortic BP was 
associated with an increased PWV, an index of aortic stiffness. This relationship may be 
explained, not only by an effect of BP on aortic stiffness, but also by an impact of aortic 
stiffness on central BP. If increases in aortic stiffness mediate aortic BP changes in those 
with normal/high normal BP values, therapeutically targeting aortic stiffness may prevent 
the progression to hypertension. In this regard, a normal/high-normal BP is a risk factor for 
the development of hypertension and progression to hypertension may occur within 10 
years in 80% of those with a normal/high-normal BP (Moreira et al 2008). 
The present results suggest that assessing the impact of BP lowering therapy on 
cardiovascular outcomes in those with normal/high-normal BP values may warrant the 
selection of only those participants with central aortic BP values that exceed optimal 
values. If this approach were adopted, a decrease in the heterogeneity of the impact of BP 
lowering therapy on outcomes may occur in those with a normal/high-normal BP, which as 
outcome studies have demonstrated (Law et al 2009, Cushman et al 2010, Nissen et al 
2004, McMurray et al 2010, Remme et al 2009, Staessen and Jiguang 2001, Yusuf et al 
2008, Schrier et al 2002, Trialists Collaboration 2003, Patel 2007, Cooper-DeHoff et al 
2010), is large. 
 In normotensives from the present randomly selected community sample, only 
14% had day BP values that exceeded 135/85 mm Hg (masked hypertension). In 
contrast, in employees of a university hospital or private company (Shimbo et al 2012) or 
in referrals to a hypertension clinic (Manios et al 2011) 34% and 24.7% respectively of 
those with a normal/high-normal BP had masked hypertension and only those with 
masked hypertension had target organ changes. As masked hypertension is 
independently associated with cardiovascular outcomes, it is possible that ambulatory BP 
monitoring also has an important role to play in further refining risk in those with a 
normal/high-normal BP, at least in groups with a high prevalence of masked hypertension. 
The limitations of the present study include the cross-sectional design which 
prevents conclusions being drawn regarding cause and effect, and the use of target organ 
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changes as surrogates for risk. Prospective studies are therefore required to assess 
whether aortic BP measurements identify earlier separation of curves describing 
cardiovascular outcomes in those with a normal/high-normal BP as compared to those 
with an optimal BP. In this regard, those persons with a normal/high-normal BP may 
experience significantly more cardiovascular events only 10-15 years after detection 
(Fukuhara et al 2012). Moreover, the present study was conducted only in a group of 
black African ancestry. Corroboration of the present findings is required in other ethnic 
groups. Last, as thresholds for central aortic BP values have not been identified from 
outcome-based studies, thresholds were identified from participants with optimal brachial 
BP values.  
 In conclusion, in contrast to the lack of ability of normal or high-normal BP 
categories to identify normotensives with target organ changes, in the present study I 
show that in normotensives, “optimal” central aortic BP values clearly identify the 
presence of target organ changes. Thus, the use of aortic BP measurements may 
enhance the ability to risk stratify those with a normal/high-normal brachial BP. Whether 
further refinement of risk stratification in pre-hypertensives may be achieved by assessing 
the impact of reflected waves, which have been demonstrated in several studies to predict 
outcomes beyond brachial BP (Wang et al 2010, Weber et al 2012, Chirinos et al 2012, 
Torjesen et al 2014), requires further study. This question was addressed in Chapter 4. 
However, before this question could be answered I first evaluated whether whether 
indices of pressure augmentation are sufficient to assess the impact of wave reflection on 
age-related increases in aortic pressure or end-organ changes across the adult lifespan or 
whether reflected wave effects should be assessed from wave separation analysis? This 
question was addressed in the next chapter (Chapter 3).  
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Chapter 3 
 
 
 
Indexes of Aortic Pressure Augmentation Markedly Underestimate the 
Contribution of Reflected Waves Toward Variations in Aortic Pressure 
and Left Ventricular Mass. 
 
The data in this chapter has been accepted for publication in the journal Hypertension:   
Booysen, H.L., Woodiwiss, A. J., Moekanyi, J. S., Hodson, B., Raymond, A., Libhaber, E., 
Sareli, P., Norton, G. R. (2015) Indexes of aortic pressure augmentation markedly 
underestimates the contribution of reflected waves toward variations in aortic pressure and 
left ventricular mass. Hypertension, 65(3), 540-546 (reprint provided in appendix 3).   
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3.1 Abstract 
 
Although indices of aortic wave reflection enhance risk prediction, the extent to 
which measures of aortic systolic pressure augmentation (augmented pressures [Pa] or 
augmentation index [AIx]) underestimate the effects of reflected waves on cardiovascular 
risk is uncertain. In participants from a community sample (age>16 years) the relative 
contribution of reflected (backward wave pressures [Pb] and the reflection index [RI]) 
versus augmented (Pa and AIx) pressure wave indices to variations in central aortic pulse 
pressure (PPc) (n=1185), and left ventricular mass index (LVMI [n=793]) were compared. 
Aortic haemodynamics and LVMI were determined using radial applanation tonometry 
(SphygmoCor) and echocardiography. Independent of confounders, RI and Pb contributed 
more than forward wave pressures (Pf), whilst Pa and AIx contributed less than incident 
wave pressure (Pi) to variations in PPc (p<0.0001 for comparison of partial r values). In 
those <50 years of age, while Pb (partial r=0.28, p<0.0001) contributed more than Pf 
(partial r=0.15, p<0.001, p<0.05 for comparison of r values), Pa (partial r=0.13, p<0.005) 
contributed to a similar extent as Pi (partial r=0.22, p<0.0001) to variations in LVMI. 
Further, in those ≥50 years of age, Pb (partial r=0.21, p<0.0001), but not Pf (p=0.98), 
whilst Pi (partial r=0.23, p<0.0001), but not Pa (p=0.80) were associated with LVMI. Thus, 
as compared to relations between indices of aortic pressure augmentation and PPc or 
LVMI, strikingly better relations are noted between aortic wave reflection and PPc or 
LVMI. 
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3.2 Introduction 
 
Although pulse pressure (PP) measured at the brachial artery is closely correlated 
with central aortic PP (PPc), PP may be considerably higher in brachial arteries as 
compared to the aorta (Avolio et al 2009, Agabiti-Rosei et al 2007). A key determinant of 
PPc is an increase in aortic wave reflection, which enhances backward wave pressures 
(Pb) and hence augments aortic systolic blood pressure (BP) if returning to the ascending 
aorta sufficiently early (Avolio et al 2009, Agabiti-Rosei et al 2007). An enhanced aortic 
wave reflection is thought to be a major cause of cardiovascular damage. Indeed, several 
studies have demonstrated that aortic augmented pressures (Pa), and augmentation 
index (AIx), indices of wave reflection, are associated with cardiovascular outcomes 
(London et al 2001, Ueda et al 2004, Weber et al 2005, Chirinos et al 2005b, 
Vlachopoulos et al 2005) and sub-clinical cardiovascular disease (Hashimoto et al 2007, 
Hashimoto et al 2006, Weber et al 2006, Westerbacka et al 2005, Sibiya et al 2014) 
independent of brachial BP. Although in several of these studies (Davies et al 2010, 
Hughes et al 2013, Fok et al 2014), the method of wave intensity analysis has been 
seriously questioned on methodological and theoretical grounds (Segers et al 2015), and 
Fok et al (2014) report an impossible flow-frequency response, apparently hand-drawn 
representative waves are shown, and control impedance values are given that differ 
markedly from Yaginuma et al (1985), more recently the use of Pa or AIx as indices of 
wave reflection in risk prediction has been challenged (Davies et al 2010, Cheng et al 
2012, Hughes et al 2013, Fok et al 2014, Torjesen et al 2014, Schultz et al 2013). 
Although in several of these studies (Davies et al 2010, Hughes et al 2013, Fok et 
al 2014), the method of wave intensity analysis has been seriously questioned on 
methodological and theoretical grounds (Segers et al 2015), and Fok et al (2014) report 
an impossible flow-frequency response, apparently hand-drawn representative waves are 
shown, and control impedance values are given that differ markedly from Yaginuma et al 
(1985), marked overlap between aortic forward and reflected waves may confound Pa and 
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AIx (Cheng et al 2012, Fok et al 2014, Torjesen et al 2014, Schultz et al 2013) and hence 
these measures may be poor indices of wave reflection. Indeed, there is a weak 
relationship between the magnitude of the reflected wave and Pa or AIx with increases in 
the timing or magnitude of the forward (Pf) or incident (Pi) wave pressures, and left 
ventricular systolic function playing a more important role than wave reflection in 
contributing to variations in Pa and AIx (Cheng et al 2012, Hughes et al 2013, Fok et al 
2014, Torjesen et al 2014, Schultz et al 2013). More recent studies have therefore 
focussed on the role of reflected waves (Pb and reflected wave index-RI), as determined 
using wave separation analysis, as independent determinants of age-related increases in 
PPc or sub-clinical cardiovascular disease (Wang et al 2010, Chirinos et al 2012, Weber 
et al 2012, Zamani et al 2014, Cooper et al 2014). However, in these studies (Wang et al 
2010, Chirinos et al 2012, Weber et al 2012, Zamani et al 2014, Cooper et al 2014) the 
extent to which Pb or RI are more closely associated with PPc or sub-clinical 
cardiovascular disease than Pa or AIx is uncertain. In this regard in these studies, 
relations with sub-clinical cardiovascular disease were not adjusted for confounders 
(Wang et al 2010, Weber et al 2012) discrepancies in the index of wave reflection that 
was better associated with sub-clinical cardiovascular disease beyond forward wave 
pressures were noted (Wang et al 2010,  Weber et al 2012); and whether the increase in 
forward wave pressures at 50 years of age impacts on these relations was not considered 
(Wang et al 2010, Chirinos et al 2012, Weber et al 2012). In addition, although in the 
Framingham Heart Study little difference in aortic and brachial BP was noted across the 
adult lifespan (Mitchell et al 2010b), an effect that has been explained on the basis of the 
application of tonometry at a site where the principles of tonometry cannot be achieved 
(brachial artery to calibrate the carotid artery pulse) (O’Rourke et al 2010), aortic forward 
wave pressure rather than Pb was reported to be the main determinant of PPc and 
outcomes (Mitchell et al 2010b, Cooper et al 2014). To clarify the extent to which indices 
of aortic systolic pressure augmentation underestimate the impact of wave reflection on 
cardiovascular disease, in the present study I therefore aimed to evaluate, in a large 
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community-based sample with a high prevalence of uncontrolled BP, the degree to which 
Pb or RI are more closely related to multivariate adjusted increases in PPc and left 
ventricular mass index (LVMI) beyond forward wave pressures than Pa or AIx, and 
whether these effects are age-specific. 
 
3.3 Methods 
 
3.3.1 Study group. 
 
The present study has been described in chapter 2, page 60. In the present 
analysis 1185 participants were evaluated and in a sub-study, 793 participants had LVMI 
determined using echocardiography. 
 
3.3.2 Clinical, demographic and anthropometric measurements. 
 
The clinical, demographic and anthropometric measurements have been 
described in chapter 2, page 61. 
 
3.3.3 Pulse wave analysis. 
 
Central aortic blood pressures were estimated using radial applanation tonometry 
and SphygmoCor software as described in chapter 2, page 62 (Sibiya et al 2014). Aortic 
augmented pressure (Pa) was determined using SphygmoCor software and identified as 
the difference between SBPc and the first systolic peak of the aortic pulse wave. Incident 
wave pressure (Pi) was defined as PPc-Pa. To avoid obtaining negative aortic AIx values 
in young participants, AIx was determined as the pressure at the second systolic peak of 
the aortic pulse wave/the pressure at the first systolic peak of the aortic pulse wave 
expressed as a percentage. Pb and Pf were determined using SphygmoCor software 
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which separates the aortic waveform using a triangular flow wave (Westerhof et al 2006). 
Reflected wave index (RI) was calculated as Pb/(Pf+DBP) as previously described 
(Hughes et al 2013). In the present study I did not employ a “physiological aortic flow 
waveform” approach to wave separation analysis as in a pilot study conducted in 26 
participants, the previously described physiological aortic flow waveform (Kips et al 2009) 
did not closely approximate aortic flow waveforms in the present community sample. 
Moreover, a wide variety of aortic flow waveforms were identified in the 26 participants 
studied, precluding the possibility of identifying a single “representative waveform” which 
could be used for wave separation analysis. 
 
3.3.4 Echocardiography. 
 
Left ventricular mass (LVM) and stroke volume were determined from 
transthoracic two-dimensional targeted M-mode echocardiographic images obtained in the 
parasternal long-axis view as largely described in chapter 2, page 65 (Sibiya et al 2014). 
Left ventricular mass was indexed (LVMI) to body surface area (LVMI-BSA) or height1.7 
(LVMI-ht1.7). Left ventricular hypertrophy (LVH) was identified as an LVMI-BSA>95 g/m2 
for women and >115 g/m2 for men. Stroke volume was evaluated from the difference 
between LV end diastolic and systolic volumes determined using the Z-derived method 
(de Simone et al 1996). 
 
3.3.5 Data analysis. 
 
For database management and statistical analysis, SAS software, version 9.1 
(SAS Institute Inc., Cary, NC) was employed. To determine relationships multivariate 
regression analysis was performed with appropriate adjustments. Adjustments included in 
multivariate models were those correlated with central haemodynamic variables or LVMI 
in bivariate analysis. To assess the relative contribution of incident and augmented waves 
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to variations in PPc, in stepwise regression analysis, Pi and AIx were included in 
multivariate models. AIx rather than Pa was included in the same regression model with Pi 
to avoid the confounding effect of forward wave amplitude on the amplitude of the 
augmented wave (Mitchell et al 2010b). To determine probability values, further 
adjustments for non-independence of family members was performed using non-linear 
regression analysis (mixed procedure as defined in the SAS package). As a sharp age-
related increase in Pf and Pi occurred between 40 and 50 years of age, relationships 
between aortic haemodynamic variables and PPc or LVMI were evaluated in participants 
< or ≥50 years of age. To ensure that relationships occured independent of the use of 
antihypertensive therapy, sensitivity analysis was conducted in participants not receiving 
antihypertensive therapy. Regression coefficients were compared with z statistics. 
 
3.4 Results 
 
3.4.1 Characteristics of the participants. 
 
The clinical and demographic characteristics of the participants are shown in Table 
3.1. 1.9% of participants had a history of cardiovascular disease. Importantly, a high 
proportion (45.9%) of participants had hypertension, and 47.2% of hypertensives were not 
receiving therapy. Moreover, 36.4% of all participants and 60.6% of participants receiving 
antihypertensive therapy had uncontrolled hypertension. Of the participants with 
echocardiography, 17% had LVH. 
 
3.4.2 Age-related increases in aortic haemodynamics. 
 
Pb, Pa and RI increased linearly across the adult lifespan, whilst Pf and Pi 
increased from between 40 and 50 years of age (Figure 3.1). In contrast, age-related 
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increases in AIx showed an increase in early life, which peaked at 50 years and then 
failed to further increase with age (Figure 3.1). In multivariate-adjusted models, including  
Table 3.1. Characteristics of the study sample. 
 
Characteristics         All               <50 years    ≥50 years 
      (n=1185)    (n=703)    (n=482) 
____________________________________________________________________ 
% Female               65.0       64.6     65.8     
Age (years)                  44.3±18.3   31.4±10.0 63.0±9.2   
Body mass index (kg/m2)                         29.6±8.1   27.4±7.4 32.7±8.0   
% Obese                   43.3       32.9      58.5      
Regular tobacco (% subjects)                            15.2       17.1     12.5       
Regular alcohol (% subjects)                  20.9                   23.6     17.0      
% with DM or HbA1c>6.1%                               25.8                  12.4     45.4        
% Hypertensive        45.9                  24.0     77.8       
% Treated for hypertension                  24.2                  6.3      50.4       
% Hypertensives controlled to target BP           20.8                 13.0      24.3       
% of all with uncontrolled BP                  36.4                 20.9      58.9            
Pulse rate (beats/min)                                      66±12               65±11     67±13                             
Brachial SBP/DBP (mm Hg)                     130±22/84±13    121±17/81±12  143±23/88±12  
Brachial pulse pressure (mm Hg)                  46±16                 39±13               53±18      
Brachial mean arterial pressure (mm Hg)     100±16                95±14              108±16   
Central aortic SBP (mm Hg)                          120±23              111±18             133±23   
Central aortic pulse pressure (PPc) (mm Hg) 35±15                29±11               44±16             
Aortic forward wave pressure (Pf) (mm Hg)    24±9                  21±7                 28±10    
Aortic reflected wave pressure (Pb)(mm Hg)  17±8                  14±6                  22±9   
Aortic reflected wave index                          0.16±0.06          0.13±0.04         0.19±0.06   
Aortic augmented pressure (Pa)                     11±8                    7±6        15±8 
Aortic Pi                                                           25±9                   22±7         29±10 
Aortic augmentation index (AIx) (%)             142±25                135±24              153±23  
Stroke volume (mls)(n)                              63±17 (793)         61±16 (468)     65±18 (325) 
Left ventricular mass index (g/m2)(n)        76±31 (793)          70±27 (468)     84±34 (325) 
Left ventricular mass index (g/m1.7)(n)      67±24 (793)          61±20 (468)     76±27 (325) 
____________________________________________________________________                          
Data expressed as mean ± SD or proportions. DM, diabetes mellitus; HbA1C, glycosylated 
haemoglobin; BP, blood pressure; SBP, systolic BP; DBP, diastolic BP; Pi=PPc-Pa. 
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Figure 3.1. Central (aortic) haemodynamic variables across deciles of age of the adult 
lifespan in a group of African descent (n=1185). See table 2 for multivariate adjusted 
relationships between age and aortic haemodynamic value in participants < or ≥ 50 years 
of age. Pi=Aortic pulse pressure-Pa. Mean±SD age in years and sample size at each 
decile of age are given in the figure. 
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adjustments for mean arterial pressure (MAP), Pb, Pa and RI were independently and 
positively associated with age above and below 50 years of age, while Pf and Pi were only 
positively associated with age above 50 years of age and AIx was associated with age 
below 50 years of age (Table 3.2). Similar findings were noted in participants not receiving 
antihypertensive therapy (Table 3.3). A modest relationship between age and stroke 
volume was noted in participants over 50 years of age only (Table 3.2). 
 
3.4.3 Relative independent contribution of reflected versus forward waves to variations 
in PPc. 
 
When included in separate models (Table 3.4) or in the same multivariatte 
stepwise models (Figure 3.2) in participants either < or ≥50 years of age, a stronger 
relationship was noted between RI and PPc or Pb and PPc than between Pf and PPc or 
AIx and PPc. Similar data were obtained irrespective of whether MAP derived from the 
equation MAP=DBP + [(SBP-DBP)/3] or from SphygmoCor software (brachial form factor) 
was included as an adjustor (Appendices 4 and 5). In contrast, a stronger relationship was 
noted between Pi and PPc, than between Pa and PPc (Table 3.4 and appendix 4) or 
between AIx and PPc (Table 3.4, Figure 3.2 and appendices 4 and 5). With RI and AIx in 
the same multivariate model, a distinctly stronger relationship was noted between RI and 
PPc than between AIx and PPc (Figure 3.2 and appendix 5). Similar findings were noted 
in participants not receiving antihypertensive therapy (Tables 3.5 and 3.6). Stroke volume 
was modestly correlated with PPc (r=0.20, p<0.0001). With the inclusion of stroke volume 
in multivariate models, similar differences between aortic hemodynamic-PPc relations 
were noted (Table 3.7). 
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Table 3.2. Multivariate adjusted relations between age and central aortic haemodynamics 
in age-specific categories in a group of African ancestry (n=1185). 
 
       Age versus                Estimate (mm Hg)*       partial r (95% CI)      p-value 
                      (±SEM)   
____________________________________________________________________ 
<50 years (n=703) 
Forward wave pressure (Pf)                 -0.17±0.05         -0.14 (-0.22 to -0.07)    <0.0005  
Reflected wave pressure (Pb)       0.31±0.07         0.17 (0.09 to 0.24)      <0.0001  
Reflected wave index (RI=Pb/Pf)                42±8              0.20 (0.13 to 0.28)     <0.0001 
Aortic Pi                                                  -0.15±0.05        -0.12 (-0.02 to -0.05)        <0.005 
Aortic augmented pressure (Pa)             0.65±0.07          0.34 (0.23 to 0.04)          <0.0001 
Aortic augmentation index (AIx)        0.17±0.01        0.43 (0.36 to 0.49)        <0.0001 
Stroke volume (n=468)        -0.02±0.03      -0.03 (-0.12 to 0.06)         =0.47 
≥50 years (n=482) 
Forward wave pressure (Pf)                  0.30±0.04         0.31 (0.23 to 0.39)      <0.0001  
Reflected wave pressure (Pb)      0.42±0.05         0.36 (0.28 to 0.44)       <0.0001  
Reflected wave index (Pb/Pf)                     69±7              0.33 (0.25 to 0.41)       <0.0001 
Aortic Pi                                                  0.40±0.05          0.36 (0.28 to 0.44)           <0.0001 
Aortic augmented pressure (Pa)             0.56±0.06         0.30 (0.21 to 0.38)           <0.0001 
Aortic augmentation index (AIx)      0.03±0.02         0.07 (-0.02 to 0.16)        =0.10 
Stroke volume (n=325)       0.07±0.03         0.14 (0.03 to 0.25)         <0.05 
____________________________________________________________________ 
SEM, Standard error of the mean; CI, confidence intervals; Pi=Aortic pulse pressure-Pa. 
*β-coefficient (slope) of the relations. Pi=aortic pulse pressure-Pa. Adjustors are sex, 
mean arterial pressure, body height, body weight, pulse rate, diabetes mellitus or an 
HbA1c>6.1%, regular smoking and regular alcohol intake. 
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Table 3.3. Multivariate adjusted relations between age and central aortic haemodynamics 
in age-specific categories in participants from a group of African ancestry not receiving 
antihypertensive therapy (n=898).  
 
Age versus                Estimate (mm Hg)*   partial r (95% CI)      p-value 
         (±SEM) 
____________________________________________________________________ 
<50 years (n=659) 
Forward wave pressure (Pf)             -0.19±0.05           -0.15 (-0.22 to -0.07)      =0.0001  
Reflected wave pressure (Pb)           0.34±0.08            0.18 (0.10 to 0.25)       <0.0001  
Reflected wave index (Pb/Pf)                47±9                 0.21 (0.14 to 0.28)       <0.0001 
Aortic Pi                                            -0.16±0.05           -0.13 (-0.21 to -0.06)     =0.0005  
Aortic augmented pressure (Pa)       0.72±0.07            0.37 (0.31 to 0.44)       <0.0001  
Aortic augmentation index (AIx)        0.19±0.01            0.46 (0.40 to 0.52)       <0.0001  
≥50 years (n=239) 
 Forward wave pressure (Pf)            0.47±0.06            0.44 (0.32 to 0.53)       <0.0001  
 Reflected wave pressure (Pb)         0.66±0.07            0.51 (0.41 to 0.60)       <0.0001  
 Reflected wave index (Pb/Pf)   80±10              0.48 (0.37 to 0.57)       <0.0001 
Aortic Pi                                            0.52±0.06           0.47 (0.36 to 0.56)       <0.0001  
Aortic augmented pressure (Pa)      0.61±0.08           0.44 (0.33 to 0.54)       <0.0001  
Aortic augmentation index (AIx)       0.05±0.03           0.11 (-0.02 to 0.24)      =0.09  
____________________________________________________________________ 
SEM, Standard error of the mean; CI, confidence intervals; Pi=Aortic pulse pressure-Pa. 
*β-coefficient (slope) of the relations. Adjustors are sex, mean arterial pressure, body 
height, body weight, pulse rate, diabetes mellitus or an HbA1c>6.1%, regular smoking and 
regular alcohol intake. 
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Table 3.4. Independent relationships between aortic hemodynamics and central aortic 
pulse pressure (PPc) in age-specific categories in a group of African ancestry. 
 
PPc vs              <50 years (n=703)       ≥50 years (n=482) 
  partial r (CI)*     p value  partial r (CI)*    p value 
___________________________________________________________________ 
Pb  0.87 (0.80 to 0.95)†    <0.0001  0.97 (0.88 to 1.10)†    <0.0001 
Pf  0.65 (0.58 to 0.72)     <0.0001  0.80 (0.71 to 0.89)     <0.0001 
Pa  0.80 (0.72 to 0.87)     <0.0001  0.88 (0.79 to 0.97)     <0.0001 
Pi  0.88 (0.81 to 0.96)‡‡  <0.0001  0.92 (0.83 to 1.01)‡    <0.0001 
RI  0.79 (0.71 to 0.86)§   <0.0001  0.86 (0.77 to 0.95)§    <0.0001 
AIx  0.17 (0.09 to 0.24)     <0.0001  0.08 (0.00 to 0.16)     <0.05 
___________________________________________________________________ 
CI, confidence intervals. See tables 3.1 and 3.2 for further abbreviations. *Adjustors are 
age, sex, mean arterial pressure, body height, body weight, pulse rate, diabetes mellitus 
or an HbA1c>6.1%, regular smoking and regular alcohol intake. †p<0.0001 for 
comparisons of partial r values with Pf, ‡p<0.05 ‡‡p<0.0001 for comparisons of partial r 
values with Pa, §p<0.0001 for comparison of partial r values with AIx (z-statistics). 
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Figure 3.2. Relative contribution of aortic haemodynamic variables to variations in central 
(aortic) pulse pressure (PPc) in age-specific categories in a group of African descent. Closed 
circles indicate indexes of wave reflection; open circles indicate indexes of forward or incident 
wave pressures. Data show multivariate adjusted correlation coefficients (partial r) derived 
from stepwise regression analysis with Pf and Pb (model 1), Pf and RI (model 2), Pi and AIx 
(model 3), or RI and AIx (model 4) + confounders included in the same regression models. 
Potential confounders included in the model are age, sex, mean arterial pressure, body height, 
body weight, pulse rate, diabetes mellitus or an HbA1c>6.1%, regular smoking and regular 
alcohol intake. Those factors not independently associated with PPc were forced into the 
model. Pi=Aortic pulse pressure-Pa. *p<0.0001 for comparisons of partial r values with Pf or 
AIx (z-statistics).
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Table 3.5. Independent relationships between aortic haemodynamics and central aortic pulse 
pressure (PPc) in age-specific categories in a group of African ancestry not receiving 
antihypertensive therapy (n=898). 
 
PPc vs        <50 years (n=659)   ≥50 years (n=239) 
  partial r (CI)*  p value partial r (CI)*  p value 
___________________________________________________________________ 
    Model with Pb and Pf included together 
Pb  0.86 (0.78-0.94)† <0.0001 0.98 (0.85-1.11)† <0.0001 
Pf  0.16 (0.08-0.24) <0.0001 0.19 (0.06-0.32) <0.0001 
    Model with RI and Pf included together 
RI  0.78 (0.70-0.86)† <0.0001 0.87 (0.74-0.99)† <0.0001 
Pf  0.25 (0.17-0.33) <0.0001 0.45 (0.32-0.58) <0.0001 
Model with AIx and Pi included together 
AIx  0.46 (0.38-0.54) <0.0001 0.35 (0.22-0.48) <0.0001 
Pi  0.88 (0.80-0.96) ‡ <0.0001 0.93 (0.80-1.06) ‡ <0.0001 
    Model with RI and AIx included together 
RI  0.78 (0.70-0.86) ‡ <0.0001 0.87 (0.74-1.00) ‡ <0.0001 
AIx  0.22 (0.14-0.30) <0.0001 0.18 (0.05-0.31) <0.0001 
___________________________________________________________________ 
CI, confidence intervals. See tables 3.1 and 3.2 for further abbreviations. *Adjustors are 
age, sex, mean arterial pressure, body height, body weight, pulse rate, diabetes mellitus 
or an HbA1c>6.1%, regular smoking and regular alcohol intake. †p<0.0001 for 
comparisons of partial r values with Pf, ‡p<0.0001 for comparison of partial r values with 
AIx (z-statistics). 
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Table 3.6. Independent relationships between aortic haemodynamics and central aortic 
pulse pressure (PPc) in age-specific categories in a group of African ancestry not 
receiving antihypertensive therapy. 
 
PPc vs             <50 years (n=659)                  ≥50 years (n=239) 
  partial r (CI)*  p value partial r (CI)*  p value 
___________________________________________________________________ 
Pb  0.86 (0.79 to 0.94)†   <0.0001 0.98 (0.85 to 1.10)†   <0.0001 
Pf  0.63 (0.55 to 0.70)   <0.0001  0.87 (0.74 to 0.99)   <0.0001 
Pa  0.79 (0.72 to 0.87)   <0.0001  0.90 (0.77 to 1.03)   <0.0001 
Pi  0.88 (0.80 to 0.96)‡  <0.0001  0.92 (0.80 to 1.05)   <0.0001 
RI  0.78 (0.70 to 0.85)§   <0.0001 0.87 (0.74 to 0.99)§   <0.0001 
AIx  0.19 (0.11 to 0.26)    <0.0001  0.05 (-0.08 to 0.18)    =0.24 
___________________________________________________________________ 
CI, confidence intervals. See tables 3.1 and 3.2 for further abbreviations. *Adjustors are 
age, sex, mean arterial pressure, body height, body weight, pulse rate, diabetes mellitus 
or an HbA1c>6.1%, regular smoking and regular alcohol intake. †p<0.0001 for 
comparisons of partial r values with Pf, ‡p<0.0001 for comparisons of partial r values with 
Pa, §p<0.0001 for comparison of partial r values with AIx (z-statistics). 
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Table 3.7. Impact of adjustments for stroke volume (SV) on the independent relationships between indices of aortic wave reflection and central 
aortic pulse pressure (PPc) in age-specific categories in a group of African ancestry. 
 
PPc vs                       <50 years (n=468)               ≥50 years (n=325) 
SV adjusted      Before            After         Before            After 
  partial r (CI)*   p value        partial r (CI)*    p value  partial r (CI)*       p value       partial r (CI)*       p value 
_______________________________________________________________________________________________________________ 
Pb          0.83 (0.74 to 0.92)† <0.0001         0.83 (0.74 to 0.92)† <0.0001        0.97 (0.86 to 1.08)† <0.0001   0.97 (0.86 to 1.08)† <0.0001 
Pf          0.56 (0.47 to 0.65) <0.0001     0.56 (0.47 to 0.65)  <0.0001        0.79 (0.68 to 0.90) <0.0001        0.79 (0.68 to 0.90) <0.0001 
Pa          0.81 (0.72 to 0.90) <0.0001     0.81 (0.72 to 0.90)  <0.0001        0.88 (0.77 to 0.99) <0.0001   0.88 (0.77 to 0.99) <0.0001 
Pi          0.88 (0.79 to 0.97)‡‡ <0.0001        0.88 (0.79 to 0.97)‡‡ <0.0001       0.92 (0.81 to 1.03)‡ <0.0001   0.92 (0.81 to 1.03)‡ <0.0001 
RI          0.75 (0.66 to 0.84)§ <0.0001         0.75 (0.66 to 0.84)$ <0.0001        0.86 (0.75 to 0.97)§ <0.0001   0.86 (0.75 to 0.97)§ <0.0001 
AIx          0.16 (0.07 to 0.25) <0.0001           0.16 (0.07 to 0.25)  <0.0001        0.05 (-0.06 to 0.16)  =0.18   0.05 (-0.06 to 0.16)  <0.0001 
_______________________________________________________________________________________________________________ 
CI, confidence intervals. See tables 3.1 and 3.2 for further abbreviations. *Adjustors are stroke volume (as indicated), age, sex, mean arterial 
pressure, body height, body weight, pulse rate, diabetes mellitus or an HbA1c>6.1%, regular smoking and regular alcohol intake. †p<0.0001 for 
comparisons of partial r values with Pf, ‡p<0.01,‡‡p<0.0005 for comparison of partial r values with Pa, §p<0.0001 for comparison of partial r 
values with AIx (z-statistics). 
97 
 
3.4.4 Comparison of independent relations between aortic haemodynamics and LVMI. 
 
In participants <50 years of age, Pb was more closely associated with LVMI 
(Figure 3.3, upper panel, Table 3.8) than Pf and in a multivariate model with Pb and Pf in 
the same model, Pb (partial r=0.31, CI=0.24 to 0.38, p<0.0001), but not Pf (partial r=0.01, 
CI=-0.06 to 0.08, p=0.72) was independently associated with LVMI. In contrast however, 
Pa showed similar associations with LVMI as did Pi (Figure 3.3, upper panel, Table 3.8). 
In addition, RI was more closely associated with LVMI than AIx (Figure 3.3, upper panel, 
Table 3.8). In participants ≥50 years of age, Pb, but not Pf was independently associated 
with LVMI (Figure 3.3, lower panel, Table 3.8). In contrast however Pi, but not Pa was 
independently associated with LVMI (Figure 3.3, lower panel, Table 3.8). In participants 
≥50 years of age RI, but not AIx was independently associated with LVMI-height1.7 (Table 
3.8), but neither RI nor AIx were independently associated with LVMI-BSA (Figure 3.3, 
lower panel). Similar data were obtained irrespective of whether MAP derived from the 
equation MAP=DBP + [(SBP-DBP)/3] or from SphygmoCor software (brachial form factor) 
was included as an adjustor (Appendices 6 and 7). Similar findings were also noted in 
participants <50 years of age not receiving antihypertensive therapy (Table 3.9). There 
were too few participants (n=151) ≥50 years of age not receiving antihypertensive therapy 
to compare relationships between aortic hemodynamics and LVMI. Stroke volume was 
correlated with LVMI (r=0.64, p<0.0001). However, with further adjustments for stroke 
volume, relative differences in relations between reflected versus forward wave indices 
and LVMI were retained (Table 3.10).  
 
3.5 Discussion 
 
The main findings of the present study are as follows: In a large (n=1185), 
community-based sample of African ancestry, independent of confounders including MAP 
(distending pressures), reflected waves (RI or Pb) accounted for more of the variation in
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Figure 3.3. Contribution of aortic hemodynamic variables to variations in left ventricular mass 
indexed to body surface area (LVMI) in age-specific categories in a group of African descent. 
Closed circles indicate indexes of wave reflection; open circles indicate indexes of forward or 
incident wave pressures. Potential confounders included in the model are age, sex, mean 
arterial pressure, pulse rate, body height, pulse rate, diabetes mellitus or an HbA1c>6.1%, 
regular smoking and regular alcohol intake. Those factors not independently associated with 
LVMI were forced into the model. Pi=Aortic pulse pressure-Pa. *p<0.05 for comparisons of 
partial r values with Pf and AIx, †p<0.05 for comparison of partial r values with AIx, #p<0.05 for 
comparison of partial r values with Pa and AIx (z-statistics). 
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Table 3.8. Independent relationships between aortic hemodynamics and left ventricular 
mass indexed to height1.7 (LVMI-ht1.7) in participants of African ancestry. 
 
    <50 years (n=468)     ≥50 years (n=325) 
LVMI-ht1.7 vs        partial r (CI)*        p value          partial r (CI)*    p value 
__________________________________________________________________ 
Pb   0.20 (0.11 to 0.29)†   <0.0001      0.20 (0.09 to 0.31)†   <0.0005 
Pf   0.08 (-0.01 to 0.17)    =0.07       0.05 (-0.06 to 0.16)    =0.37 
Pa   0.17 (0.08 to 0.26)     =0.0001      0.06 (-0.05 to 0.16)    =0.29 
Pi   0.15 (0.06 to 0.24)     =0.0005      0.25 (0.14 to 0.36)‡  <0.0001 
RI             0.19 (0.10 to 0.29)§    <0.0001      0.13 (0.02 to 0.24)     <0.02 
AIx             0.05 (-0.05 to 0.14)      =0.29       0.03 (-0.08 to 0.14)    =0.52 
__________________________________________________________________ 
CI, confidence intervals. See tables 1 and 2 for further abbreviations. *Adjustors are age, 
sex, mean arterial pressure, body weight, pulse rate, diabetes mellitus or an HbA1c>6.1%, 
regular smoking and regular alcohol intake. †p<0.05 for comparisons of partial r values 
with Pf, ‡p<0.05 for comparison of partial r values with Pa, §p<0.05 for comparison of 
partial r values with AIx (z-statistics). 
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Table 3.9. Independent relationships between aortic hemodynamics and left ventricular 
mass indexed to body surface area (LVMI-BSA) in participants of African ancestry <50 
years of age not receiving antihypertensive therapy (n=436). 
 
LVMI-BSA vs      partial r (CI)* p value 
____________________________________ 
Pb  0.29 (0.19 to 0.38) † <0.0001 
Pf  0.16 (0.07 to 0.25) <0.0005 
Pa  0.13 (0.04 to 0.22) <0.005 
Pi  0.23 (0.13 to 0.32) <0.0001  
RI  0.25 (0.16 to 0.35)‡ <0.0001 
AIx  0.12  (0.03 to 0.22) =0.01  
_____________________________________ 
CI, confidence intervals. See tables 3.1 and 3.2 for further abbreviations. *Adjustors are 
age, sex, mean arterial pressure, body height, body weight, pulse rate, diabetes mellitus 
or an HbA1c>6.1%, regular smoking and regular alcohol intake. †p<0.05 for comparisons 
of partial r values with Pf, ‡p<0.05 for comparison of partial r values with AIx (z-statistics). 
101 
 
Table 3.10. Impact of adjustments for stroke volume (SV) on the independent 
relationships between indexes of aortic wave reflection and and left ventricular mass 
indexed to body surface area (LVMI-BSA) in participants of African ancestry (n=793). 
 
LVMI-BSA vs        
SV adjusted          Before           After   
     partial r (CI)*          p value                partial r (CI)*          p value  
________________________________________________________________ 
Pb             0.31 (0.24 to 0.38)†   <0.0001            0.19 (0.12 to 0.26)†  <0.0001 
Pf             0.13 (0.06 to 0.20)    <0.0005            0.04 (-0.03 to 0.11)    =0.17  
Pa             0.26 (0.19 to 0.33)    <0.0001            0.17 (0.10 to 0.24)    <0.0001  
Pi             0.30 (0.23 to 0.37)      <0.0001            0.17 (0.10 to 0.24)       <0.0001 
RI             0.31 (0.24 to 0.38)‡‡  <0.0001            0.18 (0.11 to 0.25)‡   <0.0001 
AIx             0.09 (0.02 to 0.16)     <0.01            0.02 (-0.05 to 0.09)      =0.43 
_________________________________________________________________ 
CI, confidence intervals. See tables 3.1 and 3.2 for further abbreviations. 
*Adjustors are stroke volume, age, sex, mean arterial pressure, body height, body weight, 
pulse rate, diabetes mellitus or an HbA1c>6.1%, regular smoking and regular alcohol 
intake and either without (before) or with (after) SV. †p<0.005 for comparisons of partial r 
values with Pf, ‡p<0.005, ‡‡p<0.0001 for comparisons of partial r values with AIx (z-
statistics). 
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PPc and LVMI than did forward wave pressures (Pf), whilst incident wave pressure (Pi) 
accounted for more of the variation in PPc and LVMI than did aortic systolic pressure 
augmentation (AIx or Pa). The marked contrasting contributions of indices of reflected 
waves, RI or Pb and AIx or Pa, as compared to Pf and Pi toward variations in PPc and 
LVMI were noted below as well as above the age threshold (50 years) when forward or 
incident wave pressures (Pf and Pi) began to increase as well as in women and men 
considered separately. 
Several prior studies have reported on a relatively greater contribution of Pa as 
compared to Pi to age-related increases in PPc (McEniery et al 2008, Namasivayam et al 
2009, Cecelja et al 2009). However, it is now recognised that Pa may be confounded by 
considerable overlap between forward and backward waves and although in several of 
these studies (Davies et al 2010, Hughes et al 2013, Fok et al 2014), the method of wave 
intensity analysis has been seriously questioned on methodological and theoretical 
grounds (Segers et al 2015), and Fok et al (2014) report an impossible flow-frequency 
response, apparently hand-drawn representative waves are shown, and control 
impedance values are given that differ markedly from Yaginuma et al (1985), that there is 
a poor relationship between the magnitude of the reflected wave and Pa (Davies et al 
2010, Cheng et al 2012, Hughes et al 2013, Fok et al 2014, Torjesen et al 2014, Schultz 
et al 2013). Indeed, Pa may be determined in large part by forward wave pressures (Fok 
et al 2014). Nevertheless, studies which have employed approaches to separate Pb from 
Pf, suggest that Pb contributes little to age-related increases in PPc (Mitchell et al 2010b, 
Segers et al 2007). These studies were nonetheless conducted either in a sample where 
little difference in aortic and brachial BP was noted across the adult lifespan (Mitchell et al 
2010b), an effect that has been explained on the basis of the application of tonometry at a 
site where the principles of tonometry cannot be achieved (brachial artery to calibrate the 
carotid artery pulse) (O’Rourke et al 2010), or in a sample with a narrow age range 
(Segers et al 2007). In contrast, using wave separation analysis using techniques that do 
not rely on brachial tonometry and in a community sample with a wide age range, I show 
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that Pb has a far stronger relationship with PPc than Pf, and that these associations 
occurred irrespective of age. Hence, the present study provides the first direct evidence to 
show that across the adult lifespan of a community sample with poorly controlled 
hypertension, reflected waves account for more of the variation in PPc than do forward 
wave pressures and that indices of aortic pressure augmentation underestimate the 
contribution of aortic wave reflection to variations in PPc. 
 A few prior studies have suggested that indices of reflected waves derived from 
wave separation analysis (Pb or RI) are more closely associated with end-organ damage 
than augmented pressure indexes (Pa and AIx) (Wang et al 2010, Weber et al 2012). 
However, in neither study were these comparisons made with adjustments for 
confounders. Hence, the differences reported on (Wang et al 2010) may be attributed to 
confounders including distending pressures and heart rate. Moreover, in neither study 
(Wang et al 2010, Weber et al 2012) were comparisons of relations made in age-specific 
categories despite increases in forward wave pressures occurring only later in life. 
Furthermore, in one study (Weber et al 2012) no comparisons were made between 
correlation coefficients and similar relations were noted between reflected wave indices 
derived from wave separation analysis and end-organ changes as compared to relations 
between indices of aortic systolic pressure augmentation and end-organ changes (Weber 
et al 2012). In the present study I provide clear evidence that relations between indices of 
wave reflection and LVMI were markedly stronger than forward wave pressure effects, 
whilst indices of aortic systolic pressure augmentation considerably underestimated the 
contribution of reflected as compared to forward wave pressures. 
 As in the present study, age-related increases in AIx occurred in those less than, 
but not greater than 50 years of age, a lack of relationship between AIx and LVMI in those 
older than 50 years of age is not unexpected. However, augmented pressures increased 
across the full adult age range, and yet, in those older than 50 years, reflected, but not 
augmented wave pressures accounted for variations in LVMI. Thus, without the use of 
wave separation analysis, even when indices of pressure augmentation that increase with 
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age across the full adult lifespan are employed, the impact of reflected wave function on 
end-organ changes may be markedly underestimated. 
 Although the confounding effects of overlap between aortic forward and backward 
waves may explain the inferior ability of AIx and AP to associate with aortic PP or LVMI as 
compared to Pb and RI, other possibilities should be considered. These include the 
impact of similar increases in augmentation pressure and pulse pressure with age, or a 
decrease in left ventricular ejection. Irrespective of the explanation however, the present 
study suggests that Pb and RI may be more useful indices of the adverse effects of aortic 
reflected waves than indices of aortic augmentation. 
 As previously demonstrated (Kips et al 2009) the assumptions intrinsic to the use 
of the ‘triangulation method’ of aortic wave separation are not ideal. However, this 
approach produces correlations between reflected wave indexes derived from the 
‘triangulation method’ and actual aortic flow waveforms (r2=0.55) that are considerably 
stronger than between AIx and indexes derived from actual aortic flow waveforms 
(r2=0.34) (Kips et al 2009). Thus, the triangulation method of wave separation is better 
than augmentation indices at identifying reflected wave effects. Despite employing a 
relatively imprecise method of identifying reflected wave magnitude and index, I was still 
able to show that indices of aortic wave reflection were more closely associated with PPc 
and LVMI than forward wave pressures, whilst indices of aortic pressure augmentation 
showed weaker associations than forward wave pressures with PPc and LVMI. Hence, 
the present study provides evidence that improved measures of wave reflection are 
indeed better than augmentation indices at detecting relations between reflected wave 
effects and both PPc and LVMI. 
 Dobutamine, which enhances PPc through increases in myocardial contractility 
and stroke volume, largely increases forward wave pressures (Fok et al 2014). In contrast, 
norepinephrine, which augments PPc through marked vasoconstriction, mainly increases 
backward wave pressures but does not produce as much of an increase in PPc (Fok et al 
2014). Further, increases in forward wave pressures may account for more of the 
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increment in PPc in hypertensives than reflected wave pressures (Fok et al 2014). It has 
therefore been suggested that forward wave pressures, mediated by increases in stroke 
volume may be more important than reflected wave pressures in determining variations in 
PPc in hypertension (Fok et al 2014). However, as in the present and previous (Cecelja et 
al 2009, Segers et al 2007) studies where no increase (Segers et al 2007) or only modest 
increases (present study) in stroke volume were noted with increasing age, or where 
stroke volume contributed little to variations in PPc (Cecelja et al 2009), increases in 
stroke volume are unlikely to explain a significant proportion of age-related increases in 
PPc. Moreover, norepinephrine-induced effects on aortic reflected waves (Fok et al 2014) 
are more likely to represent the hypertensive state where a major effect on BP is through 
increases in vascular smooth muscle tone. Further, in the present study the greater 
impact of Pb as compared to Pf on variations in PPc and LVMI were replicated even when 
stroke volume was included in multivariate adjusted analysis. 
 Additional limitations of the present study are as follows: The present study was a 
cross-sectional design. Therefore, I cannot determine whether the age-related changes 
reported on are attributed to the long-term impact of age or a cumulative effect of 
alternative risk factors over time or whether relations between aortic haemodynamics and 
LVMI are indeed cause and effect. Further longitudinal studies are required to determine 
these effects. 
 In conclusion, in the present study conducted in a community sample with a high 
prevalence of uncontrolled hypertension, I show that reflected waves are more closely 
associated with PPc and LVMI than forward waves, but that indices of aortic systolic 
pressure augmentation markedly underestimate these effects. These data provide support 
for a role of reflected wave function in mediating the adverse effects of aortic PP, effects 
which nonetheless cannot be accurately detected using indices of aortic systolic pressure 
augmentation. Moreover, given the high prevalence of hypertension and related 
cardiovascular events in urban communities in Africa, the present study suggests that 
approaches to decreasing age-related increases in aortic wave reflection may produce a 
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major impact on the burden of disease in these communities. These data therefore 
provide the evidence to indicate that in a study conducted to assess whether aortic 
reflected waves may refine the ability to detect end-organ changes in pre-hypertensives, 
indices of aortic pressure augmentation are likely to underestimate the impact of wave 
reflection. In this regard, this question was addressed in the subsequent chapter of the 
present thesis (Chapter 4). 
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Chapter 4 
 
 
Reflected Wave Indices Do Not Enhance the Ability of Aortic Blood 
Pressure to Identify Target Organ Changes in Normotensives. 
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4.1 Abstract 
 
 Whether indices of aortic wave reflection enhance the ability to detect 
cardiovascular damage beyond brachial and aortic BP in normotensives is uncertain. In 
1185 participants of a community-based sample, 27% of whom had normal-high normal 
BP values, aortic BP, backward wave pressure (Pb) and the reflected wave index (RI) 
were determined using radial applanation tonometry and SphygmoCor software, and 
target organ changes assessed from carotid-femoral pulse wave velocity (PWV), 
estimated glomerular filtration rate (eGFR), and left ventricular mass index (LVMI). In 
normotensives aortic systolic blood pressure (SBP) was associated with LVMI (g/m1.7) 
(n=410, partial r=0.18, p<0.0005), PWV (n=570, partial r=0.19, p<0.0001) and eGFR 
(n=605, partial r=-0.08, p<0.05) independent of confounders and brachial BP. Similar 
findings were noted for aortic pulse pressure (PP). In contrast, although Pb was 
independently associated with LVMI (partial r=0.19, p<0.0005) and a trend for an effect 
was noted for eGFR (partial r=-0.07, p=0.09) independent of confounders and brachial 
BP, no independent relations were noted with PWV (partial r=0.06, p=0.15). Similar 
relations were noted between RI and end-organ changes. The area under the receiver 
operating curve (AUC) for the detection of left ventricular hypertrophy (LVH)(n=168 of 410 
normotensives) showed a greater ability of aortic PP (AUC=0.68±0.03) and aortic Pb 
(AUC=0.67±0.03), but not RI (AUC=0.65±0.03) to detect LVH as compared to brachial 
SBP (AUC=0.60±0.03) and brachial PP (AUC=0.61±0.03) (p<0.05 for comparison of 
AUC). However, the performance for LVH detection was no greater for Pb than for aortic 
PP. In conclusion, in normotensives although Pb is better than brachial BP for the 
detection of sub-clinical cardiovascular disease, indices of wave reflection do not enhance 
the ability to detect end-organ changes beyond aortic SBP or PP. 
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4.2 Introduction 
 
Although prospective, observational studies (Hsia et al 2007, Conen et al 2007, 
Dorjgochoo et al 2009, Qureshi et al 2005, Vasan et al 2001, Blake et al 2003, Liszka et al 
2005, Gu et al 2009, Zhang et al 2006, Butler et al 2011, Kshirsagar et al 2006), some 
randomised, controlled trials (Nissen et al 2004, Remme et al 2009, Staessen and 
Jiguang 2001, Schrier et al 2002, Patel 2007) and meta-analyses of BP lowering trials 
(Trialists Collaboration 2003, Law et al 2009) indicate that those with BP values in the 
normal/high-normal range (120-139/80-89 mm Hg) are at an increased risk for 
cardiovascular events, several more recent intervention studies suggest that 
antihypertensive treatment to thresholds lower than 140/90 mm Hg has no added benefit 
to risk reduction (Yusuf et al 2008, Cushman et al 2010, McMurray et al 2010). These 
data highlight the markedly variable BP-related risk conferred by a normal/high-normal BP. 
As recently demonstrated aortic blood pressure (BP) may refine the ability to detect those 
with a normal/high-normal BP at risk of BP-related cardiovascular damage (Booysen et al 
2013, Chapter 2). However, the role of aortic reflected wave indices in risk predicting in 
those with brachial BP in the normotensive range is uncertain. 
Both aortic forward (Pf) and backward (Pb) wave pressures contribute toward 
aortic BP. Whilst Pf is determined by stroke volume and aortic stiffness and impedance, 
Pb is determined by wave reflection. Several studies suggest that indices of aortic wave 
reflection are more closely associated with cardiovascular end-organ damage than 
brachial BP (Wang et al 2010, Weber et al 2012, Booysen et al 2015) or are better 
predictors of cardiovascular outcomes than brachial BP (Wang et al 2010, Chirinos et al 
2012, Weber et al 2012, Zamani et al 2014). As wave reflection increases across the adult 
lifespan (Wang et al 2010, Booysen et al 2015), whilst Pf increases only after 50 years of 
age (Booysen et al 2015), and those with normal-high normal BP values are mostly 
younger than 50 years of age (Booysen et al 2013), the question arises as to whether 
indices of aortic wave reflection may further enhance risk prediction beyond even aortic 
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BP, particularly in those with normal-high normal BP values. Hence, in the present study I 
compared brachial BP-independent relations between end-organ changes and indices of 
aortic wave reflection versus aortic BP in normotensive participants of a community-based 
study. I also compared the ability of brachial BP, aortic BP and indices of wave reflection 
to detect sub-clinical cardiovascular disease in normotensive individuals. 
 
4.3 Methods 
4.3.1 Study samples. 
 
The present study has been described in chapter 2, page 60 In the present 
analysis 793 participants had echocardiography, 1030 aortic pulse wave velocity (PWV), 
and 1125 estimated glomerular filtration rate (eGFR). 
 
4.3.2 Clinical, demographic and anthropometric measurements. 
 
The clinical (including office and ambulatory BP), demographic and anthropometric 
measurements have been described in chapter 2, page 61. 
 
4.3.3 Pulse wave analysis. 
 
Central aortic blood pressures, Pf, Pb and the reflected wave index (RI) were 
estimated using radial applanation tonometry and SphygmoCor software as described in 
chapter 2, page 62 and chapter 3, page 84.  
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4.3.4 End organ changes. 
 
Left ventricular mass (LVM), aortic pulse wave velocity (PWV) and estimated 
glomerular filtration rate (eGFR) were determined as described in chapter 2, page 65. Left 
ventricular mass was indexed (LVMI) to body surface area (LVMI-BSA), height2.7 (LVMI-
ht2.7) and height1.7 (LVMI-ht1.7). Left ventricular hypertrophy (LVH) was identified as an 
LVMI-BSA ≥83 g/m2 for women and 111 g/m2. for men (Chirinos et al 2010), LVMI-ht2.7 ≥46 
g/m2.7 for women and 50 g/m2.7 for men (de Simone et al 2013), and LVMI-ht1.7 ≥60 g/m1.7 
for women and 80 g/m1.7 for men (Chirinos et al 2010). An increased PWV was identified 
as ≥10 m/sec (van Bortel et al 2012). Estimated GFR was considered to be reduced when 
<60 mls/min/1.73 m2 (Levey et al 2003). 
 
4.3.5 Data analysis 
 
Data analysis was performed using SAS version 9.1 (SAS Institute, North 
Carolina, USA). Unadjusted means and proportions were compared by the large-sample 
z-test and the χ2-statistic, respectively. Independent relationships with target organ 
changes were determined using multivariate regression analysis with adjustments for age, 
sex, BMI, diabetes mellitus and/or an HbA1c>6.1%, regular tobacco use, regular alcohol 
intake and pulse rate in the models. To determine probability values, further adjustments 
for non-independence of family members was performed using non-linear regression 
analysis (mixed procedure as defined in the SAS package). Correlation coefficients were 
compared with z-statistics. The performance of brachial BP, aortic BP and indices of wave 
reflection for LVH detection was determined from the area under the receiver operating 
characteristic (ROC) curves (area under the curve [AUC]). The performance of brachial 
BP, aortic BP and indices of wave reflection for the detection of an increased PWV or 
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decreased eGFR was not determined as too few participants had these end-organ 
changes. 
  
4.4 Results  
 
4.4.1 Characteristics of participants 
 
 27.7% of participants had either normal or high-normal BP. 17% had a normal BP 
and 10.6% had high-normal BP values. Age, BMI, waist circumference, and the frequency 
of participants who were overweight or obese were similar to that described in chapter 2, 
Table 2.1. Also, hypertensives, but not those with a normal or high-normal BP, had more 
diabetes mellitus and/or an impaired blood glucose control, and an increased total/HDL 
cholesterol (see Table 2.2 for representative data). No differences were noted between 
BP categories in regular alcohol and tobacco intake or pulse rate (see Table 2.2 for 
representative data). 
 
4.4.2 Blood pressures within BP categories.  
 
Conventional and central aortic BP values as well as aortic Pf, Pb and RI 
increased across BP categories (Table 4.1).   
 
4.4.3 Continuous relationships between various measures of BP or aortic 
haemodynamics and target organ changes in normotensive participants.  
 
With adjustments for confounders, with the exception of RI which was not 
correlated with PWV (Table 4.5), all other BP measurements and aortic haemodynamic 
values were correlated with target organ changes (Tables 4.2 to 4.5). Relationships 
between aortic pulse pressure (PP), or Pb, but not Pf and LVMI-BSA were greater than 
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Table 4.1. Aortic haemodynamic variables across categories of brachial blood pressures (BP). 
BP categories           Optimal                   Normal            High-normal           Hypertensives 
BP range (mm Hg)       <120/80              ≥120/80 and            ≥130/85 and             ≥140/90 or 
                       <130/85    <140/90  Treatment 
________________________________________________________________________________________ 
Sample size    312   202   126   545     
Conventional SBP/DBP (mm Hg) 108±7/72±6  119±7/80±4**  129±7/85±4**†† 146±22/92±13**††## 
Aortic SBP (mm Hg)   100±14  110±9**  119±10**††  136±22**††## 
Aortic pulse pressure (mm Hg)   26±11        29±8*   34±9**†  43±17**††## 
Aortic Pf (mm Hg)   20±6   21±5   22±5   28±11**††## 
Aortic Pb (mm Hg)   12±5   14±4*   17±5**††  22±9**††## 
Aortic RI    0.13±0.04  0.14±0.04  0.15±0.05*  0.18±0.07**††## 
___________________________________________________________________________________________     
SBP, systolic BP; DBP, diastolic BP, forward wave pressure; Pf, forward wave pressures; Pb, backward wave pressures; RI, reflected wave 
index. *p<0.05, **p<0.005, ***p<0.0001 vs optimal; †p<0.05, ††p<0.005, †††p<0.0005 vs normal; #p<0.05, ##p<0.005, ###p<0.0001 vs high-normal. 
114 
 
Table 4.2. Multivariate adjusted relationships between brachial blood pressures (BP) and 
target organ changes in normotensive participants (conventional BP<140/90 mm Hg) of 
the community sample. 
 
     n     partial r (CI)*    p-value     
______________________________________________________ 
Brachial SBP vs               
     PWV        570     0.23 (0.15 to 0.30) <0.0001 
     eGFR          605           -0.13 (-0.21 to -0.05) =0.001 
     LVMI-BSA  410            0.19 (0.09 to 0.28) =0.0001   
     LVMI-ht1.7    410    0.16 (0.06 to 0.25)    <0.005  
     LVMI-ht2.7    410    0.15 (0.06 to 0.25) <0.005  
Brachial PP vs 
     PWV        570     0.14 (0.06 to 0.22) =0.0006 
     eGFR          605           -0.01 (-0.08 to 0.07) =0.89 
     LVMI-BSA  410    0.22 (0.13 to 0.31)    <0.0001   
     LVMI-ht1.7    410    0.19 (0.10 to 0.28)    =0.0001  
     LVMI-ht2.7    410    0.18 (0.08 to 0.27) <0.0005  
_________________________________________________________ 
CI, confidence intervals; SBP, systolic BP; PP, pulse pressure; PWV, aortic pulse wave 
velocity; eGFR, estimated glomerular filtration rate; LVMI, left ventricular mass index; 
BSA, body surface area; ht, height. *Adjustments are for age, sex, BMI, diabetes mellitus 
and/or an HbA1c>6.1%, regular tobacco intake, regular alcohol intake and pulse rate.  
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Table 4.3. Multivariate adjusted relationships between aortic blood pressures (BP) and target organ changes in normotensive participants 
(conventional BP<140/90 mm Hg) of the community sample. 
 
     n            partial r (CI)         p-value          partial r (CI)        p-value                  partial r  (CI)          p-value 
__________________________________________________________________________________________________________ 
Aortic SBP vs                      Adjusted for *                                  Adjusted for                                     Adjusted for     
                                          *+brachial SBP               * + brachial PP 
      PWV          570         0.28 (0.20 to 0.35)   p<0.0001      0.19 (0.11 to 0.27)    p<0.0001         0.25 (0.17 to 0.32) p<0.0001 
      eGFR         605   -0.14 (-0.22 to -0.07) p<0.0005        -0.08 (-0.16 to -0.01)  p<0.05             -0.16 (-0.24 to -0.08) p=0.0001   
      LVMI-BSA            410    0.28  (0.19 to 0.37)  p<0.0001      0.22 (0.12 to 0.31)   p<0.0001        0.21 (0.11 to 0.30)      p<0.0001 
      LVMI-ht1.7   410    0.24  (0.15 to 0.33)   p<0.0001         0.18 (0.09 to 0.28)   p<0.0005         0.18 (0.08 to 0.27) p<0.0005 
      LVMI-ht2.7   410     0.26† (0.17 to 0.35) p<0.0001         0.22 (0.12 to 0.31)   p<0.0001         0.21 (0.11 to 0.30) p<0.0001 
Aortic PP vs 
      PWV    570   0.16 (0.08 to0.24)      p=0.0001        0.09 (0.004 to 0.17) p<0.05          0.10 (0.02 to 0.18)      p=0.015 
      eGFR          605  -0.11† (-0.19 to -0.03)  p=0.0005       -0.07 (-0.15 to 0.01) p=0.11         -0.14 (-0.21 to -0.06) p=0.0008 
      LVMI-BSA  410        0.31† (0.21 to 0.39)   p<0.0001        0.26 (0.17 to 0.35) p<0.0001         0.22 (0.13 to 0.31)      p<0.0001 
      LVMI-ht1.7  410        0.24  (0.14 to 0.33)   p<0.0001         0.2 (0.1 to 0.29) p<0.0001         0.16 (0.06 to 0.25)      p=0.0013 
      LVMI-ht2.7  410        0.24  (0.15 to 0.33)   p<0.0001        0.21 (0.11 to 0.30) p<0.0001         0.18 (0.08 to 0.27)      p<0.0005 
____________________________________________________________________________________________________________ 
CI, confidence intervals; SBP, systolic BP; PP, pulse pressure; PWV, aortic pulse wave velocity; eGFR, estimated glomerular filtration rate; 
LVMI, left ventricular mass index; BSA, body surface area; ht, height. *Adjustments are for age, sex, BMI, diabetes mellitus and/or an 
HbA1c>6.1%, regular tobacco intake, regular alcohol intake and pulse rate. †p<0.05 vs relationships between brachial SBP or PP and end organ 
changes given in Table 4.2 (z-statistics). 
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Table 4.4. Multivariate adjusted relationships between aortic forward (Pf) or backward (Pb) wave pressures and target organ changes in 
normotensive participants (conventional BP<140/90 mm Hg) of the community sample. 
           n    partial r (CI)  p-value      partial r (CI)             p-value        partial r  (CI)             p-value 
____________________________________________________________________________________________________________ 
                                   Adjusted for *                      Adjusted for                      Adjusted for     
                                        *+brachial SBP        * + brachial PP 
Aortic Pf vs  
PWV     570      0.09 (0.006 to 0.17) p=0.03  -0.001 (-0.08 to 0.08) p=0.97          0.007 (-0.08 to 0.09) p=0.87 
eGFR     605     -0.09 (-0.17 to -0.01) p=0.02         -0.04 (-0.12 to 0.04)    p=0.29      -0.12 (-0.2 to -0.04) p=0.0029        
LVMI-BSA  410      0.25 (0.16 to 0.34)  p<0.0001        0.19 (0.09 to 0.28)     p=0.0001     0.13 (0.04 to 0.23)     p=0.007 
LVMI-ht1.7  410      0.22 (0.13 to 0.32) p<0.0001        0.17 (0.07 to 0.27) p=0.0005 0.13 (0.03 to 0.22) p=0.01 
LVMI-ht2.7  410      0.19 (0.1 to 0.28) p=0.0001        0.14 (0.04 to 0.23) p=0.0057 0.09 (-0.004 to 0.19) p=0.06 
Aortic Pb vs 
PWV     570      0.16 (0.08 to 0.24) p=0.0002        0.06 (-0.02 to 0.14) p=0.15             0.10# (0.02 to 0.18) p=0.017 
eGFR           605     -0.12 (-0.2 to -0.04) p=0.0024      -0.07 (-0.15 to 0.01) p=0.09            -0.15 (-0.23 to -0.07) p=0.0003 
LVMI-BSA  410      0.36# (0.27 to 0.44)  p<0.0001        0.31†# (0.22 to 0.40)   p<0.0001         0.29# (0.2 to 0.38)    p<0.0001 
LVMI-ht1.7  410      0.26† (0.17 to 0.35) p<0.0001 0.21 (0.12 to 0.30) p<0.0001     0.19 (0.09 to 0.28) p=0.0002 
LVMI-ht2.7  410     0.28†# (0.19 to 0.37) p<0.0001 0.24# (0.15 to 0.33) p<0.0001   0.23# (0.13 to 0.32) p<0.0001 
 
______________________________________________________________________________________________________________ 
CI, confidence intervals; PWV, aortic pulse wave velocity; eGFR, estimated glomerular filtration rate; LVMI, left ventricular mass index; BSA, 
body surface area; ht, height. *Adjustments are for age, sex, BMI, diabetes mellitus and/or an HbA1c>6.1%, regular tobacco intake, regular 
alcohol intake and pulse rate. †p<0.05 vs relationships between brachial SBP or PP and end organ changes given in Table 4.2. #p<0.05 vs 
relationships between Pf and end organ changes. 
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Table 4.5. Multivariate adjusted relationships between the aortic reflection wave index (RI) and target organ changes in normotensive 
participants (conventional BP<140/90 mm Hg) of the community sample. 
 
Aortic RI vs          n    partial r (CI)    p-value      partial r (CI)    p-value   partial r  (CI)     p-value 
_________________________________________________________________________________________________________________ 
                                   Adjusted for *                        Adjusted for           Adjusted for     
                                   *+brachial SBP           * + brachial PP 
PWV              570      0.08 (-0.005 to 0.16) p=0.07  0.005 (-0.08 to 0.09) p=0.9  0.01 (-0.07 to 0.09) p=0.82     
eGFR             605      -0.1 (-0.18 to -0.02) p=0.015          -0.06 (-0.14 to 0.02) p=0.15  -0.12 (-0.19 to -0.04)   p=0.0045 
LVMI-BSA           410 0.32 (0.23 to 0.4) p<0.0001 0.28 (0.19 to 0.37) p<0.0001 0.24 (0.15 to 0.33) p<0.0001 
LVMI-ht1.7           410      0.21 (0.11 to 0.3)  p<0.0001        0.17 (0.07 to 0.26)  p=0.0007 0.13 (0.03 to 0.22)  p=0.01 
LVMI-ht2.7           410      0.23 (0.14 to 0.32)  p<0.0001        0.2 (0.1 to 0.29)  p<0.0001 0.16 (0.07 to 0.26)  p=0.0009 
_________________________________________________________________________________________________________________ 
CI, confidence intervals; PWV, aortic pulse wave velocity; eGFR, estimated glomerular filtration rate; LVMI, left ventricular mass index; BSA, 
body surface area; ht, height. *Adjustments are for age, sex, BMI, diabetes mellitus and/or an HbA1c>6.1%, regular tobacco intake, regular 
alcohol intake and pulse rate. 
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between brachial BP and LVMI-BSA (data shown in Tables 4.3 and 4.4 as compared to 
data shown in Table 4.2 [z-statistics]). Furthermore, relationships between Pb and LVMI 
were greater than relations between Pf and LVMI (Table 4.4). After further adjustments for 
brachial SBP or PP, relationships between aortic SBP or PP and PWV or LVMI persisted 
(Table 4.3). Moreover, after further adjustments for brachial SBP or PP, relationships 
between aortic Pf, Pb (Table 4.4) or RI (Table 4.5) and LVMI, persisted.  
 
4.4.4 Performance of measures of BP or aortic haemodynamics to detect target organ 
changes in normotensive participants.  
 
In normotensives with all end-organ measurements 96 of 410 (23.4%), had LVH 
based on LVMI-BSA thresholds, 168 of 410 (41%), had LVH based on LVMI-ht1.7 
thresholds, 73 of 410 (17.8%), had LVH based on LVMI-ht2.7 thresholds, 3 of 570 (0.5%) 
had an increases aortic PWV and 0 of 605 (0%) had a decreased eGFR. Hence, I 
assessed the performance of aortic versus brachial BP measurements for LVH detection, 
but not for the detection of increases in PWV or decreases in eGFR. All BP 
measurements and aortic haemodynamic values showed significant performance for LVH 
detection (Table 4.6). However, aortic SBP and PP as well as Pb showed a significantly 
greater performance for LVH detection than brachial SBP or PP (Table 4.6 and Figure 
4.1). Importantly, neither Pf, nor RI showed a greater performance for LVH detection than 
either brachial SBP or PP (Table 4.6). Furthermore, Pb did not show a greater 
performance for LVH detection than either aortic SBP or PP (Table 4.6). The addition of 
Pb to either aortic SBP or PP failed to enhance the performance of either of these 
variables (Figure 4.2).   
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Table 4.6. Performance (area under the receiver operating curve [AUC]) of brachial and aortic haemodynamic variables for the detection of left 
ventricular hypertrophy (LVH) in normotensive participants (conventional BP<140/90 mm Hg) of the community sample. 
       
              LVH detected using thresholds for 
         LVMI-BSA     LVMI-ht1.7           LVMI-ht2.7 
    96 of 410 (23.4%)         168 of 410 (41.0%)    73 0f 410 (17.8%) 
                AUC±SEM       p-value       AUC±SEM       p-value      AUC±SEM p-value 
_______________________________________________________________________________________________ 
Brachial systolic BP       0.586±0.034     =0.0072     0.595±0.029    =0.0010     0.618±0.037    =0.0014    
Brachial pulse pressure   0.631±0.032      <0.0001        0.613±0.028    <0.0001  0.626±0.036    =0.0004    
Aortic systolic BP       0.646±0.034*    <0.0001        0.652±0.028*   <0.0001  0.714±0.034***<0.0001    
Aortic pulse pressure       0.682±0.031*    <0.0001                0.693±0.026** <0.0001  0.693±0.034*   <0.0001    
Aortic Pf        0.629±0.031     <0.0001     0.593±0.028    =0.0016  0.614±0.036    =0.0018    
Aortic Pb        0.674±0.031     =0.0002     0.672±0.027*   <0.0001  0.698±0.035*  <0.0001    
Aortic RI        0.662±0.032     <0.0001     0.654±0.027*   <0.0001  0.663±0.036   <0.0001 
_______________________________________________________________________________________________ 
LVMI, left ventricular mass index; BSA, body surface area; ht, height; BP, blood pressure; Pf, forward wave; Pb, backward wave, RI, reflected 
wave index. *p<0.05, **p<0.005, ***p<0.0005 for comparison with AUC values for brachial systolic blood pressure or pulse pressure. 
120 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Receiver operating characteristic curves of brachial and aortic haemodynamic 
variables for the detection of left ventricular (LV) hypertrophy (168 of 410 participants 
[41%] with LV mass indexed to height1.7 greater than thresholds) in normotensive 
participants (conventional BP<140/90 mm Hg) of the community sample. A comparison of 
the area under the receiver operating curves [AUC]) is made in Table 4.6. 
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Figure 4.2. Impact on receiver operating characteristic curves for aortic systolic blood 
pressure or pulse pressure for the detection of left ventricular (LV) hypertrophy (168 of 
410 participants [41%] with LV mass indexed to height1.7 greater than thresholds)  by the 
addition of aortic backward wave pressures (Pb) in normotensive participants 
(conventional BP<140/90 mm Hg) of the community sample. No differences in the area 
under the receiver operating curves (AUC) was noted. 
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4.5  Discussion 
  
The main findings of the present study are as follows: In a large (n=1185), 
community-based sample of African ancestry, in those with normal brachial BP values 
(optimal, normal or high-normal BP), Pb was more closely related to LVMI than Pf, and 
Pb, but not Pf was better than brachial BP at LVH detection. Furthermore, in 
normotensives Pb, but not Pf was more closely associated with LVMI than brachial BP. 
However, in normotensives although aortic BP was associated with all end-organ changes 
independent of confounders and brachial BP, neither Pb, Pf, nor the reflection wave index 
(RI) were independently associated with all end-organ changes independent of 
confounders and brachial BP. In addition, although in normotensives Pb, but not Pf was 
more closely associated with LVMI than brachial BP and better than brachial BP at LVH 
detection, this effect was no better than aortic BP per se and the addition of Pb to aortic 
BP did not improve on the performance for LVH detection. 
Several recent studies suggest that indices of aortic wave reflection, including Pb, 
but not forward wave pressures (Pf), may predict cardiovascular outcomes better than or 
independent of brachial BP (Wang et al 2010, Chirinos et al 2012, Weber et al 2012, 
Zamani et al 2014). Consistent with these data (Wang et al 2010, Chirinos et al 2012, 
Weber et al 2012, Zamani et al 2014), in the present study I also show that Pb, but not Pf 
is better than brachial BP at detecting LVH in those with brachial BP values in the 
normotensive range. However, in contrast to one previous study which reported a stronger 
relationship between reflected wave magnitude and cardiovascular outcomes than 
between PP amplification, an index of differences between aortic and brachial PP, and 
cardiovascular outcomes (Chirinos et al 2012), in the present study I show that RI and Pb 
are not more closely associated with end-organ changes than aortic BP per se, and that 
RI and Pb are no better than aortic PP at detecting LVH in normotensives. However, 
whether reflected wave magnitude predicted outcomes better than aortic pressure per se 
in this previous study (Chirinos et al 2012) was not reported on. Moreover, consistent with 
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backward wave pressures offering no further prognostic information than aortic BP per se, 
in one study adjustments for aortic BP eliminated the brachial BP-independent 
relationship between backward wave pressures and cardiovascular outcomes (Wang et al 
2010) and in another study, backward wave and aortic pressures provided comparable 
prognostic information (Weber et al 2012).   
The results of the present and previous studies (Wang et al 2010, Chirinos et al 
2012, Weber et al 2012, Zamani et al 2014) demonstrating a stronger relationship 
between reflected as compared to forward wave pressures or indices and cardiovascular 
end-organ changes or outcomes, does not imply that forward wave pressures do not 
contribute to cardiovascular damage. Indeed, consistent with previous studies (Wang et al 
2010, Weber et al 2012, Booysen et al 2015 [Chapter 3]) the present study shows that 
relationships between Pf and end-organ changes do occur and that Pf is important for 
LVH detection.  
It may be argued that the more important role of Pb as compared to Pf in 
accounting for variations in LVMI and producing LVH in normotensives is consistent with 
the average age of those with normal and high-normal brachial BP values. In this regard, 
those with a normal or high-normal brachial BP are markedly younger than those with 
hypertension and as demonstrated in Chapter 3, Pb increases across the adult lifespan 
whilst Pf only begins to increase later in life (Booysen et al 2015). However, as also 
demonstrated in Chapter 3, Pf contributes to variations in LVMI in those younger rather 
than older than 50 years of age. Why Pf increases at 50 years of age, but plays no role in 
mediating LVH in this age group, whilst Pf remains unchanged prior to 50 years of age, 
but contributes to variations in LVMI over this age range cannot as yet be explained. 
The clinical implications of the present study warrant consideration. First, the 
present study suggests that increases in Pb are likely to explain the ability of aortic BP to 
detect LVH beyond brachial BP in normotensives. Hence, therapeutic approaches that 
target aortic reflected waves are required in those with normal/high-normal BP values. In 
this regard, to the best of my knowledge, at present there are no studies that have 
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evaluated the impact of antihypertensive therapy or lifestyle modification on Pb and 
reflected wave magnitude or index derived from wave separation analysis. Hence, further 
studies are required. Second, although increases in Pb are likely to explain the ability of 
aortic BP to detect LVH beyond brachial BP in normotensives, the present study also 
suggests that the impact of Pb is no greater than aortic BP on end-organs. Thus, to 
enhance risk prediction beyond brachial BP in normotensives, aortic BP, which does not 
require wave separation analysis, may be all that is required. 
The finding that Pb or RI are unable to show stronger associations with end-organ 
changes than aortic BP per se, does not exclude the possibility that measures of the 
factors that influence backward waves may not enhance risk prediction. For example, 
non-invasive measures of pressure and flow may allow for the derivation of ascending 
aortic impedance, a well-recognized determinant of backward wave function, and 
ascending aortic impedance may enhance risk prediction beyond aortic BP. 
Although not an aim of the present study, the possible mechanisms responsible for 
increases in aortic backward waves in those with normotensive BP levels warrant 
consideration. In this regard, decreases in distensibility result in increases in characteristic 
impedance in the ascending aorta and through its effect on wave velocity cause a shift of 
impedance curves to higher frequencies (O’Rourke 1970). Although it is well recognized 
that the impedance modulus-frequency curve is shifted up and to the right in hypertension, 
an effect that is not attributed to change in vascular resistance (O’Rourke 1970), whether 
similar effects characterize pre-hypertension has not been described. Further work is 
therefore required to evaluate whether alterations in impedance modulus-frequency 
curves characterize increases in backward wave pressures in pre-hypertension. 
Moreover, the environmental (salt intake or obesity), neurohormonal (sympathetic 
activation or activation of the renin-angiotensin-aldosterone system), genetic (Djami-
Tchatchou et al 2015) or molecular (factors that modify vascular structure and function) 
systems that influence characteristic impedance and hence possibly Pb and RI in pre-
hypertension require further study. In this regard, galectin-3, a pro-fibrotic inflammatory 
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molecule has recently been demonstrated by our group to show independent relations 
with RI in men (Libhaber et al 2015). 
There are several limitations to the present study that have largely been 
acknowledged in Chapters 2 and 3. First, the assumptions intrinsic to the use of the 
‘triangulation method’ of aortic wave separation are not ideal. However, this approach 
produces correlations between reflected wave indices derived from the ‘triangulation 
method’ and actual aortic flow waveforms (r2=0.55) that are considerably stronger than 
between AIx and indexes derived from actual aortic flow waveforms (r2=0.34) (Kips et al 
2009). Second, the present study was a cross-sectional design. Hence, conclusions 
regarding cause and effect cannot be drawn. Longitudinal studies are therefore required. 
Third, end-organ changes are surrogate measures of cardiovascular outcomes. Hence, 
whether aortic reflected wave indices predict cardiovascular outcomes better than aortic 
BP in normotensives requires further study.   
    In conclusion, in the present study I show that although increases in aortic wave 
reflection are likely to explain the ability of aortic BP to refine the ability to detect end-
organ changes (LVH) in normotensives, measures of wave reflection are not more closely 
associated with end-organ changes than aortic BP. Furthermore, increases in aortic wave 
reflection do not detect LVH in normotensives better than aortic BP per se. Hence, indices 
of aortic wave reflection may not be more useful than aortic BP per se when refining the 
ability to risk predict in those with BP values in the normal/high-normal BP range.  
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Chapter 5 
 
 
 
Imputation of Central Aortic Pulse Pressure from Simple Clinical 
Measurements: Validity and Ability to Detect End-Organ Changes in 
Normotensives 
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5.1 Abstract 
 
Although arterial pulse wave analysis (PWA)-derived central aortic blood pressure 
(BP) may refine the ability to detect those with a normal/high-normal brachial BP at risk of 
BP-related cardiovascular damage, the cost of measurement devices precludes the use of 
this approach in resource-limited settings. Whether aortic BP may be imputed from simple 
clinical measures, is uncertain. An imputation equation for central aortic pulse pressure 
(PPc), incorporating brachial PP, age, mean arterial pressure and pulse rate was 
identified from multivariate modelling of the factors associated with radial applanation 
tonometry (PWA)-derived PPc (SphygmoCor) in 1179 community participants. Imputed 
PPc values closely approximated PPc determined from PWA in all participants of the 
community-based sample (r2=0.96, slope=1.00±0.006, mean difference (±2xSD)=1.4±6.2 
mm Hg) and in 351 patients from a clinical sample (r2=0.943, slope=0.96±0.01, mean 
difference (±2xSD)=-2.17±7.44 mm Hg). In normotensives imputed aortic pulse pressure 
(PP) was associated with left ventricular mass index (n=410, partial r=0.17, p<0.001), 
aortic pulse wave velocity (n=570, partial r=0.09, p<0.05) and estimated glomerular 
filtration rate (n=605, partial r=-0.15, p<0.0005) independent of confounders and brachial 
BP. Independent relations with end-organ changes were similar for imputed and PWA-
derived aortic BP. The area under the receiver operating curve (AUC) for the detection of 
left ventricular hypertrophy (n=168 of 410 normotensives) showed a greater performance 
of both imputed (AUC=0.656±0.027) and PWA-derived (AUC=0.678±0.027) aortic PP as 
compared to brachial PP (AUC=0.613±0.028) or systolic BP (AUC=0.595±0.029) (p<0.05 
for comparisons of AUC). In conclusion, aortic BP imputed from simple clinical measures 
closely approximates PWA-derived aortic BP and refines the ability to detect 
normotensives at risk of BP-related sub-clinical cardiovascular disease. 
128 
 
5.2 Introduction 
 
As highlighted in chapters 1, 2 and 4, prospective, observational studies indicate 
that those with BP values in the normal/high-normal range (120-139/80-89 mm Hg) are at 
an increased risk for cardiovascular events (Hsia et al 2007, Conen et al 2007, 
Dorjgochoo et al 2009, Qureshi et al 2005, Vasan et al 2001, Blake et al 2003, Liszka et al 
2005, Gu et al 2009, Zhang et al 2006, Butler et al 2011, Kshirsagar et al 2006). In 
addition, some randomised, controlled trials (Nissen et al 2004, Remme et al 2009, 
Staessen and Jiguang 2001, Schrier et al 2002, Patel 2007) and meta-analyses of BP 
lowering trials (Trialists Collaboration 2003, Law et al 2009) in high risk patients support a 
view that treatment of those with a normal/high-normal BP has benefits for outcomes. In 
contrast, several more recent intervention studies suggest that antihypertensive treatment 
to thresholds lower than 140/90 mm Hg has no added benefit (Yusuf et al 2008, Cushman 
et al 2010, McMurray et al 2010). These studies (Yusuf et al 2008, Cushman et al 2010, 
McMurray et al 2010) highlight the markedly variable BP-related risk conferred by a 
normal/high-normal BP. Strategies are therefore required to better identify those with a 
normal/high-normal BP at risk for BP-related cardiovascular outcomes. Although, as 
recently demonstrated, aortic blood pressure (BP) may refine the ability to detect those 
with a normal/high-normal BP at risk of BP-related cardiovascular damage (Booysen et al 
2013, Chapter 2), the current cost of devices employed for non-invasive aortic BP 
measurements precludes their routine use at a primary care level in resource-limited 
settings. 
One possible solution to the potential high costs of non-invasive aortic BP 
measurement, may be to impute aortic pulse pressure (PPc) from routinely attained 
clinical measures (Camacho et al 2004). Indeed, the major determinants of PPc 
(Camacho et al 2004, Wilkinson et al 2001, McEniery et al 2008) are normally acquired as 
part of standard risk prediction. Thus, deriving an imputation equation from multivariate 
modelling (Camacho et al 2004) and applying this equation to routinely acquired clinical 
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measures may serve as an approximate of aortic PPc. In this regard, aortic BP imputed 
from simple clinical measurements closely correlates with pulse wave analysis-derived 
aortic BP with minimal mean differences (Benetos et al 2010, Regnault et al 2012). 
However, in these studies (Benetos et al 2010, Regnault et al 2012) imputed PPc was 
unable to predict outcomes beyond brachial BP. Nevertheless, mean arterial pressure 
(MAP) and pulse rate, two of the principal determinants of PPc (Camacho et al 2004, 
Wilkinson et al 2001, McEniery et al 2008) were not included in the imputation equation 
for PPc (Benetos et al 2010, Regnault et al 2012). I therefore aimed to identify an 
imputation equation that incorporates MAP and pulse rate that closely approximates PPc 
and subsequently to determine whether imputed aortic BP may refine the ability to detect 
those with a normal/high-normal BP at risk of BP-related sub-clinical cardiovascular 
disease. 
 
5.3 Methods 
5.3.1 Study samples. 
 
The present study has been described in chapter 2, page 60. In the present 
analysis to derive the imputation equation 1179 participants were evaluated. Of these 
participants, 788 had 24-hour ambulatory BP measurements that met with pre-specified 
quality control criteria (see Chapter 2). To assess whether aortic BP derived from the 
imputation equation refines the ability to detect those with a normal/high-normal BP at risk 
of BP-related cardiovascular damage, 793 participants had echocardiography, 1030 aortic 
pulse wave velocity (PWV), and 1125 estimated glomerular filtration rate (eGFR).  To 
validate the imputation equation in an external sample, 351 patients derived from several 
clinical samples (217 with critical limb ischaemia, 89 with renal failure requiring dialysis, 
45 with severe or refractory hypertension), 248 of whom were of black African origins and 
103 of whom were of European, Asian and mixed ancestry were evaluated. 
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5.3.2 Clinical, demographic and anthropometric measurements. 
 
The clinical (including office and ambulatory BP), demographic and anthropometric 
measurements have been described in chapter 2, page 61. 
 
5.3.3 Imputation of aortic pulse pressure. 
 
To derive an appropriate imputation equation, aortic BP was first determined as 
described in Chapters 2-4 (pages 62 and 84). Central aortic systolic BP (SBPc) was 
determined both from the generalised transfer function (GTF) and from the peak pressure 
of the second pressure wave of the radial pulse wave (P2) (Norton et al 2012). Both GTF- 
and P2-derived PPc were calculated as SBPc-DBP. Both GTF- and P2-derived PPc were 
determined as P2-derived aortic BP does not depend on the use of a GTF and there is 
uncertainty as to whether the application of a GTF to derive central pressures is 
appropriate for both sexes and all disease groups (Norton et al 2012). Mean arterial 
pressure (MAP) was calculated as brachial diastolic BP (DBP) + (1/3 [brachial SBP-DBP]), 
or from the brachial form factor (MAP-DBP)/PPb, where MAP was obtained from 
SphygmoCor software and was derived from the area under the radial pulse wave 
calibrated to brachial BP. The brachial form factor was employed to determine the 
average of the brachial waveform independent of absolute BP (Camacho et al 2004). To 
assess the validity of the imputation equation, the equation was evaluated in a number of 
subgroups, including in those above and below the median for aortic augmentation index 
(AIx). To avoid obtaining negative aortic AIx values in young participants, AIx was 
determined as the pressure at the second systolic peak of the aortic pulse wave/the 
pressure at the first systolic peak of the aortic pulse wave expressed as a percentage.   
To derive an appropriate imputation equation, multiple linear regression analysis 
was performed to identify the factors that account for most of the variation in radial pulse 
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wave-derived PPc. The β-coefficient for each factor was employed to derive the final 
equation. To determine the appropriateness of the imputation equation, the correlation 
coefficients and slopes of the imputed versus pulse wave-derived PPc relationships were 
evaluated and the mean±2SDs for the imputed versus pulse wave-derived PPc values 
were compared using Bland-Altman analysis in the population from which the equation 
was derived, subgroups of the population from which the equation was derived, and in the 
separate clinical population (external validation). 
 
5.3.4 End-organ changes 
 
 End-organ changes were assessed as described in chapter 2, page 65 and 
chapter 4, page 111.  
 
5.3.5 Data analysis. 
 
To determine the factors that account for variations in SphygmoCor-derived PPc, 
multivariate linear regression analysis was performed with appropriate adjustments using 
SAS version 9.1 (SAS Institute, North Carolina, USA). Unadjusted means and proportions 
were compared by the large-sample z-test and the χ2-statistic, respectively. Optimal 
thresholds for aortic BP were identified from upper 95% confidence intervals obtained in 
311 participants with optimal conventional BP values and without diabetes mellitus, as 
described in chapter 2. The aortic systolic BP threshold was identified as 112 mm Hg. 
Differences in indices of organ changes between participants in categories of BP and 
independent relations between BP and target organ changes were determined using 
multivariate regression analysis with adjustments for age, sex, BMI, diabetes mellitus 
and/or an HbA1c>6.1%, regular tobacco use, regular alcohol intake and pulse rate in the 
models. To determine probability values, further adjustments for non-independence of 
family members was performed using non-linear regression analysis (mixed procedure as 
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defined in the SAS package). The performance of brachial BP, SphygmoCor-derived 
aortic BP and imputed aortic BP for LVH detection was determined from the area under 
the receiver operating characteristic (ROC) curves (area under the curve [AUC]). The 
performance of brachial and aortic BP for the detection of an increased PWV or 
decreased eGFR was not determined as too few participants had these end-organ 
changes which exceeded currently accepted thresholds. 
 
5.4 Results 
 
5.4.1 Characteristics of participants. 
 
The clinical and demographic characteristics of community-based participants and 
participants from the clinical sample are shown in Table 5.1. In the community-based 
sample 1.5% had a history of cardiovascular disease. Of the community-based sample 
27.8% of participants had either normal or high-normal BP. 17.1% had a normal BP and 
10.7% had high-normal BP values. Age, BMI, waist circumference, and the frequency of 
participants who were overweight or obese were similar to that described in chapter 2, 
Table 2.1. Also, hypertensives, but not those with a normal or high-normal BP, had more 
diabetes mellitus and/or an impaired blood glucose control, and an increased total/HDL 
cholesterol (see Table 2.2 for representative data). No differences were noted between 
BP categories in regular alcohol and tobacco intake or pulse rate (see Table 2.2 for 
representative data). 
 
5.4.2 Derivation of imputed aortic pulse pressure. 
 
The factors most strongly associated with pulse wave-derived central aortic pulse 
pressure (PPc) were brachia PP (PPb), age, pulse rate (obtained from SpygmoCor), MAP 
and female gender (Table 5.2). Although PPb was closely correlated with pulse-wave  
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Table 5.1. Characteristics of study samples. 
 
               Community-based  Clinical sample              
                               study (±SD)            (±SD) 
______________________________________________________________________ 
Sample size (% female)                  1179 (65.1)         351 (51.3%) 
Age (years)                     43.5±18.1         55.9±14.8 
Body mass index (kg/m2)                    29.5±8.1         26.5±6.1 
Regular tobacco (% subjects)           14.9          35.9  
Regular alcohol (% subjects)            21.3          48.5  
Treated diabetes mellitus (% subjects)         6.8                        29.3  
Treated hypertension (% subjects)             24.1          73.5 
Body height (cm)    161.1±8.7   167.5±10 
Body weight (kg)    76.2±19.5   74.4±19.9 
Pulse rate (Beats/min)   66±12    78±17 
Measured BP and PP amplification 
Brachial SBP/DBP (mm Hg)                          129±23/84±13              137±23/84±14 
Brachial PP (mm Hg)                                     45±17                       53±17 
Aortic PP (mm Hg)                                    36±15                       40±15 
PP amplification                                     1.29±0.18                              1.34±0.18 
Brachial mean Arterial Pressure (mm Hg) 100±16   102±17  
Imputed BP and PP amplification 
Aortic PP (mm Hg)                                    36±15                       43±16 
PP amplification                                     1.29±0.18   1.27±0.16 
End organ values 
Left ventricular mass index (g/m1.7)        67.7±24.2   - 
Aortic pulse wave velocity (m/sec)         6.42±2.67   - 
Estimated GFR (mls/min/1.73 m2)        116±33   - 
__________________________________________________________ 
SBP/DBP, systolic/diastolic blood pressures; PP, pulse pressure; GFR, glomerular 
filtration rate. – indicates “not available”. 
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Table 5.2. Factors independently associated with central aortic pulse pressure (PPc) in 
1179 participants from a community sample. 
 
                                       partial r2*  β-coefficient† p value     
       ±SEM            
Aortic PPc vs 
_____________________________________________ 
Brachial PP  0.920       0.844±0.007   <0.0001 
Age   0.014       0.146±0.008   <0.0001 
Pulse rate  0.019      -0.159±0.006   <0.0001 
MAP   0.006       0.101±0.007   <0.0001 
Female gender 0.005       0.060±0.008   <0.0001 
Body height  0.0007    -0.040±0.008   <0.0001 
Treatment for HT 0.0005    -0.024±0.007   <0.0005 
Regular tobacco use 0.0003    -0.017±0.006   =0.0001 
Model r2  0.97 
_______________________________________________ 
MAP, mean arterial pressure; HT, hypertension. *Additional factors included in the model 
which were not associated are body weight, regular alcohol intake, and diabetes mellitus 
or an HbA1c<6.1%. Probability values are further adjusted for non-independence of family 
members. †Standardized slopes of the relationships. #MAP determined using diastolic BP 
+ (systolic-diastolic BP)/3. 
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derived PPc (Figure 5.1, upper left panel, Table 5.3), brachial PP consistently 
overestimated PPc with a greater bias toward a lower PPc as compared to brachial PP at 
higher PPc values (Figure 5.1, lower left panel). Imputing PPc from the size effects of 
PPb, age, pulse rate and MAP using the formula given in Table 5.3, generated a 
relationship between imputed PPc and pulse wave-derived PPc with an improved 
correlation coefficient, slope and intercept (Figure 5.1, upper right panel and Table 5.3), 
with a markedly reduced mean difference (Figure 5.1, lower right panel and Table 5.3) 
and no bias toward a lower PPc as compared to brachial PP at  higher PPc values (Figure 
5.1, lower right panel, Table 5.3). 
The addition of sex to the PPc imputation equation resulted in a greater mean 
(±2SD) difference (-4.20±5.80) between imputed PPc and pulse wave-derived PPc than 
that achieved without the addition of sex to the model (p<0.0001 for comparisons of mean 
differences). The exclusion of pulse rate and MAP from the PPc imputation equation also 
generated a greater mean (±2SD) difference between imputed and pulse wave-derived 
PPc values (-6.5±7.9, p<0.0001 versus with pulse rate and MAP). The inclusion of the 
brachial form factor, rather than MAP failed to improve the mean (±2SDs) differences 
between pulse wave-derived and imputed PPc (-11.6±5.0 mm Hg). The addition of body 
height, treatment for hypertension or smoking failed to improve the correlation coefficients, 
or slopes of the imputed versus pulse wave-derived PPc relationships or the mean 
differences between these values (data not shown). The relationship between imputed 
PPc and P2-derived, rather than GTF-derived PPc showed a similar correlation coefficient 
(0.94), slope (0.99±0.007), intercept (-1.22±0.29) and mean difference ±2SD (-1.61±7.63).
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Figure 5.1. Correlations between radial pulse wave-derived central aortic pulse pressure (measured PPc) and either brachial PP (PPb) (left 
upper panel) or imputed PPc (right upper panel) and Bland Altman plots showing mean differences (±2 x SD) between pulse wave-derived PPc 
and PPb (left lower panel) or pulse wave-derived and imputed PPc (right lower panel) in the community sample. 
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Table 5.3. Characteristics of relationships between brachial or imputed aortic pulse pressure (PP) and pulse wave (PW)-derived central aortic 
PP (PPc) and the mean differences between these values in subgroups of the study sample. 
                                              r2 (CI)               β-coefficient       Intercept±SEM     Mean difference 
Pulse wave-derived PPc vs             n=                                   (slope)±SEM          (mm Hg)           ±2SD (mm Hg) 
_______________________________________________________________________________________________ 
Brachial PP (PPb)                           1179      0.920 (0.911-0.929)      0.891±0.008        -4.27±0.37         -9.16±9.39 
Imputed  PPc 
  All participants                                1179     0.959* (0.954-0.964)   1.000±0.006*          -1.37±0.24*       -1.37±6.20*   
  Women                        769      0.965 (0.961-0.970)      0.989±0.007         -0.21±0.26        -0.62±5.38 
  Men                         410      0.962 (0.955-0.969)      1.030±0.010         -3.94±0.42        -2.77±6.64 
  Hypertensives                   540      0.964 (0.958-0.970)      1.031±0.012         -2.93±0.41        -1.54±6.42 
  DM                         165      0.961 (0.949-0.972)      0.990±0.016        -1.52±0.73        -1.97±6.54 
  Smokers                        176      0.957 (0.945-0.969)      1.050±0.017         -3.36±0.67        -1.48±6.42 
  Increased WC                   513      0.963 (0.957-0.969)      0.986±0.009         -0.47±0.36        -1.05±5.80 
  White-coat effect†              138 0.960 (0.944-0.971)      1.048±0.018         -3.68±0.84        -1.59±6.28 
  No white-coat effect              650 0.950 (0.942-0.957)      0.983±0.009         -0.73±0.34        -1.32±6.40 
  Office BP within 5 mm Hg day BP‡  104 0.932 (0.900-0.953)      0.936±0.025          1.03±0.83        -0.10±5.03 
  Office BP > 5 mm Hg of day BP‡ 684 0.954 (0.947-0.960)      0.998±0.008         -1.36±0.34        -1.43±6.55 
  PW derived PPc≥50 mm Hg  185 0.950 (0.933-0.962)      1.002±0.017         -0.25±1.09        -0.11±6.62 
________________________________________________________________________________________________ 
Imputed  PPc = (0.782 x PPb) + (0.115 x age) + (0.090 x MAP) – (0.184 x PR). 
MAP, mean arterial pressure derived from brachial diastolic BP + 1/3(systolic BP- diastolic BP); PR, pulse rate; DM, diabetes mellitus defined as treatment or HbA1c>6.5%; 
increased WC, increased waist circumference defined as 102 in men and 88 in women. *p<0.0001 vs PW-derived PPc vs brachial PP. †indicates office systolic or diastolic BP > 
day systolic or diastolic BP, ‡for systolic BP. All r2 values, β-coefficients, intercepts and mean differences are significant at p<0.0001. 
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5.4.3 Validity of the imputation equation in subgroups of the community sample. 
 
The characteristics of the relationships and mean (±2SD) differences between 
imputed PPc and pulse wave-derived PPc were similar in men and women, in those with 
an increased waist circumference, hypertensives, those with diabetes mellitus, and in 
smokers (Table 5.3). Furthermore, the characteristics of the relationships and mean 
(±2SD) differences between imputed PPc and pulse wave-derived PPc were similar to all 
participants in those with a PPc≥50 mm Hg (Table 5.3) where a greater bias toward a 
lower PPc as compared to brachial PP was noted (Figure 5.1, lower left panel). The mean 
(±2SD) differences between imputed PPc and pulse wave-derived PPc were similar below 
(-2.9.±6.14 mm Hg) and above (0.16±4.54 mm Hg) the median of AIx (140.2). However, 
the slope (β-coefficient) of the relationship between imputed PPc and pulse wave-derived 
PPc was reduced in those with an AIx below (0.86±0.01) as compared to above 
(1.00±0.006 mm Hg) the median value (140.2). Nevertheless this difference was largely 
attributed to the slope of the relationship between brachial PP and pulse wave-derived 
PPc being reduced in those with an AIx below (0.73±0.01) as compared to above 
(0.89±0.005 mm Hg) the median value (140.2) rather than an inability of the imputation 
equation to improve on the slope. 
 
5.4.4 Validation of the imputation equation in clinical sample (external validation). 
 
As with the community-based sample, in the clinical population, as indicated in 
Figure 5.2, brachial PP was closely correlated with pulse-wave derived PPc (r2=0.882), 
but consistently overestimated PPc with a greater bias toward a lower PPc as compared 
to brachial PP at higher PPc values (slope=0.82±0.02, mean difference ± 2xSD = -
12.46±12.30 mm Hg). Imputing PPc using the formula given in Table 5.3, generated a 
relationship between imputed PPc and pulse wave-derived PPc in the clinical sample with
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Figure 5.2. Correlations between radial pulse wave-derived central aortic pulse pressure (measured PPc) and either brachial PP (PPb) (left 
upper panel) or imputed PPc (right upper panel) and Bland Altman plots showing mean differences (±2 x SD) between pulse wave-derived PPc 
and PPb (left lower panel) or pulse wave-derived and imputed PPc (right lower panel) in the clinical sample. 
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an improved correlation coefficient (r2=0.943), and slope (0.96±0.01) with a markedly 
reduced mean difference ± 2xSD (-2.17±7.36 mm Hg)(p<0.0001 for comparisons of r2, β-
coefficient and mean difference) (Figure 5.2). The relationship between imputed PPc and 
pulse wave-derived PPc in those of European, Asian and mixed ancestry showed a 
similar correlation coefficient (r2=0.946), slope (β-coefficient=0.964±0.023) and mean 
difference±2SD (-2.50± 7.54 mm Hg) as did the relationship between imputed PPc and 
pulse wave-derived PPc in those of black African ancestry (r2=0.941, slope=0.957±0.015, 
mean difference ± 2xSD= -2.03±7.38 mm Hg). 
 
5.4.5 Aortic blood pressures within BP categories.  
 
Conventional and 24-hour BP values in the community sample are similar to that 
given in Chapter 2, Table 2.2. The mean imputed aortic SBP values across categories of 
brachial BP (imputed aortic SBP in mm Hg: optimal brachial BP=101±14 mm Hg, normal 
brachial BP=112±9 mm Hg, high-normal brachial BP=120±9 mm Hg, 
hypertensives=138±22 mm Hg p<0.0001 across BP categories) were similar to the mean 
SphygmoCor-derived aortic SBP values across categories of brachial BP (SphygmoCor-
derived aortic SBP in mm Hg: optimal brachial BP=100±14 mm Hg, normal brachial 
BP=110±9 mm Hg, high-normal brachial BP=119±10 mm Hg, hypertensives=136±22 
p<0.0001 across brachial BP categories) (p>0.08) for comparison of imputed and 
SphgmoCor-derived aortic SBP within brachial BP categories). Furthermore, the mean 
imputed aortic PP values across categories of brachial BP (imputed aortic PP in mm Hg: 
optimal brachial BP=28±12 mm Hg, normal brachial BP=31±8 mm Hg, high-normal 
brachial BP=35±9 mm Hg, hypertensives=45±16 mm Hg p<0.0001 across BP categories) 
were similar to the mean SphygmoCor-derived aortic PP values across categories of 
brachial BP (SphygmoCor-derived aortic PP in mm Hg: optimal brachial BP=27±11 mm 
Hg, normal brachial BP=29±8 mm Hg, high-normal brachial BP=34±9 mm Hg, 
hypertensives=43±17 mm Hg p<0.0001 across brachial BP categories) (p>0.19 for 
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comparison of imputed and SphgmoCor-derived aortic SBP within optimal, normal and 
high-normal brachial BP categories) and modestly greater (p=0.024) within the 
hypertensive brachial BP category. Importantly, in those with a normal/high-normal BP, 
47.5% had an imputed aortic SBP and 53.7% had SphygmoCor-derived aortic SBP that 
did not exceed the upper 95% confidence intervals of healthy participants with an optimal 
BP. 
 
5.4.6 Continuous relationships between various measures of PP and target organ 
changes in normotensive participants.  
 
In normotensive participants (BP<140/90 mm Hg and no antihypertensive 
treatment) of the community sample, with adjustments for confounders, conventional, 
imputed central aortic and SphygmoCor-derived aortic PP (Table 5.4) and SBP (Table 
5.5) were correlated with target organ changes. The relationships between imputed and 
SphygmoCor-derived aortic PP or SBP and LVMI-BSA were stronger than those between 
brachial PP or SBP and LVMI-BSA (Table 5.4). After further adjustments for aortic PP or 
SBP, the relationships between conventional PP or SBP and target organ changes in 
normotensives were abolished (Tables 5.4 and 5.5). In contrast, with further adjustments 
for conventional PP or SBP, imputed aortic and SphygmoCor-derived aortic PP or SBP 
retained independent relationships with target organ changes in normotensives (Tables 
5.4 and 5.5). In addition, with further adjustments for 24-hour brachial PP, imputed aortic 
(PWV; partial r=0.15, confidence intervals=0.05 to 0.25, p=0.003, n=386; eGFR; partial r= 
-0.11, confidence intervals= -0.20 to -0.01, p<0.05, n=412; LVMI; partial r=0.25, 
confidence intervals=0.13 to 0.35, p<0.0001, n=290) and SphgmoCor-derived aortic 
(PWV; partial r=0.14, confidence intervals=0.04 to 0.24, p=0.006, n=386; eGFR; partial r= 
-0.10, confidence intervals= -0.20 to -0.006, p<0.05, n=412; LVMI; partial r=0.23, 
confidence intervals=0.12 to 0.34, p<0.0001, n=290) PP also retained independent  
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Table 5.4. Multivariate adjusted relationships between brachial and aortic pulse pressure 
(PP) and target organ changes in normotensive participants (conventional BP<140/90 mm 
Hg) of the community sample. 
      
PP vs               n     partial r      CI       p-value partial r       CI        p-value             
______________________________________________________________________ 
                                       Brachial PP adjusted for*    Brachial PP adjusted for          
    imputed aortic PP+*                 
Pulse wave velocity   570 0.14 (0.06 to 0.22) =0.0006 0.06 (-0.02 to 0.13) =0.14 
Estimated GFR    605 -0.01 (-0.08 to 0.07) =0.89 0.09 (0.01 to 0.17)  <0.05       
LVMI-BSA  410 0.22 (0.13 to 0.31) <0.0001 0.03 (-0.07 to 0.12) =0.58 
LVMI-ht1.7  410 0.19 (0.10 to 0.28) =0.0001 0.05 (-0.05 to 0.14) =0.35 
LVMI-ht2.7  410 0.18 (0.08 to 0.27) <0.0005 0.04 (-0.06 to 0.13) =0.18 
                                    Imputed aortic PP adjusted for*      Imputed aortic PP adjusted 
      for brachial PP+*     
Pulse wave velocity   570 0.16 (0.07 to 0.24) =0.0002 0.09 (0.01 to 0.17)  <0.05 
Estimated GFR    605 -0.12† (-0.20 to -0.04) <0.005      -0.15 (-0.23 to -0.07) <0.0005       
LVMI-BSA  410 0.32†# (0.23 to 0.41) <0.0001 0.24 (0.14 to 0.33) <0.0001 
LVMI-ht1.7  410 0.25# (0.15 to 0.34) <0.0001 0.17 (0.07 to 0.26) =0.0008 
LVMI-ht2.7  410 0.24# (0.14 to 0.33) <0.0001 0.17 (0.07 to 0.26) =0.0009 
                                    SphygmoCor-derived aortic PP SphygmoCor-derived aortic  
adjusted for*                          PP adjusted for brachial PP+*     
Pulse wave velocity   570 0.16 (0.08 to 0.24) =0.0001 0.10 (0.02 to 0.18)  =0.015 
Estimated GFR    605 -0.11† (-0.19 to -0.03) <0.01      -0.14 (-0.21 to -0.06) =0.0008       
LVMI-BSA  410 0.31†# (0.21 to 0.39) <0.0001 0.22 (0.13 to 0.31) <0.0001 
LVMI-ht1.7  410 0.24# (0.14 to 0.33) <0.0001 0.16 (0.06 to 0.25) =0.0013 
LVMI-ht2.7  410 0.24# (0.15 to 0.33) <0.0001 0.18 (0.08 to 0.27) <0.0005 
_______________________________________________________________________ 
CI, confidence intervals; GFR, glomerular filtration rate; LVMI, left ventricular mass index; 
BSA, body surface area; ht, height. *Adjustments are for age, sex, BMI, diabetes mellitus 
and/or an HbA1c>6.1%, regular tobacco intake, regular alcohol intake and pulse rate. 
†p<0.05 vs r values for brachial PP versus end-organ changes, #p<0.05 vs r values for 
brachial SBP versus end-organ changes (z-statistics). 
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Table 5.5. Multivariate adjusted relationships between brachial and aortic systolic blood 
pressure (SBP) and target organ changes in normotensive participants (conventional 
BP<140/90 mm Hg) of the community sample. 
      
SBP vs              n     partial r      CI       p-value partial r       CI        p-value             
______________________________________________________________________ 
                                       Brachial SBP adjusted for*   Brachial SBP adjusted for          
    imputed aortic SBP+*                 
Pulse wave velocity   570   0.23 (0.15 to 0.30)  <0.0001 0.07 (-0.01 to 0.15) =0.10 
Estimated GFR           605  -0.13 (-0.21 to -0.05 =0.001      -0.05 (-0.13 to 0.03) =0.20 
LVMI-BSA  410   0.19 (0.09 to 0.28  =0.0001       0.01 (-0.09 to 0.11) =0.84 
LVMI-ht1.7  410   0.16 (0.06 to 0.25)  =0.002        0.01 (-0.09 to 0.11) =0.86 
LVMI-ht2.7  410   0.15 (0.06 to 0.25)    <0.002 -0.01 (-0.11 to 0.09) =0.88 
                                    Imputed aortic SBP adjusted for*      Imputed aortic SBP adjusted 
      for brachial SBP+*    
Pulse wave velocity   570   0.28 (0.15 to 0.30)  <0.0001 0.18 (0.10 to 0.26)   <0.0001 
Estimated GFR           605  -0.15 (-0.23 to -0.07) =0.0002  -0.08 (-0.16 to -0.01)  <0.05 
LVMI-BSA  410   0.29† (0.20 to 0.38)  <0.0001 0.23 (0.13 to 0.32)   <0.0001 
LVMI-ht1.7  410   0.25  (0.16 to 0.34)  <0.0001 0.19 (0.10 to 0.29)   <0.0001 
LVMI-ht2.7  410   0.26† (0.17 to 0.35)  <0.0001 0.21 (0.12 to 0.30)  <0.0001 
                                    SphygmoCor-derived aortic SBP SphygmoCor-derived aortic  
adjusted for*                       SBP adjusted for brachial SBP+*     
Pulse wave velocity   570   0.28 (0.20 to 0.36)  <0.0001 0.19 (0.11 to 0.27)   <0.0001 
Estimated GFR           605  -0.14 (-0.22 to -0.07) =0.0004   -0.08 (-0.16 to -0.01) <0.05 
LVMI-BSA  410   0.28  (0.19 to 0.37)  <0.0001      0.22 (0.12 to 0.31)   <0.0001 
LVMI-ht1.7  410   0.24† (0.15 to 0.33)  <0.0001 0.18 (0.09 to 0.28)   =0.0002 
LVMI-ht2.7  410   0.26† (0.17 to 0.35)  <0.0001 0.22 (0.12 to 0.31)  <0.0001 
_______________________________________________________________________ 
CI, confidence intervals; GFR, glomerular filtration rate; LVMI, left ventricular mass index; 
BSA, body surface area; ht, height. *Adjustments are for age, sex, BMI, diabetes mellitus 
and/or an HbA1c>6.1%, regular tobacco intake, regular alcohol intake and pulse rate. 
†p<0.05 vs r values for brachial SBP versus end-organ changes (z-statistics). 
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relationships with target organ changes in normotensives. Further, with adjustments for 
24-hour brachial SBP, imputed aortic (PWV; partial r=0.24, confidence intervals=0.14 to 
0.33, p<0.0001, n=386; eGFR; partial r= -0.12, confidence intervals= -0.21 to -0.02, 
p<0.05, n=412; LVMI; partial r=0.24, confidence intervals=0.13 to 0.35, p<0.0001, n=290) 
and SphgmoCor-derived aortic (PWV; partial r=0.23, confidence intervals=0.14 to 0.33, 
p<0.0001, n=386; eGFR; partial r= -0.11, confidence intervals= -0.21 to -0.01, p<0.05, 
n=412; LVMI; partial r=0.24, confidence intervals=0.11 to 0.33, p=0.0001, n=290) SBP 
also retained independent relationships with target organ changes in normotensives. 
Before or after adjustments for brachial BP, relations between end-organ changes and 
imputed aortic versus SphygmoCor-derived aortic BP were identical (Tables 5.4 and 5.5). 
 
5.4.7 Target organ changes in those with a normal or high-normal BP irrespective of 
aortic BP.  
 
Before adjustments for confounders, as compared to participants with optimal BP 
values, hypertensives and those with either normal or high-normal BP values had a 
markedly increased PWV, LVMI and eGFR (Table 5.6). However, after adjustments for 
confounders, only modest target organ changes were noted in those with a normal or 
high-normal BP (Table 5.6). Moreover, with the exception of eGFR which was higher in 
these with a high-normal BP, normal versus high-normal BP categories failed to 
distinguish between those with and without target organ changes (Table 5.6). 
 
5.4.8 Imputed aortic BP distinguishes target organ changes in those with a normal/high-
normal BP.  
 
As compared to those with an optimal BP, both unadjusted and multivariate 
adjusted target organ changes were consistently noted in those with a normal/high-normal 
BP with, but not in those without imputed aortic systolic BP values≥upper 95% confidence 
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Table 5.6. Unadjusted and multivariate adjusted indices of target organ changes of study participants of the community sample. 
 BP categories          Optimal               Normal           High-normal             Hypertensives 
BP range (mm Hg)         <120/80            ≥120/80 and              ≥130/85 and           ≥140/90 or 
                  <130/85               <140/90                 Treatment 
_______________________________________________________________________________________________________ 
Unadjusted values 
PWV (m/sec)(n)   4.86(285)  5.36(178)  6.11(107)*** †  7.87(459)*** †††###                  
eGFR (mls/min/1.73 m2)(n)    131.8(296)  123.6(190)*  114.1(117)*** † 104.8(518)*** †††# 
LV mass index (g/m2)(n)  65.9(197)  75.8(133)*  74.8(80)  81.9(367)*** 
LV mass index (g/m1.7)(n)  57.2(197)  66(133)**  65.9(80)*  74.3(367)*** ††# 
LV mass index (g/m2.7)(n)  35.4(197)  39.7(133)*  40.8(80)*  46.5(367)*** †††## 
 
Multivariate adjusted values 
PWV (m/sec)(n)   5.92(285)  6.21(178)  6.37(107)  6.82(459)*** †     
eGFR (mls/min/1.73 m2)(n)      121.2(296)  115.2(190)  111.2(117)*  114.6(518) 
LV mass index (g/m2)(n)  71.4(197)  78.8(133)  75.5(80)  77.7(367) 
LV mass index (g/m1.7)(n)  64.5(197)  69.7(133)  66(80)   69(367) 
LV mass index (g/m2.7)(n)  40(197)  42.4(133)  41.1(80)  43(367) 
______________________________________________________________________________________________________________ 
BP, blood pressure; PWV, aortic pulse wave velocity; eGFR, estimated glomerular filtration rate; LV, left ventricle. Adjustments are for age, sex, 
BMI, diabetes mellitus and/or an HbA1c>6.1%, regular tobacco use, regular alcohol intake and pulse rate. *p<0.05, **p<0.005, ***p<0.0001 vs 
optimal; †p<0.05, ††p<0.005, †††p<0.0005 vs normal; #p<0.05, ##p<0.005, ###p<0.0001 vs high-normal. 
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interval for healthy participants with optimal BP values (Table 5.7). Importantly, even those 
with a normal as opposed to high-normal conventional BP values, but whom had an imputed 
aortic SBP that exceeded “optimal” values had multivariate adjusted increases in PWV, LVMI 
and decreases in eGFR. 
 
5.4.9 Performance of measures of BP to detect target organ changes in normotensive 
participants.  
 
In normotensives with all end-organ measurements 96 of 410 (23.4%) had LVH 
based on LVMI-BSA thresholds, 168 of 410 (41%) had LVH based on LVMI-ht1.7 thresholds, 
73 of 410 (17.8%) had LVH based on LVMI-ht2.7 thresholds, 3 of 570 (0.5%) had an 
increases aortic PWV and 0 of 605 (0%) had a decreased eGFR. Hence, I assessed the 
performance of aortic versus brachial BP measurements for LVH detection, but not for the 
detection of increases in PWV or decreases in eGFR. All BP measurements showed 
significant performance for LVH detection (Table 5.8). However, SphygmoCor-derived and 
imputed aortic SBP and PP showed a greater performance for LVH detection than brachial 
SBP or PP (Table 5.8 and Figure 5.3). Imputed aortic SBP and PP showed a similar 
performance for LVH detection as SphygmoCor-derived aortic BP (Table 5.8 and Figure 5.3). 
 
5.5 Discussion 
 
The main findings of the present study are as follows: In a large community-based 
sample I identified an equation that incorporates the simple clinical measures of age, PPb, 
MAP and pulse rate and which generates imputed PPc values that closely approximate pulse 
wave analysis (PWA)-derived PPc values. Second, this equation was validated when applied 
to a clinical sample consisting of patients with severe and refractory hypertension, critical 
limb ischaemia and renal failure and performed equally as well in those of black African 
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Table 5.7. Unadjusted and multivariate adjusted indices of target organ changes of prehypertensives of the community sample with (Yes) or 
without (No) imputed aortic systolic blood pressures (SBP) greater than thresholds (112 mm Hg) defined in those with optimal conventional BP 
values.  
Blood pressure categories           Optimal                        Normal/high-normal          Hypertensives 
Blood pressure range (mm Hg)       <120/80             ≥120/80 and <140/90             ≥140/90 or        
      with aortic SBP≥112 mm Hg                    Treatment 
                      No         Yes 
_________________________________________________________________________________________________________ 
Unadjusted values 
PWV (m/sec)(n)    4.86(285)  4.99(112)  6.06(173)*** ††  7.87(459)*** †††###     
eGFR (mls/min/1.73 m2)(n)       131.8(296)  128.2(117)  114.9(190)*** †† 104.8(518)*** †††## 
LV mass index (g/m2)(n)   65.9(197)  66.9(79)  80.4(134)*** †  82(367)*** ††† 
LV mass index (g/m1.7)(n)   57.2(197)  59.1(79)  70(134)*** ††  74.3(367)*** ††† 
LV mass index (g/m2.7)(n)   35.4(197)  36(79)   42.5(134)*** †  46.5(367)*** †††# 
 
Multivariate adjusted values 
PWV (m/sec)(n)      5.54(285)  5.67(112)  6.07(173)**  6.51(459)*** †††# 
eGFR (mls/min/1.73 m2)(n)       121.4(296)  117.1(117)  111.7(190)**  114.5(518)* 
LV mass index (g/m2)(n)   70.8(197)  71(79)   81.1(134)*  78.2(367) 
LV mass index (g/m1.7)(n)    64.1(197)  63.8(79)  70.7(134)*  69.3(367)    
LV mass index (g/m2.7)(n)   39.8(197)  39.3(79)  43.2(134)  43.2(367) 
_________________________________________________________________________________________________________ 
PWV, aortic pulse wave velocity; eGFR, estimated glomerular filtration rate LV, left ventricle. Adjustments are for age, sex, BMI, diabetes 
mellitus and/or an HbA1c>6.1%, regular tobacco use, regular alcohol intake and pulse rate. *p<0.05, **p<0.005, ***p<0.0001 vs optimal; 
†p<0.05, ††p<0.005, †††p<0.0005 vs aortic BP<112 mm Hg; #p<0.05, ##p<0.005, ###p<0.0001 vs aortic BP≥112 mm Hg. 
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Table 5.8. Performance (area under the receiver operating curve [AUC]) of brachial blood pressures (BP), SphygmoCor-derived aortic BP, or 
imputed aortic BP for left ventricular hypertrophy detection in normotensive participants (conventional BP<140/90 mm Hg) of the community 
sample. 
       
              LVH detected using thresholds for 
         LVMI-BSA     LVMI-ht1.7           LVMI-ht2.7 
    96 of 410 (23.4%)         168 of 410 (41.0%)    73 0f 410 (17.8%) 
                AUC±SEM       p-value       AUC±SEM       p-value      AUC±SEM p-value 
_______________________________________________________________________________________________ 
Brachial systolic BP       0.586±0.034     =0.0072     0.595±0.029    =0.0010     0.618±0.037    =0.0014    
Brachial pulse pressure   0.631±0.032      <0.0001        0.613±0.028    <0.0001  0.626±0.036    =0.0004    
SphygmoCor† SBPc       0.646±0.034*    <0.0001        0.652±0.028*   <0.0001  0.714±0.034***<0.0001    
SphygmoCor† PPc       0.682±0.031*    <0.0001                0.693±0.026** <0.0001  0.693±0.034*   <0.0001    
Imputed SBPc        0.652±0.033*    <0.0001                0.645±0.028*  <0.0001  0.714±0.034***<0.0001 
Imputed PPc        0.682±0.032*    <0.0001                0.657±0.028*  <0.0001  0.683±0.036*   =0.0001 
_______________________________________________________________________________________________ 
LVMI, left ventricular mass index; BSA, body surface area; ht, height; BP, blood pressure; SBPc, central aortic systolic BP; PPc, central aortic 
pulse pressure. †Refers to values obtained using radial applanation tonometry and SphygmoCor software. *p<0.05, **p<0.005, ***p<0.0005 for 
comparison with AUC values for brachial systolic blood pressure or pulse pressure. 
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Figure 5.3. Performance of brachial blood pressures (BP), SphygmoCor-derived aortic 
BP, or imputed aortic BP for left ventricular hypertrophy detection (168 of 410 participants 
[41%] with LV mass indexed to height1.7 greater than thresholds) in normotensive 
participants (conventional BP<140/90 mm Hg) of the community sample. A comparison of 
the area under the curves is made in Table 5.8. 
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origins as in those of other ethnic groups. Third, when applying this imputation equation to 
those with normal-high normal BP values of the community sample, as compared to those 
with an optimal BP, both unadjusted and multivariate adjusted target organ changes were 
consistently noted in those with a normal/high-normal BP with, but not in those without 
imputed aortic SBP values≥upper 95% confidence interval for healthy participants with 
optimal BP values. In contrast, normal and high-normal brachial BP categories failed to 
consistently identify those with target organ changes. Furthermore, in normotensives 
independent of brachial BP, imputed aortic BP was just as strongly associated with end-
organ changes as PWA-derived aortic BP; imputed and PWA-derived aortic BP both 
showed similarly stronger relations with LVMI-BSA than brachial BP; and in comparison to 
PWA-derived aortic BP, imputed aortic BP showed a similarly improved ability (area under 
the receiver operating curve) to detect LVH than brachial BP. 
Prior studies where PPc was imputed from an equation which did not incorporate 
pulse rate and MAP, although demonstrating independent relationships between imputed 
PP amplification and outcomes, failed to show that imputed PPc predicts outcomes 
beyond brachial PP (Benetos et al 2010, Regnault et al 2012). Furthermore, the 
imputation equation derived by Benetos et al (2010), failed to predict outcomes in 
alternative populations (unpublished data). These findings (Benetos et al 2010, Regnault 
et al 2012) may be attributed to an inability to generate an optimal imputation equation for 
estimating PPc, in-part because of the exclusion of MAP and pulse rate from the 
imputation equation. Indeed, in contrast to these studies (Benetos et al 2010, Regnault et 
al 2012) where only 85.8% of the variation in PPc could be accounted for, in the present 
study I could account for 97.5% of the variation in aortic BP, 96% of which was attributed 
to brachial PP, age, pulse rate and MAP. Importantly, in the present study I show that 
without pulse rate and MAP included in the model, imputed PPc remained markedly lower 
than pulse wave-derived PPc. The present study therefore underscores the importance of 
pulse rate and MAP as determinants of central aortic BP. Indeed, prior studies have 
demonstrated that the differential effects of β-adrenoreceptor blocker-based as compared 
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to alternative antihypertensive therapy on cardiovascular outcomes, may be attributed in-
part to an attenuated beneficial effect of heart rate-lowering therapy on aortic BP (Williams 
et al 2006, Williams et al 2009). 
An important caveat of the present study is that the present results do not suggest 
that imputed PPc may replace non-invasively measured PPc in enhancing risk-prediction 
in those with normal-high normal BP values. In this regard, although 96% of the variation 
of PPc was attributed to brachial PP, age, pulse rate and MAP, and these factors were 
included in the imputation equation, the unaccounted for 4% of the variability of PPc may 
translate into a 6.2 mm Hg (2xSD) difference in PPc, which may have potentially important 
effects on cardiovascular risk. Furthermore, in those with a lower augmentation index 
(younger individuals), largely because the slope of the relationship between brachial PP 
and PPc is reduced, the slope (β-coefficient) of the relationship between imputed PPc and 
PWA-derived PPc is further from unity (0.86) than that desired. Hence, in younger 
individuals with a lower augmentation index, the imputation equation is not ideal. The 
clinical importance of the present study is that in resource-limited settings where the 
devices for the non-invasive assessment of aortic BP may not be cost-effective methods 
of risk assessment, the use of an imputation equation as applied to simple clinical 
measurements may be a reasonable alternative with no cost implications.  
Several limitations of the present study require consideration: First, the present 
study was conducted in a community sample of black African ancestry. Hence, whether 
similar data occur in other ethnic groups requires confirmation. However, in the clinical 
cohort employed for external validation I noted that the imputation equation applied 
equally as well in a small group of European, Asian and mixed ancestry as it did in the 
group of black African origins. Second, the present study was a cross-sectional design. 
Hence, conclusions regarding cause and effect cannot be drawn. Longitudinal studies are 
therefore required. Third, end-organ changes are surrogate measures of cardiovascular 
outcomes. Hence, whether imputed aortic BP predicts cardiovascular outcomes as well as 
PWA-derived-aortic BP in normotensives requires further study. In this regard, although 
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not conducted specifically in normotensives, in 4795 patients from a Mid-Eastern 
population in Israel referred for ambulatory BP monitoring, where 648 patients died over 
20 years, independent of awake brachial PP, the hazards ratio for all-cause mortality per 
SD of ambulatory awake imputed PPc was 2.02 (95% CI:1.19-3.41, p<0.01). Similarly, 
independent of awake brachial systolic BP, imputed awake PPc predicted survival 
(p<0.0001) (Bursztyn et al, PLoS One, under-review). 
In conclusion, in the present study I show that aortic PP can be imputed from an 
equation that employs simple clinical measures (age, brachial PP, MAP and pulse rate) 
and that imputed aortic PP produces values that closely approximate non-invasively 
determined aortic PP (applanation tonometry and SphygmoCor software). In addition, I 
show that aortic PP imputed from this equation may refine the ability to detect those with a 
normal/high-normal BP at risk of BP-related sub-clinical cardiovascular disease. In view of 
the cost of devices designed to measure aortic BP non-invasively, aortic BP imputed from 
simple clinical measures may be of value when risk-predicting in those individuals with 
normotensive office BP values (<140/90 mm Hg) in resource-limited settings. 
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Chapter 6 
 
 
 
Contextual Narrative and Conclusions 
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In the present thesis I explored the possibility that the use of various measures of 
central aortic haemodynamics may enhance the ability to identify cardiovascular end-
organ changes in those individuals with a normal/high-normal brachial BP. Although these 
individuals are well-recognised as being at risk for a cardiovascular event, whether this 
risk is attributed to the effects of BP has generated considerable debate. Although the 
findings of the present thesis have largely been discussed in each data chapter (chapters 
2 to 5), the present chapter provides an overarching view of the data provided in the 
context of our current understanding of the field. The present chapter has therefore been 
provided to lead the reader through a series of arguments which support the final 
conclusions and hence raise the possibility of future studies. 
 
6.1 Pre-hypertension: Is the risk increased because of a high brachial BP? 
 
 As extensively outlined in chapter 1, and again in chapters 2, 4 and 5, there is no 
question that a considerable proportion of those with normal/high-normal BP values (120-
139/80-89 mm Hg) are at risk of a cardiovascular event. This notion is supported by 
several prospective, observational studies (Hsia et al 2007, Conen et al 2007, Dorjgochoo 
et al 2009, Qureshi et al 2005, Vasan et al 2001, Blake et al 2003, Liszka et al 2005, Gu 
et al 2009, Zhang et al 2006, Butler et al 2011, Kshirsagar et al 2006), some randomised, 
controlled trials (Nissen et al 2004, Remme et al 2009, Staessen and Jiguang 2001, 
Schrier et al 2002, Patel 2007) and meta-analyses of BP lowering trials (Trialists 
Collaboration 2003, Law et al 2009). In this regard, as highlighted in the present thesis, 
approximately 27% of the SOWETO community may be at risk of a cardiovascular event, 
because they have normal/high normal BP values. This represents a substantial 
population attributable risk. The question that obviously arises from these data is whether 
antihypertensive therapy should be employed to treat those with normal/high-normal BP 
values? Because of the proportion of any population with BP values within this range, this 
question has major cost implications to any country, but particularly to resource-limited 
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countries such as South Africa. Nonetheless, several intervention studies have 
demonstrated that antihypertensive treatment to thresholds lower than 140/90 mm Hg 
produced no added benefit to risk reduction (Yusuf et al 2008, Cushman et al 2010, 
McMurray et al 2010). These findings (Yusuf et al 2008, Cushman et al 2010, McMurray 
et al 2010) have challenged the paradigm that normal/high-normal brachial BP values 
represent risk for a cardiovascular event caused by BP per se and provide the evidence to 
indicate that pre-hypertension should not be treated with antihypertensive drug therapy. 
However, the obvious question that arises is if it is not BP causing excessive 
cardiovascular events in persons with a normal/high-normal brachial BP, what then could 
explain the higher risk? 
As first pointed out by our group (Norton et al 2008), although those with a 
normal/high-normal BP have marked cardiovascular end-organ changes, these end-organ 
changes are eliminated with adjustments for associated cardiovascular risk factors. Hence, 
the concept arose that perhaps the high cardiovascular risk related to normal/high-normal 
BP values may be attributed to associated risk factors such as age, obesity, diabetes 
mellitus and dyslipidaemia. Indeed, several studies provide the evidence to show that a 
high proportion of those with pre-hypertension have at least one other associated risk 
factor or are at an increased risk of developing associated cardiovascular risk factors 
(Greenlund et al 2004, Mainous III et al 2004, Grotto et al 2006, Zhang et al 2006, King et 
al 2004, Chrysohoou et al 2004). In the present study I also show that in SOWETO, those 
with a normal/high-normal BP are indeed older and more obese. However, until the time of 
the present thesis, little consideration had been given to the possibility that although 
brachial BP may not be an accurate indicator of BP-related cardiovascular damage in pre-
hypertension that BP may still be responsible for excess cardiovascular events in the 
normal/high-normal brachial BP range. In this regard, I considered the possibility that 
aortic BP may better herald the presence of cardiovascular damage. What was the 
evidence to suggest this possibility and how has the present thesis added to our 
understanding of cardiovascular risk related to pre-hypertension? 
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6.2 Pre-hypertension: Is the risk increased because of a high aortic BP? 
 
  The initial suggestion that normal/high-normal brachial BP values may signal the 
presence of a wide range of aortic BP values came from the findings of the Anglo-Cardiff 
Study which demonstrated considerable overlap in aortic BP across categories of optimal, 
pre-hypertensive (normal or high-normal) and hypertensive BP ranges (McEniery et al 
2008). As several studies have demonstrated that aortic BP is more closely associated 
with end-organ changes than brachial BP or that the ratio of aortic-to-brachial PP predicts 
outcomes beyond brachial BP (Safar et al 2002, Roman et al 2007, Roman et al 2009, 
Jankowski et al 2008, Pini et al 2008, Wang et al 2010, Benetos et al 2010, Regnault et al 
2012, Benetos et al 2012), overlap in aortic BP across categories of optimal, pre-
hypertensive (normal or high-normal) and hypertensive BP ranges (McEniery et al 2008), 
raised the possibility that a considerable proportion of pre-hypertensives are not at risk of a 
BP-related cardiovascular event. This possibility may explain why several clinical trials 
have failed to show that antihypertensive treatment to thresholds lower than 140/90 mm 
Hg add no benefit to risk reduction (Yusuf et al 2008, Cushman et al 2010, McMurray et al 
2010). In this regard, a high proportion of those treated may have had aortic BP values 
within optimal BP ranges. The overlap in aortic BP across categories of optimal, pre-
hypertensive (normal or high-normal) and hypertensive BP ranges (McEniery et al 2008) 
raised the question of whether non-invasively determined aortic BP may further refine the 
ability to detect those pre-hypertensives at risk of a cardiovascular event. What is the 
evidence to suggest that a high proportion of pre-hypertensives treated with 
antihypertensive therapy may have had aortic BP values within optimal BP ranges and 
what is the evidence to show that non-invasively determined aortic BP may further refine 
the ability to detect those pre-hypertensives at risk of a cardiovascular event? 
 In chapter 2, data published in 2013 (Booysen et al 2013), I provide the evidence to 
show that 46% of those with normal/high-normal brachial BP values living in SOWETO 
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have aortic BP values that lie within optimal BP ranges. Hence, in keeping with the Anglo-
Cardiff study (McEniery et al 2008) in a population of African ancestry across the adult 
age-range, a considerable proportion of pre-hypertensives are unlikely to be at risk of a 
BP-related cardiovascular event. In this same study, whilst only 39% of those with a 
normal brachial BP had an aortic BP higher than the upper 95% confidence intervals for 
optimal brachial BP values, 80% of those with a high-normal brachial BP had an aortic BP 
higher than the upper 95% confidence intervals for optimal brachial BP values. Hence, the 
question arose as to whether the brachial BP threshold that separates normal from high 
normal brachial BP categories (130/95 mm Hg) is not sufficient to identify those at risk? In 
this regard, one must consider whether it is worth treating 39% of those with a normal 
brachial BP whom have aortic BP values greater than optimal BP thresholds. This would 
represent 6.4% of any adult sample and in my opinion would be a significant chance to 
limit cardiovascular events, if indeed aortic BP above optimal thresholds does identify 
those at risk. Are those with normal/high-normal brachial BP values and an aortic BP 
above optimal thresholds at risk? 
In chapter 2 (Booysen et al 2013), I also provide the first evidence to show that 
aortic BP may refine the ability to detect end-organ changes (sub-clinical cardiovascular 
disease) beyond brachial BP in the normotensive (optimal, normal and high-normal) BP 
range. These data provide the first direct evidence to suggest that a considerable 
proportion of pre-hypertensives both are, and are not at risk of a cardiovascular event 
through BP-related mechanisms and also suggest that the identification of pre-
hypertensives whom may warrant antihypertensive therapy may be refined by non-
invasively determined aortic BP measurements. Although there are clearly a number of 
limitations to this study (Booysen et al 2013, chapter 2) including the cross-sectional 
design and the lack of cardiovascular outcomes data, these data nevertheless provide a 
possible explanation as to why intervention studies have failed to support the paradigm 
that brachial BP in pre-hypertension is causally related to cardiovascular risk in some 
studies (Yusuf et al 2008, Cushman et al 2010, McMurray et al 2010). The data described 
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in the present thesis (Booysen et al 2013, chapter 2) also suggest that studies should be 
conducted to evaluate whether specifically targeting pre-hypertensives with aortic BP 
values above optimal thresholds with BP lowering drug therapy could benefit 
cardiovascular risk. Unfortunately, as causes of death in South Africa are poorly reported, 
and verbal autopsy data have far too many limitations to be reliable, this study is not 
feasible in this country. 
An important consideration of the finding that aortic BP is able to refine the ability to 
detect end-organ changes in pre-hypertension beyond brachial BP is the mechanisms 
responsible for this effect? This question is important for several reasons. The first reason 
of which is whether these mechanisms can be targeted by current antihypertensive 
therapy. Second, is whether other measurements of aortic BP which specifically describe 
these mechanism, may predict end-organ changes in pre-hypertension better than aortic 
BP per se. What are the possible mechanisms responsible for the ability of aortic BP to 
refine the detection of end-organ changes in pre-hypertension? 
 
6.3 What are the possible mechanisms that explain the ability of aortic BP to 
refine the identification of end-organ changes in pre-hypertension? 
 
Aortic SBP is generally considered to be lower than brachial SBP and because of 
the proximity of the aorta to cardiovascular end-organs, aortic BP is thought to enhance 
risk prediction beyond brachial BP. Indeed, a number of studies support this notion (Safar 
et al 2002, Roman et al 2007, Roman et al 2009, Jankowski et al 2008, Pini et al 2008, 
Wang et al 2009, Benetos et al 2010, Regnault et al 2012, Benetos et al 2012). Several 
possibilities explain differences between aortic and brachial BP and these have been 
extensively reviewed in chapter 1 (section 1.3.2). Briefly, with the effects of ageing and 
cardiovascular risk factors, the aorta stiffens, whilst brachial artery stiffness increases to a 
lesser extent. Hence, with ageing aortic BP increases much more than brachial BP. With 
ageing aortic reflected waves derived largely from the lower limbs and the visceral bed are 
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thought to increase. Thus on return to the proximal aorta, these waves enhance aortic 
SBP. However, because reflected waves are transmitted to the brachial artery much later 
than aortic forward waves, thus producing a second systolic shoulder, and because 
reflected wave pressures are lower than forward wave pressures, changes in reflected 
waves are generally not detected by brachial BP measurements. 
In short aortic, but not brachial BP closely mirrors the effects on BP of increases in 
aortic stiffness (which determines the aortic forward and backward wave) and/or wave 
reflection (which determines the aortic backward wave). Hence, the question which arises 
is whether it is increases in aortic forward or backward wave pressures which explain the 
ability of aortic BP to refine the detection of end-organ changes in pre-hypertension? In 
this regard, before I could address this question in the present thesis, I first needed to 
provide clarity on the best method of assessing the role of aortic forward and backward 
wave effects on aortic pressure and cardiovascular damage. What were the important 
questions to address on this topic and how has the work described in the present thesis 
advanced our knowledge of this field?  
 
6.3.1 How best should aortic forward and backward wave effects be evaluated? 
 
As extensively described in chapter 1, section 1.3.3, the relative contribution of 
aortic forward and backward waves to variations in aortic BP and cardiovascular damage 
continues to elicit heated debate. In this regard, a number of earlier studies indicate that 
across the adult age range, reflected waves, assessed from indices of pressure 
augmentation, dominate age-related increases in aortic pressure (McEniery et al 2008, 
Namasivayam et al 2009, Cecelja et al 2009) and predict cardiovascular damage 
(Hashimoto et al 2007, Hashimoto et al 2006, Weber et al 2006, Westerbacka et al 2005, 
Sibiya et al 2014), and cardiovascular outcomes (Chirinos et al 2005b, London et al 2001, 
Ueda et al 2004, Weber et al 2005) beyond brachial BP. Further, a meta-analysis of these 
and other outcome studies provided clear evidence that indices of pressure augmentation 
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predict outcomes beyond brachial BP (Vlachopoulos et al 2010). In contrast however, the 
Framingham Heart Study failed to show that indices of aortic pressure augmentation 
predict outcomes independent of brachial BP (Mitchell et al 2010a). Nevertheless, in the 
Framingham Heart Study, in contrast to the expected 5-15 mm Hg difference between 
aortic and brachial BP (PP amplification), little difference was noted across the adult 
lifespan (Mitchell et al 2010b). This has been explained on the basis of the application of 
tonometry at a site where the principles of tonometry cannot be achieved (brachial artery 
to calibrate the carotid artery pulse) and the use of an inaccurate mean pressure for 
calibrating carotid artery pressures (O’Rourke et al 2010). In this regard, the brachial 
artery, with tendon aponeurosis superficial to it, and with no bone to support it, cannot be 
reliably applanated, so that the theory of Drzewiecki et al (1983), cannot be relied upon. 
This error resulted in an assumption that little carotid to brachial amplification occurs, but 
that marked brachial-to-radial amplification occurs. In addition, although in several of these 
studies (Davies et al 2010, Hughes et al 2013, Fok et al 2014), the method of wave 
intensity analysis has been seriously questioned on methodological and theoretical 
grounds (Segers et al 2015), and Fok et al (2014) report an impossible flow-frequency 
response, apparently hand-drawn representative waves are shown, and control 
impedance values are given that differ markedly from Yaginuma et al (1985), the use of Pa 
or AIx as measures of aortic wave reflection have recently been criticised (Davies et al 
2010, Cheng et al 2012, Hughes et al 2013, Fok et al 2014, Torjesen et al 2014, Schultz et 
al 2013). Indeed, marked overlap between aortic forward and reflected waves may 
confound Pa and AIx (Cheng et al 2012, Fok et al 2014, Torjesen et al 2014, Schultz et al 
2013) and hence these measures may be poor indices of wave reflection. Increases in the 
timing or magnitude of Pf or Pi, and left ventricular systolic function may in fact play a more 
important role than wave reflection in contributing to variations in Pa and AIx (Davies et al 
2010, Cheng et al 2012, Hughes et al 2013, Fok et al 2014, Torjesen et al 2014, Schultz et 
al 2013). More recently, wave separation analysis has been employed to identify aortic 
backward wave effects, thus excluding confounding effects on wave reflection. What have 
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these studies demonstrated and how has data from the present thesis added to this 
debate? 
Several recent studies suggest an important contribution of wave reflection, 
determined from wave separation analysis, to aortic BP and cardiovascular damage 
(Wang et al 2010, Chirinos et al 2012, Weber et al 2012, Zamani et al 2014). However, in 
these studies (Wang et al 2010, Chirinos et al 2012, Weber et al 2012, Zamani et al 2014) 
the extent to which indices of wave reflection determined from wave separation analysis 
were more closely associated with aortic BP or sub-clinical cardiovascular disease than 
indices of aortic pressure augmentation is uncertain (Wang et al 2010, Chirinos et al 2012, 
Weber et al 2012, Zamani et al 2014). In this regard in these studies, relations with end-
organ changes were not adjusted for confounders (Wang et al 2010, Weber et al 2012); 
discrepancies in the index of wave reflection that was better associated with end-organ 
changes beyond forward wave pressures were noted (Wang et al 2010, Weber et al 2012); 
and whether the increase in forward wave pressures at 50 years of age impacts on these 
relations was not considered (Wang et al 2010, Chirinos et al 2012, Weber et al 2012). 
Moreover, although conducted either in a sample where little difference in aortic and 
brachial BP was noted across the adult lifespan (Mitchell et al 2010b), an effect that has 
been explained on the basis of the application of tonometry at a site where the principles 
of tonometry cannot be achieved (brachial artery to calibrate the carotid artery pulse) 
(O’Rourke et al 2010), forward rather than backward wave pressures have been reported 
to be the main determinant of aortic BP (Mitchell et al 2010b). However, in the present 
thesis I provide strong evidence accepted for publication in the journal Hypertension 
(Booysen et al 2015), that in a group of African ancestry living in SOWETO with a high 
prevalence of uncontrolled hypertension, with adjustments for confounders, across the 
adult lifespan (younger and older than 50 years of age), reflected waves contribute more 
than forward waves to variations in aortic BP and left ventricular mass index. Hence, these 
data suggest the possibility that aortic wave reflection could largely explain the ability of 
aortic BP to refine the detection of end-organ changes in pre-hypertension and hence that 
162 
 
measures of aortic reflected wave function may improve on the ability of aortic BP per se 
to risk predict in those with normal/high-normal BP values. These questions were 
addressed as part of the present thesis in chapter 4. What did these data show and what 
are the implications? 
 
 6.3.2 Aortic backward waves in pre-hypertension 
 
 In chapter 4 of the present thesis I show that in normotensives (optimal, normal, 
and high-normal brachial BP) backward wave pressures were indeed more closely 
associated with LVMI and better at detecting LVH than forward wave pressures. However, 
I also demonstrated that despite aortic BP being associated with all end-organ changes 
independent of confounders and brachial BP, neither backward, nor forward wave 
pressures were independently associated with all end-organ changes independent of 
confounders and brachial BP. In addition, although in normotensives backward wave, but 
not forward wave pressures were better than brachial BP at LVH detection and backward 
wave, but not forward wave pressures were more strongly associated with LVMI, these 
effects of backward wave pressures were no better than aortic BP per se. What are the 
implications of these findings?  
 First, the finding that in normotensives backward wave, but not forward wave 
pressures were better than brachial BP at LVH detection suggests that to reduce risk in 
pre-hypertensives, therapeutic approaches should target backward wave pressures. As 
discussed in chapter 4 however, although most antihypertensive agents are thought to 
reduce wave reflection, to the best of my knowledge, in these studies this conclusion has 
been reached without wave separation analysis (i.e, with the use of indices of aortic 
pressure augmentation alone). Hence, further studies are required to test the hypothesis 
that antihypertensive agents reduce wave reflection and which agents are best at 
producing these effects. 
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    A second finding that requires consideration is that although aortic BP was 
associated with end-organ changes independent of brachial BP, neither backward, nor 
forward wave pressures were independently associated with all end-organ changes 
independent of confounders and brachial BP. In this regard, these data suggest that 
backward wave pressures are not the only factor explaining end-organ changes in pre-
hypertensives. Indeed, although backward wave, but not forward wave pressures were 
better than brachial BP at LVH detection, forward wave pressures did indeed detect LVH, 
at least as well as brachial BP. Hence, therapeutic approaches to risk reduction in those 
with normal/high-normal brachial BP values should also target forward wave pressures. As 
acknowledged by consensus documents (Agabiti-Rosei et al 2007), there is unfortunately 
little evidence to indicate that current therapy modifies the structural aortic changes 
responsible for increases in aortic forward wave pressures. 
 The third finding that requires consideration is that although in normotensives, 
backward wave, but not forward wave pressures were better than brachial BP at LVH 
detection, this effect was no better than aortic BP per se. These data suggest that indices 
of wave reflection are unlikely to improve on risk prediction in normotensives beyond aortic 
BP per se. Hence, the more complicated measures of aortic wave reflection may not be 
required to replace aortic BP when risk predicting in normotensives. This has major 
implications with regard to the final question that I answered in the present thesis and that 
is whether in the absence of sufficient resources for routine risk prediction in 
normotensives using valid devices to non-invasively assess aortic BP, is there a 
reasonable alternative? The finding that Pb or RI may offer no prognostic information 
beyond aortic BP in normotensives, suggests that when risk predicting, surrogate 
measures of aortic PP or SBP may be sufficient, at least in normotensives. Hence, the 
question is whether reasonable alternatives to non-invasively measured aortic PP or SBP 
may be employed to enhance risk prediction beyond brachial BP? This question was 
answered in chapter 5 of the present thesis. What were the findings of this study and what 
are the potential implications? 
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6.4 Imputing aortic BP in pre-hypertension from simple clinical measures 
 
 As first suggested some years ago (Camacho et al 2004) aortic BP may be 
imputed from simple clinical measures. Indeed, in a recent study 85.8% of the variation in 
pulse wave analysis (PWA)-derived aortic PP could be accounted for by simple clinical 
measures (Benetos et al 2010). However, in this (Benetos et al 2010) and a subsequent 
(Regnault et al 2012) study, although PP amplification predicted outcomes beyond 
brachial BP, aortic BP per se was unable to predict outcomes beyond brachial BP. These 
findings (Benetos et al 2010, Regnault et al 2012) may be attributed to an inability to 
generate an optimal imputation equation for estimating aortic PP, in-part because of the 
exclusion of MAP and pulse rate from the imputation equation. Indeed, in contrast to these 
studies (Benetos et al 2010, Regnault et al 2012) where only 85.8% of the variation in 
aortic PP could be accounted for, as described in chapter 5 of the present thesis I could 
account for 97.5% of the variation in aortic BP, 96% of which was attributed to brachial PP, 
age, pulse rate and MAP. Importantly, in the present study I show that without pulse rate 
and MAP included in the model, imputed aortic PP remained markedly lower than pulse 
wave-derived aortic PP. 
Not only did the imputation equation identified in the present thesis account for a 
significant proportion of the variability of PWA-derived aortic BP, but the equation markedly 
reduced the difference between brachial and aortic PP, and corrected the intrinsic bias 
toward lower aortic as compared to brachial PP values at higher BP values. Furthermore, 
in contrast to previous studies which failed to validate the equation in a separate study 
sample (Benetos et al 2010, Regnault et al 2012), in the present thesis I externally 
validated the equation in a clinical sample; demonstrated the validity of the equation 
across a number of subgroups of the community sample; and demonstrated in the clinical 
sample that the equation was equally as valid in patients of black African ancestry as it 
was for other ethnic groups. As in all instances the equation proved to be valid, in the 
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present thesis I therefore evaluated whether imputed aortic BP provides similar information 
as PWA-derived aortic BP when assessing relations with end-organ changes. What did 
these analyses show? 
In chapter 5, I show that in normotensives, independent of brachial BP, imputed 
aortic BP is as closely associated with end-organ changes as PWA-derived aortic BP and 
that both imputed aortic BP and PWA-derived aortic BP are more strongly associated with 
end-organ changes than brachial BP. I also demonstrate that in normotensives, imputed 
aortic BP detects LVH better than brachial BP (area under the receiver operating 
characteristic curve) and as well as PWA-derived aortic BP. Hence, these data provide 
proof of principle that in resource-limited settings where valid devices to non-invasively 
assess aortic BP for routine risk prediction in normotensives would be cost-prohibitive, that 
the use of simple clinical data to impute aortic BP may be a useful approximate. However, 
again further outcome-driven studies are warranted to address this question. 
 
6.5 Challenges and further limitations 
 
 Although the limitations of the present study have largely been addressed in the 
discussion section of each chapter and further highlighted in the present chapter, 
limitations of adequately indexing LVM to account for the non-pathological effects on the 
left ventricle require further discussion. In this regard, there is still considerable debate as 
to whether LVM should be indexed to allometric signals of body surface area, thus largely 
excluding the impact of obesity on cardiac growth, or to allometric signals of height, which 
recognise the ill-effect of obesity on cardiac growth. As discussed in a recent review of the 
topic (Woodiwiss and Norton, 2015), recent guidelines have now recognised the use of 
allometric signals to height in obese individuals (a high proportion of the present 
community sample were overweight or obese). Nevertheless, debate still remains as to 
whether indexation to height2.7 or height1.7 should be employed (Woodiwiss and Norton 
2015). At the time of analysing the data for chapter 2, the debate as to whether indexation 
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to height2.7 or height1.7 should be employed had only recently begun based on the work of 
Chirinos et al (2010) who demonstrated that the use of height2.7 may markedly 
overestimate the prevalence of LVH in women. Hence, in this chapter LVM was indexed to 
the power of 2.7, the accepted index at this point. Nevertheless, in subsequent chapters, I 
employed a range of indexation approaches including LVM indexed to body surface area, 
height2.7 and height1.7. The range of approaches adopted were largely employed to satisfy 
the fact that the ill-effects of BP and not obesity were being studied as well as the fact that 
no consensus has yet been achieved as to whether indexation to height2.7 and height1.7 
should be employed (Woodiwiss and Norton 2015). Nevertheless, irrespective of whether 
LVM was indexed to body surface area, height2.7 or height1.7, in the present thesis I was 
able to show that aortic pressure, either determined from pulse wave analysis or imputed 
from simple clinical measures, was more closely associated with LVMI in pre-
hypertensives than brachial BP, that this was largely accounted for by backward wave 
pressure effects, but that the association between backward wave pressures and LVMI 
was no better than associations between aortic BP per se and LVMI.      
 
6.6 Conclusions 
 
 Hence, in conclusion, in the present thesis I provide evidence to support a possible 
solution to the conundrum of how best to identify normotensives who may be at risk of a 
BP-related cardiovascular event. In this regard I show that PWA-derived aortic BP may 
refine the ability to detect cardiovascular damage in normotensives. Second, I show that 
although aortic wave reflection, determined using ‘wave-separation analysis’ in-part 
accounts for the ability of aortic BP to detect end-organ damage better than brachial BP in 
normotensives, that these effects are no better than aortic BP per se. Third, I show that 
aortic BP imputed from simple clinical measures closely approximates PWA-derived aortic 
BP and performs as well as PWA-derived aortic BP in the detection of cardiovascular 
damage in normotensives. All of these findings have generated hypotheses that require 
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testing in longitudinal outcome-based studies and in intervention studies where the effects 
in normotensives of targeting aortic as compared to brachial BP with antihypertensive 
therapy are compared. 
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Aortic, but not brachial blood pressure category
enhances the ability to identify target organ changes
in normotensives
Hendrik L. Booysena,, Gavin R. Nortona,, Muzi J. Masekoa, Carlos D. Libhaberb,
Olebogeng H.I. Majanea, Pinhas Sarelia, and Angela J. Woodiwissa,
Aims: We sought to determine whether within normal/
high-normal blood pressure (BP) ranges (120–139/80–
89mmHg), aortic BP may further refine BP-related
cardiovascular risk assessment, as determined from target
organ changes.
Methods: In 1169 participants from a community sample
of African ancestry, 319 (27%) of whom had a normal/
high-normal BP, aortic BP was determined using radial
applanation tonometry and SphygmoCor software, and
target organ changes assessed from carotid-femoral pulse
wave velocity (PWV) (n¼1025), estimated glomerular
filtration rate (eGFR) (n¼944), and left ventricular mass
indexed to height2.7 (LVMI) (n¼690).
Results: Normal versus high-normal BP categories failed to
differentiate between those participants with a BP above
optimal values with versus without multivariate-adjusted
target organ changes. However, in those with a normal/
high-normal BP with aortic SBP values that were less than
95% confidence interval of healthy participants with
optimal BP values (45% of those with a normal/high-
normal BP), no unadjusted or multivariate adjusted target
organ changes were noted. In contrast, those with a
normal/high-normal BP with aortic SBP values that
exceeded optimal thresholds, demonstrated unadjusted
and multivariate adjusted increases in PWV and LVMI and
decreases in eGFR (P< 0.05 to P<0.005 after multivariate
adjustments).
Conclusion: In contrast to normal versus high-normal BP
categories which do not clearly distinguish normotensives
with from those without organ damage, noninvasively
determined aortic BP measurements may refine the ability
to detect those with a normal/high-normal BP at risk of
BP-related cardiovascular damage.
Keywords: aortic BP, normal/high-normal BP, risk factors,
target organ changes
Abbreviations: BP, blood pressure; DM, diabetes mellitus;
eGFR, estimated glomerular filtration rate; HbA1c, glycated
haemoglobin; HDL, high density lipoprotein; LV, left
ventricular; LVMI, left ventricular mass indexed to
height2.7; PWV, pulse wave velocity
INTRODUCTION
A
lthough guidelines recommend threshold blood
pressure (BP) values of 140/90mmHg for the
diagnosis of hypertension, BP is continuously
associated with cardiovascular outcomes from values as
low as 115/75mmHg [1]. Prospective, observational studies
indicate that those with BP values in the normal/high-
normal range (120–139/80–89mmHg) are at an increased
risk for cardiovascular events [2–9]. In addition, some
randomized, controlled trials [10–12] and meta-analyses
of BP-lowering trials [13–15] in high-risk patients support
a view that treatment of those with a normal/high-normal
BP has benefits for outcomes. In contrast, several more
recent intervention studies suggest that antihypertensive
treatment to thresholds lower than 140/90mmHg has no
added benefit [16–23]. Contrasting results of intervention
studies in normal/high-normal BP ranges [10–23] highlight
the markedly variable BP-related risk conferred by a nor-
mal/high-normal BP. Strategies are, therefore, required to
better identify those with a normal/high-normal BP at risk
for BP-related cardiovascular outcomes.
One possible reason for the variable BP-related cardio-
vascular risk in those with a normal/high-normal BP is that
brachial BP measurements may be insufficiently accurate
for risk determination. In this regard, prior studies indicate
that a number of those with a normal/high-normal BP
may have aortic BP values that are more consistent
with either an optimal or hypertensive BP range [24]. As
aortic BP as assessed using easy and reproducible non-
invasive measurements is more closely associated with
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cardiovascular outcomes than brachial BP [25–29], non-
invasive aortic BP measurement may further refine cardio-
vascular risk in those with a normal/high-normal BP. To test
this hypothesis, in the present study we, therefore, assessed
whether aortic BP enhances the ability to identify inde-
pendent relationships between BP and target organ
changes in the normotensive range and whether ‘optimal’
aortic BP thresholds may refine the ability to identify organ
damage in the normal/high-normal BP range.
METHODS
The study protocol was approved by the University of the
Witwatersrand Committee for Research in Humans (appro-
val numbers: M02-04–72 renewed as M07-04–69 and
M12-04–108). Participants gave informed, written consent.
The study design has previously been described [30–32].
Briefly, nuclear families of black African ancestry consisting
of siblings with a minimum age of 16 years were randomly
recruited from the South West Township (SOWETO) of
Johannesburg, South Africa. Of the 1191 participants
enrolled, 1169 had central aortic BP measurements and
in these participants, carotid-femoral pulse wave velocity
(PWV) was available in 1025 participants, estimated
glomerular filtration rate (eGFR) in 944 participants, and
in a substudy, echocardiographic data in 690 participants.
Seven hundred and eighty-two participants had ambulatory
BP recordings that met with prespecified quality control
criteria (longer than 20 h andmore than 10 and five readings
for the computation of daytime and night-time means,
respectively).
Clinical, demographic and anthropometric
measurements
A standardized questionnaire was administered to obtain
demographic data and information on each participant’s
medical history, smoking habits, intake of alcohol, use of
medication and menopausal status [30–32]. Participants
were identified as being overweight if their BMI was at
least 25 kg/m2 and obese if their BMI was at least 30 kg/m2.
Laboratory blood tests of renal function, liver function,
blood glucose, haematological parameters, lipid profiles
and percentage glycated haemoglobin (HbA1C) (Roche
Diagnostics, Mannheim, Germany) were performed. Dia-
betes mellitus was defined as the use of insulin or oral
hypoglycaemic agents and an impaired blood glucose
control was identified from an HbA1C more than 6.1% [33].
Conventional and 24-h blood pressure
Details as previously described [30,31] of nurse-derived
conventional BP and 24-h BPmeasurements and the quality
of these measurements are provided in the on-line supple-
ment (see on-line supplement for details, http://links.
lww.com/HJH/A249). Hypertension was defined as the
presence of antihypertensive treatment or a mean conven-
tional BP at least 140/90mmHg; a high-normal BP as a
conventional BP at least 130/85 and less than 140/
90mmHg; a normal BP as a conventional BP at least
120/80 and less than 130/85mmHg; and an optimal BP
as less than 120/80mmHg.
Aortic blood pressure and target organ
changes
Aortic BP and carotid-femoral PWV were determined using
applanation tonometry and SphygmoCor software as pre-
viously described [30–32] (see on-line supplement for
details, http://links.lww.com/HJH/A249). eGFR was deter-
mined using the abbreviated Modification of Diet in Renal
Disease study group equation: 186.3 (serum creatinine in
mg//decilitreÿ1.154) (age in yearsÿ0.203) 1.212 0.742
(if female) [34]. Echocardiographic measurements of left
ventricular (LV) diastolic dimensions were performed using
previously described methods [30–32] (see on-line supple-
ment for interobserver and intraobserver variability, http://
links.lww.com/HJH/A249). Left ventricular mass was
derived according to an anatomically validated formula
[35] and indexed to height2.7 (LVMI).
Data analysis
For database management and statistical analysis, SAS
software, version 9.1 (SAS Institute Inc., Cary, North
Carolina, USA) was employed. Unadjusted means and
proportions were compared by the large-sample z-test
and the x2-statistic, respectively. Optimal thresholds
for aortic and 24-h BP were identified from upper 95%
confidence intervals (CI) obtained in 311 participants
with optimal conventional BP values and without
diabetes mellitus, 212 of whom had 24-h BP measure-
ments that met with prespecified quality control criteria.
The aortic SBP threshold was identified as 112mmHg and
the 24-h SBP and DBP thresholds as 123 and 78mmHg,
respectively. Differences in indices of organ changes
between participants in categories of BP and independ-
ent relations between BP and target organ changes were
determined using multivariate regression analysis with
adjustments for age, sex, BMI, diabetes mellitus and/or an
HbA1c more than 6.1%, regular tobacco use, regular
alcohol intake and pulse rate in the models. To determine
probability values, further adjustments for nonindepend-
ence of family members was performed using nonlinear
regression analysis (mixed procedure as defined in the
SAS package).
RESULTS
Characteristics of participants in categories of
blood pressure
Of the total sample, 27.3% of participants had either normal
or high-normal BP; 16.5% had a normal BP and 10.8% had
high-normal BP values. Age, BMI, waist circumference and
the frequency of participants who were overweight or
obese were intermediate in those with a normal or high-
normal BP between values noted in persons with an
optimal BP and in hypertensives (Table 1). Hypertensives,
but not those with a normal or high-normal BP, had more
diabetesmellitus and/or an impaired blood glucose control,
and an increased total/HDL cholesterol (Table 1). No
differences were noted between BP categories in regular
alcohol and tobacco intake or pulse rate (Table 1). The
distribution of antihypertensive medication given to treated
hypertensives is given in Supplemental Table S1, http://
links.lww.com/HJH/A249. The characteristics of the sample
Aortic blood pressure in normotensives
Journal of Hypertension www.jhypertension.com 1125
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
with and without echocardiography were similar (Supple-
mental Table S2, http://links.lww.com/HJH/A249).
Blood pressures and proportions with elevated
aortic or ambulatory blood pressure within
blood pressure categories
Conventional, 24 h and central aortic BP values were inter-
mediate in those with a normal or high-normal BP between
values noted in persons with an optimal BP and in hyper-
tensives (Table 2). A greater proportion of hypertensives as
well as those with a normal or high-normal BP had aortic
SBP values that exceeded that of the upper 95% CI of
healthy participants with an optimal BP (Table 2). Of those
with a normal/high-normal BP, 45% had an aortic SBP that
did not exceed the upper 95% CI of healthy participants
with an optimal BP. A greater proportion of hypertensives
and those with high-normal BP values, but not those with
normal BP values had 24-h SBP and DBP values that
exceeded that of the upper 95% CIs of healthy participants
with an optimal BP (Table 2).
Continuous relationships between various
measures of blood pressure and target organ
changes in normotensive participants
In normotensive participants (BP <140/90mmHg and no
antihypertensive treatment), with adjustments for con-
founders, conventional and central aortic BP were corre-
lated with target organ changes (Table 3). After further
adjustments for aortic BP, the relationship between con-
ventional BP and target organ changes in normotensives
was abolished. In contrast, with further adjustments for
conventional BP, aortic BP retained independent relation-
ships with target organ changes in normotensives (Table 3).
In addition, with further adjustments for 24-h SBP, aortic
BP also retained independent relationships with target
organ changes in normotensives (PWV; partial r¼ 0.18,
TABLE 1. Characteristics of study participants
BP categories Optimal Normal High-normal Hypertensives
BP range (mmHg) <120/80 120/80 and <130/85 130/85 and <140/90 140/90 or treatment
Sample size (% female) 311 (69.1) 193 (62.7) 126 (61.1) 539 (64.9)
Age (years) 30.712.4 34.013.6 40.216.8,yy 55.115.0,yyy,##
BMI (kg/m2) 25.36.3 28.08.1 29.68.0,y 32.47.9,yyy,##
Waist circumference (cm) 80.613.9 86.215.5 89.215.1 97.615.4,yyy,##
% Overweight/obese 21.2/22.5 22.8/32.6 22.2/43.7 23.9/57.9,yyy,#
Regular tobacco intake (%) 13.8 18.7 16.7 14.3
Regular alcohol intake (%) 18.7 21.8 25.4 21.9
% With DM or HbA1C>6.1% 10.0 15.0 10.3 41.4
,yyy,##
Pulse rate (beats/min) 69.511.3 69.510.9 69.011.0 69.410.3
Total/HDL cholesterol 3.131.17 3.221.06 3.601.53 3.841.26,yy
BP, blood pressure; DM, diabetes mellitus; HbA1C, glycosylated haemoglobin; HDL:, high density lipoprotein.

P<0.05.

P<0.005.

P<0.0001 versus optimal.
y
P<0.05.
yy
P<0.005.
yyy
P<0.0005 versus normal.
#
P<0.005.
##
P<0.0001 versus high-normal.
TABLE 2. Blood pressures of study participants
BP categories Optimal Normal High-normal Hypertensives
BP range (mmHg) <120/80 120/80 and <130/85 130/85 and <140/90 140/90 or treatment
Sample size 311 193 126 539
Conventional SBP/DBP (mmHg) 1087/726 1197/804 1288/864,yyy 14622/9213,yyy,###
Aortic SBP (mmHg) 10013 1107 1198,yyy 13622,yyy,###
Aortic pulse pressure (mmHg) 26.611.0 29.17.5 33.68.8 43.516.7,yyy,###
24-h SBP (mmHg) (n) 1099 (212) 1139 (134) 11711,yyy (84) 12716,yyy,### (352)
24-h DBP (mmHg) (n) 677 (212) 697 (134) 727 (84) 7811,yyy,### (352)
n (%) with aortic SBP >thresholda 16 (5) 75 (39) 99 (80),yyy 471 (88),yyy,#
n (%) with 24-h SBP >thresholdb 12 (6) 16 (12) 21 (25),y 201 (57),yyy,###
n (%) with 24-h DBP >thresholdb 11 (5) 10 (8) 18 (21),yy 147 (42),yyy,##
aUpper threshold for aortic SBP in those with an optimal conventional BP¼112mmHg.
bUpper threshold for 24-h SBP/DBP in those with an optimal conventional BP¼123/78mmHg.

P<0.05.

P<0.005.

P<0.0001 versus optimal.
y
P<0.05.
yy
P<0.005.
yyy
P<0.0005 versus normal.
#
P<0.05.
##
P<0.005.
###
P< 0.0001 versus high-normal.
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CI¼ 0.08–0.28, P< 0.0005, n¼ 389; eGFR; partial
r¼ÿ0.15, CI¼ÿ0.25 to ÿ0.04, P< 0.01, n¼ 342; LVMI;
partial r¼ 0.22, CI¼ 0.10–0.33, P< 0.0005, n¼ 265).
Target organ changes in those with a normal
or high-normal blood pressure irrespective of
aortic blood pressure
Before adjustments for confounders, as compared to
participants with optimal BP values, hypertensives and
those with either normal or high-normal BP values had a
markedly increased PWV and LVMI and decreased eGFR
(Table 4). However, after adjustments for confounders,
only modest target organ changes were noted in those
with a normal or high-normal BP (Table 4). Moreover,
normal versus high-normal BP categories failed to dis-
tinguish between those with and without target organ
changes (Table 4).
Aortic blood pressure distinguishes target
organ changes in those with a normal/high-
normal blood pressure
As compared to those with an optimal BP, both unadjusted
and multivariate adjusted target organ changes were con-
sistently noted in those with a normal/high-normal BP with,
but not in those without aortic SBP values at least upper
95% CI for healthy participants with optimal BP values
(Table 5). Importantly, even those with a normal as
opposed to high-normal conventional BP values, but whom
had an aortic BP that exceeded ‘optimal’ values had multi-
variate adjusted decreases in eGFR (ml/min per 1.73m2)
(108 4 versus 116 2, P< 0.05) and increases in LVMI
(g/m2.7) (46.7 1.8 versus 40.8 1.2, P< 0.005).
DISCUSSION
The main findings of the present study are as follows: First,
in a randomly selected community sample, although a
normal/high-normal BP was noted in 27% of the sample,
45% of these participants had central aortic BP values that
did not exceed the upper 95% CI of aortic BP values in
healthy participants with optimal BP values. Second, nor-
mal and high-normal BP categories failed to identify those
with target organ changes. In contrast, in those with either a
normal or high-normal BP, aortic BP values above ‘optimal’
thresholds clearly identified those with target organ
changes.
Persons with a BP in the normal/high-normal range are
considered at sufficient risk to warrant antihypertensive
therapy if in-part they have diabetes mellitus, or established
TABLE 3. Multivariate adjusted relationships between SBP and target organ changes in normotensive participants (conventional BP<140/
90mmHg)
BP versus n Partial r CI P Partial r CI P
SBPc adjusted fora SBPc adjusted for aortic SBPþa
Pulse wave velocity 568 0.24 0.16 to 0.32 <0.0001 0.05 ÿ0.03 to 0.13 ¼0.24
Estimated GFR 501 ÿ0.10 ÿ0.19 to ÿ0.01 <0.05 0.06 ÿ0.03 to 0.14 ¼0.22
LV mass index 372 0.20 0.10 to 0.30 <0.0001 ÿ0.05 ÿ0.15 to 0.06 ¼0.36
Aortic SBP adjusted fora Aortic SBP adjusted for SBPcþa
Pulse wave velocity 568 0.26 0.18 to 0.34 <0.0001 0.12 0.04 to 0.20 <0.005
Estimated GFR 501 ÿ0.17 ÿ0.25 to ÿ0.08 <0.0005 ÿ0.15 ÿ0.23 to ÿ0.06 ¼0.001
LV mass index 372 0.28 0.18 to 0.37 <0.0001 0.20 0.10 to 0.30 ¼0.0001
CI, confidence intervals; GFR, glomerular filtration rate; LV, left ventricle; SBPc, conventional SBP.
aAdjustments are for age, sex, BMI, diabetes mellitus and/or an HbA1c>6.1%, regular tobacco intake, regular alcohol intake and pulse rate.
TABLE 4. Unadjusted and multivariate adjusted indices of target organ changes of study participants
BP categories Optimal Normal High-normal Hypertensives
BP range (mmHg) <120/80 120/80 and <130/85 130/85 and <140/90 140/90 or treatment
Unadjusted values
PWV (m/s) (n) 4.831.24 (289) 5.361.55 (172) 6.091.97 (107) 7.902.99,yyy,### (457)
eGFR (ml/min per
1.73m2) (n)
12832 (244) 12229 (153) 11128 (104) 10328,yyy,# (443)
LV mass index (g/m2.7) (n) 35.510.2 (181) 41.111.2 (117) 42.213.3 (74) 47.515.8,yyy,## (318)
Multivariate adjusted values
PWV (m/s) (n) 5.892.21 (289) 6.151.97 (172) 6.341.97 (107) 6.872.35,yyy,# (457)
eGFR (ml/min per
1.73m2) (n)
11731 (244) 11328 (153) 10827 (104) 11331 (443)
LV mass index (g/m2.7) (n) 40.314.4 (181) 43.613.0 (117) 42.412.6 (74) 43.814.6 (318)
BP, blood pressure; eGFR, estimated glomerular filtration rate; LV, left ventricle; PWV, aortic pulse wave velocity. Adjustments are for age, sex, BMI, diabetes mellitus and/or an
HbA1c>6.1%, regular tobacco use, regular alcohol intake and pulse rate.

P<0.05.

P<0.005.

P<0.0001 versus optimal.
y
P< 0.05.
yy
P<0.005.
yyy
P<0.0005 versus normal.
#
P<0.05.
##
P<0.005.
###
P<0.0001 versus high-normal.
Aortic blood pressure in normotensives
Journal of Hypertension www.jhypertension.com 1127
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
cardiovascular or renal disease [36]. However, intervention
studies targeting high-risk patients with preexisting cardio-
vascular disease or diabetes mellitus, have produced dis-
crepant outcomes [10–23]. This approach nevertheless
assumes that most high-risk patients with normal/high-
normal conventional BP values would benefit from BP-
lowering therapy. In contrast, as indicated in the present
study, in those participants with normal/high-normal BP
values who also had ‘optimal’ aortic BP values (45% of
participants), no evidence of target organ changes were
noted. Thus, a high proportion of persons with a normal/
high-normal BP are not at risk for BP-related cardiovascular
damage.
As suggested by guidelines [36], the presence of organ
damage may identify persons with a BP in the high-normal
range at sufficient risk to warrant antihypertensive therapy.
Indeed, two recent studies indicate that by adding markers
of subclinical organ damage to traditional risk assessment,
risk prediction may be considerably improved [37,38].
However, the mean BP values in those experiencing a
cardiovascular event in the one study [37] suggest that
almost half of these participants were hypertensive. More-
over, in the other study [38], 42% were hypertensives. Thus,
in neither of these studies [37,38] can conclusions be drawn
from data obtained only in the normotensive range. More-
over, in these studies [37,38], the presence of organ damage
identified using one measure of target organ change, did
not necessarily imply the presence of organ damage using
another measure of target organ change. Thus, the benefit
of target organ assessment would require the evaluation of
damage in multiple organs [37,38]. This combined
approach would incur considerable costs, necessitate the
use of trained technicians and not necessarily identify organ
damage attributed to BP effects as opposed to alternative
risk factors. In contrast, aortic BP measurements are simple,
reliable and reproducible, are likely to incur considerably
lower costs and reflect the impact of BP rather than alterna-
tive risk factors.
In the present study, 39% of those with a BP in the normal
conventional BP range as compared to 80% in the high-
normalBP rangehad aorticBPvalues that exceeded ‘optimal’
values. Rather than measure aortic BP, a more cost-effective
approach could, therefore, be to treat those with a high
normal, but not a normal BP.However, 75 of the total sample
of 319 participants with a normal or high-normal conven-
tional BP had a normal conventional, but an increased aortic
BP. Importantly, these individuals had multivariate adjusted
decreases in eGFR and increases in LVMI. Hence, approxi-
mately one-quarter of all those with a normal/high-normal
BP at risk of cardiovascular damagewould be excluded from
potentially necessary antihypertensive therapy if treatment
were withheld from those with a normal BP. Clearly, this
dilemma would be avoided if aortic BP rather than normal
versus high-normal conventional BP categories were
employed to identify at-risk persons.
In the present study, in those with normal/high-normal
BP values, aortic BP was associated with an increased PWV,
an index of aortic stiffness. This relationship may be
explained, not only by an effect of BP on aortic stiffness,
but also by an impact of aortic stiffness on central BP. If
increases in aortic stiffness mediate aortic BP changes in
those with normal/high normal BP values, therapeutically
targeting aortic stiffness may prevent the progression to
hypertension. In this regard, a normal/high-normal BP is a
risk factor for the development of hypertension and pro-
gression to hypertension may occur within 10 years in 80%
of those with a normal/high-normal BP [39].
The present results suggest that assessing the impact of
BP-lowering therapy on cardiovascular outcomes in those
with normal/high-normal BP values may warrant the
selection of only those participants with central aortic BP
values that exceed optimal values. If this approach were
adopted, a decrease in the heterogeneity of the impact of
BP-lowering therapy on outcomes may occur in those with
a normal/high-normal BP, which as recent outcome studies
have demonstrated [16–23], is large.
TABLE 5. Unadjusted andmultivariate adjusted indices of target organ changes of prehypertensives with (Yes) or without (No) aortic SBP
greater than thresholds (112mmHg) defined in those with optimal conventional blood pressure values
Blood pressure categories Optimal
Normal/high-normal
Hypertensives
Blood pressure range (mmHg) <120/80
120/80 and <140/90 with
aortic SBP112mmHg
140/90 or treatmentNo Yes
Unadjusted values
PWV (m/s) (n) 4.831.24 (289) 5.071.30 (128) 6.121.94,yyy (151) 7.902.99,yyy,### (457)
Estimated GFR (ml/min per 1.73 m2) (n) 12832 (244) 12632 (108) 11126,yyy (149) 10328,yyy,## (443)
LV mass index (g/m2.7) (n) 35.510.2 (181) 38.211.0 (82) 44.012.1,yyy (109) 47.515.8,yyy,# (318)
Multivariate adjusted values
Pulse wave velocity (m/s) (n) 5.892.21 (289) 6.092.05 (128) 6.301.95 (151) 6.872.29,yyy,## (457)
eGFR (ml/min per 1.73m2) (n) 11829 (244) 11527 (108) 10826,y (104) 11230 (443)
LV mass index (g/m2.7) (n) 40.014.3 (181) 40.713.2 (82) 44.512.6,y (109) 44.014.6 (318)
eGFR, estimated glomerular filtration rate LV, left ventricle; PWV, aortic pulse wave velocity. Adjustments are for age, sex, BMI, diabetes mellitus and/or an HbA1c>6.1%, regular
tobacco use, regular alcohol intake and pulse rate.

P<0.05.

P<0.005.

P<0.0001 versus optimal.
y
P<0.05.
yy
P<0.005.
yyy
P<0.0005 versus aortic BP <112mmHg.
#
P<0.05.
##
P<0.005.
###
P< 0.0001 versus aortic BP112mmHg.
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In normotensives from the present randomly selected
community sample, only 14% had day BP values that
exceeded 135/85mmHg (masked hypertension). In con-
trast, in employees of a university hospital or private
company [40] or in referrals to a hypertension clinic [41]
34 and 24.7%, respectively, of those with a normal/high-
normal BP had masked hypertension and only those with
masked hypertension had target organ changes. As masked
hypertension is independently associated with cardiovas-
cular outcomes, it is possible that ambulatory BP monitor-
ing also has an important role to play in further refining risk
in those with a normal/high-normal BP, at least in groups
with a high prevalence of masked hypertension.
The limitations of the present study include the cross-
sectional design that prevents us from drawing conclusions
regarding cause and effect, and the use of target organ
changes as surrogates for risk. Prospective studies are,
therefore, required to assess whether aortic BP measure-
ments identify earlier separation of curves describing
cardiovascular outcomes in those with a normal/high-
normal BP as compared to those with an optimal BP. In
this regard, those persons with a normal/high-normal BP
may experience significantly more cardiovascular events
only 10–15 years after detection [42]. Moreover, the present
study was conducted only in a group of black African
ancestry. Corroboration of the present findings is required
in other ethnic groups. Last, as thresholds for central aortic
BP values have not been identified from outcome-based
studies we identified thresholds from participants with
optimal brachial BP values.
In conclusion, in contrast to the lack of ability of normal
or high-normal BP categories to identify normotensives
with target organ changes, in the present study we show
that in normotensives, ‘optimal’ central aortic BP values
clearly identify the presence of target organ changes.
Thus, the use of aortic BP measurements may enhance
the ability to risk stratify those with a normal/high-normal
brachial BP.
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Reviewers’ Summary Evaluations
Reviewer 1
The authors studied the relationship between aortic SBP
and target organ damage in a normotensive population of
1169 participants to the SOWETO study, remarkable for
their black African ancestry, and individualized those with
normal and high-normal BP. They conclude that aortic SBP
was better correlated with target organ damage than bra-
chial SBP. These findings provide additional evidence for
the pathophysiological importance of central BP and wave
reflections (increasing aortic SBP), and their better relation-
ship with target organ damage than peripheral (brachial)
BP, in line with the concept that the true damaging SBP is
local SBP, i.e. the maximum hemodynamic load that the
target organ ‘sees’.
Reviewer 2
The study investigates to what extent high aortic blood
pressure is present in individuals with normal/high-normal
blood pressure, and will reclassify individuals at low risk to
high risk.
Individuals with normal/high-normal blood pressure
and high aortic systolic blood pressure show increases in
pulse wave velocity, left ventricular mass index and
decreases in estimated glomerular infiltration rate.
The limitation is a cross-sectional design. Long-term
follow-up is needed to clarify absolute risk. Neither does
the study define whether aortic blood pressure is superior
to, e.g. 24-h blood pressure for risk prediction.
The study adds to our understanding of the relationship
between various measures of subclinical target organ dam-
age.
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Although pulse pressure measured at the brachial artery is closely correlated with central aortic pulse pressure 
(PPc), pulse pressure may be considerably higher in brachial 
arteries as compared with the aorta.1,2 A key determinant of 
PPc is an increase in aortic wave reflection, which enhances 
backward wave pressures (Pb) and hence augments aortic sys-
tolic blood pressure (BP) if returning to the ascending aorta 
sufficiently early.1,2 An enhanced aortic wave reflection is 
thought to be a major cause of cardiovascular damage. Indeed, 
several studies have demonstrated that aortic augmented pres-
sures (Pa), augmentation index (AIx), and indexes of wave 
reflection are associated with cardiovascular outcomes3–7 and 
end-organ damage8–12 independent of brachial BP. However, 
more recently the use of Pa or AIx as indexes of wave reflec-
tion in risk prediction has been challenged.13–18
Marked overlap between aortic forward and reflected waves 
may confound Pa and AIx14,16–18 and hence these measures may 
be poor indexes of wave reflection. Indeed, there is a weak 
relationship between the magnitude of the reflected wave and 
Pa or AIx with increases in aortic reservoir function, the tim-
ing or magnitude of the forward (Pf) or incident (Pi) wave 
pressures, and left ventricular systolic function playing a more 
important role than wave reflection in contributing to varia-
tions in Pa and AIx.13–18 More recent studies have, therefore, 
focussed on the role of reflected waves (Pb and reflected wave 
index [RI]), as determined using wave separation analysis, as 
independent determinants of age-related increases in PPc or 
cardiovascular damage.19–22 However, in these studies19–22 the 
extent to which Pb or RI are more closely associated with PPc 
or cardiovascular damage than Pa or AIx is uncertain. In this 
regard in these studies, relations with end-organ damage were 
not adjusted for confounders;19,21 discrepancies in the index 
of wave reflection that was better associated with end-organ 
damage beyond Pf were noted19,21; whether the increase in Pf at 
Abstract—Although indexes of wave reflection enhance risk prediction, the extent to which measures of aortic systolic 
pressure augmentation (augmented pressures [Pa] or augmentation index) underestimate the effects of reflected waves on 
cardiovascular risk is uncertain. In participants from a community sample (age >16), we compared the relative contribution 
of reflected (backward wave pressures and the reflected wave index [RI]) versus augmented (Pa and augmentation index) 
pressure wave indexes to variations in central aortic pulse pressure (PPc; n=1185), and left ventricular mass index 
(LVMI; n=793). Aortic hemodynamics and LVMI were determined using radial applanation tonometry (SphygmoCor) 
and echocardiography. Independent of confounders, RI and backward wave pressures contributed more than forward 
wave pressures, whereas Pa and augmentation index contributed less than incident wave pressure to variations in PPc 
(P<0.0001 for comparison of partial r values). In those <50 years of age, while backward wave pressures (partial r=0.28, 
P<0.0001) contributed more than forward wave pressures (partial r=0.15, P<0.001; P<0.05 for comparison of r values), 
Pa (partial r=0.13, P<0.005) contributed to a similar extent as incident wave pressure (partial r=0.22, P<0.0001) to 
variations in LVMI. Furthermore, in those ≥50 years of age, backward wave pressures (partial r=0.21, P<0.0001), but 
not forward wave pressures (P=0.98), while incident wave pressure (partial r=0.23, P<0.0001), but not Pa (P=0.80) were 
associated with LVMI. Pa and augmentation index underestimated the effect of wave reflection on PPc and LVMI in both 
men and women. Thus, as compared with relations between indexes of aortic pressure augmentation and PPc or LVMI, 
strikingly better relations are noted between aortic wave reflection and PPc or LVMI.  (Hypertension. 2015;65:540-546. 
DOI: 10.1161/HYPERTENSIONAHA.114.04582.) ? Online Data Supplement
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50 years of age affects these relations was not considered19–21; 
and Pf rather than Pb was reported to be the main determinant 
of PPc in a community sample with a high prevalence of well-
controlled BP values.22 To clarify the extent to which indexes 
of aortic systolic pressure augmentation underestimate the 
effect of wave reflection on cardiovascular disease, in this 
study we, therefore, aimed to evaluate, in a large community-
based sample with a high prevalence of uncontrolled BP, the 
degree to which Pb or RI are more closely related to multivari-
ate adjusted increases in PPc and left ventricular mass index 
(LVMI) beyond Pf than Pa or AIx, and whether these effects 
are age- or sex-specific.
Methods
Study Group and Clinical, Demographic, and 
Anthropometric Measurements
This study was conducted according to the principles outlined in 
the Helsinki declaration. The Committee for Research on Human 
Subjects of the University of the Witwatersrand approved the pro-
tocol (approval number: M02-04-72 and renewed as M07-04-69 and 
M12-04-108). Participants gave informed, written consent. Briefly, 
1185 participants from families of black African descent (Nguni 
and Sotho chiefdoms) with siblings >16 years with central hemody-
namic measurements were randomly recruited from the South West 
Township (Soweto) of Johannesburg, South Africa. In a substudy, 793 
participants had LVMI determined using echocardiography. For clini-
cal, demographic, and anthropometric measurements see online-only 
Data Supplement for further details.
Pulse Wave Analysis
Central aortic systolic BP, PPc, Pi, Pa, and AIx were estimated using 
radial applanation tonometry and SphygmoCor software as previ-
ously described.12 See online-only Data Supplement for further 
details. Pb and Pf were determined using SphygmoCor software, 
which separates the aortic waveform using a triangular flow wave.23 
RI was determined as previously described.15
Echocardiography
Left ventricular mass and stroke volume were determined from trans-
thoracic 2-dimensional targeted M-mode echocardiographic images 
obtained in the parasternal long-axis view as previously described12 
(see online-only Data Supplement for further details).
Data Analysis
For database management and statistical analysis, SAS software, 
version 9.1 (SAS Institute Inc, Cary, NC) was used. To determine 
relationships, multivariate regression analysis was performed with 
appropriate adjustments. Adjustments included in multivariate 
models were those correlated with central hemodynamic variables 
or LVMI in bivariate analysis. To assess the relative contribution 
of incident and augmented waves to variations in PPc, in stepwise 
regression analysis, Pi and AIx were included in multivariate mod-
els. AIx rather than Pa was included in the same regression model 
with Pi to avoid the confounding effect of forward wave amplitude 
on the amplitude of the augmented wave.22 To determine probability 
values, further adjustments for nonindependence of family members 
was performed using nonlinear regression analysis (mixed procedure 
as defined in the SAS package). As a sharp age-related increase in 
Pf and Pi occurred between 40 and 50 years of age, relationships 
between aortic hemodynamic variables and PPc or LVMI were evalu-
ated in participants < or ≥50 years of age. To ensure that relationships 
occurred independent of the use of antihypertensive therapy, sensitiv-
ity analysis was conducted in participants not receiving antihyperten-
sive therapy. Regression coefficients were compared with z statistics.
Results
Characteristics of the Participants
The clinical and demographic characteristics of the par-
ticipants are shown in Table 1; 1.9% of participants had a 
history of cardiovascular disease. Importantly, a high propor-
tion (45.9%) of participants had hypertension and 47.2% of 
Table 1. Characteristics of the Study Sample
Characteristics
All  
(n=1185)
<50 yr  
(n=703)
≥50 yr  
(n=482)
% Female 65.0 64.6 65.8
Age, yr 44.3±18.3 31.4±10.0 63.0±9.2
Body mass index, kg/m2 29.6±8.1 27.4±7.4 32.7±8.0
% Obese 43.3 32.9 58.5
Regular tobacco (% 
subjects)
15.2 17.1 12.5
Regular alcohol (% 
subjects)
20.9 23.6 17.0
% With DM or HbA1c 
>6.1%
25.8 12.4 45.4
% Hypertensive 45.9 24.0 77.8
% Treated for 
hypertension
24.2 6.3 50.4
% Hypertensives 
controlled to target BP
20.8 13.0 24.3
% Of all with uncontrolled 
BP
36.4 20.9 58.9
Pulse rate, bpm 66±12 65±11 67±13
Brachial SBP/DBP,  
mm Hg
130±22/84±13 121±17/81±12 143±23/88±12
Brachial pulse pressure, 
mm Hg
46±16 39±13 53±18
Brachial mean arterial 
pressure, mm Hg
100±16  95±14 108±16
Central aortic SBP, mm Hg 120±23 111±18 133±23
Central aortic pulse 
pressure (PPc), mm Hg
35±15 29±11 44±16
Aortic forward wave 
pressure (Pf), mm Hg
24±9 21±7 28±10
Aortic reflected wave 
pressure (Pb), mm Hg
17±8 14±6 22±9
Aortic reflected wave 
index
0.16±0.06 0.13±0.04 0.19±0.06
Aortic augmented 
pressure (Pa)
11±8 7±6 15±8
Aortic Pi 25±9 22±7 29±10
Aortic augmentation index 
(AIx), %
142±25 135±24 153±23
Stroke volume, mL (n) 63±17 (793) 61±16 (468) 65±18 (325)
Left ventricular mass 
index, g/m2 (n)
76±31 (793) 70±27 (468) 84±34 (325)
Left ventricular mass 
index, g/m1.7 (n)
67±24 (793) 61±20 (468) 76±27 (325)
Data expressed as mean±SD or proportions. Pi=PPc−Pa. BP indicates 
blood pressure; DBP, diastolic BP; DM, diabetes mellitus; HbA1c, glycosylated 
hemoglobin; Pi, incident wave pressure; PPc, central aortic pulse pressure; and 
SBP, systolic BP.
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hypertensives were not receiving therapy. Moreover, 36.4% 
of all participants and 60.6% of participants receiving anti-
hypertensive therapy had uncontrolled hypertension. Of the 
participants with echocardiography, 17% had LVH.
Age-Related Increases in Aortic Hemodynamics
See online-only Data Supplement .
Relative Independent Contribution of Reflected 
Versus Forward Waves to Variations in PPc
When included in separate models (Table S4 in the online-
only Data Supplement) or in the same multivariate stepwise 
models (Figure 1) in participants either < or ≥50 years of age, 
a stronger relationship was noted between RI and PPc or Pb 
and PPc than between Pf and PPc or AIx and PPc. In con-
trast, a stronger relationship was noted between Pi and PPc, 
than between Pa and PPc (Table S4) or between AIx and PPc 
(Table S4; Figure 1). With RI and AIx in the same multivariate 
model, a distinctly stronger relationship was noted between 
RI and PPc than between AIx and PPc (Figure 1). Similar dif-
ferences in the relative contribution of reflected versus for-
ward wave indexes to variations in PPc were noted in women 
and men (Table 2; Table S5). Similar findings were noted in 
participants not receiving antihypertensive therapy (Tables 
S6 and S7). Stroke volume was modestly correlated with PPc 
(r=0.20, P<0.0001). With the inclusion of stroke volume in 
multivariate models, similar differences between aortic hemo-
dynamic–PPc relations were noted (Table S8).
Comparison of Independent Relations Between 
Aortic Hemodynamics and LVMI
In participants <50 years of age, Pb was more closely associ-
ated with LVMI (Figure 2, upper panel; Table S9) than Pf and 
in a multivariate model with Pb and Pf in the same model, 
Pb (partial r=0.31, confidence interval=0.24–0.38, P<0.0001), 
but not Pf (partial r=0.01, confidence interval=−0.06 to 0.08, 
P=0.72) was independently associated with LVMI. In con-
trast, however, Pa showed similar associations with LVMI as 
did Pi (Figure 2, upper panel; Table S9). In addition, RI was 
more closely associated with LVMI than AIx (Figure 2, upper 
panel; Table S9). In participants ≥50 years of age, Pb, but not 
Pf was independently associated with LVMI (Figure 2, lower 
panel; Table S9). In contrast, however, Pi, but not Pa was 
independently associated with LVMI (Figure 2, lower panel; 
Table S9). In participants ≥50 years of age RI, but not AIx was 
independently associated with LVMI-height1.7 (Table S9), but 
neither RI nor AIx were independently associated with LVMI-
body surface area (Figure 2, lower panel). Similar differences 
in the relative contribution of reflected versus forward wave 
indexes and LVMI were noted in men and women (Table 3). 
Importantly, although the relations between Pa or AIx and 
LVMI were stronger in men than in women (P=0.01 to 0.0002 
for comparison of r values; Table 3), these differences were 
Figure 1. Relative contribution of aortic 
hemodynamic variables to variations in 
central aortic pulse pressure (PPc) in 
age-specific categories in a group of 
African descent. Closed circles indicate 
indexes of wave reflection and open 
circles indicate indexes of forward (Pf) 
or incident (Pi) wave pressures. Data 
show multivariate adjusted correlation 
coefficients (partial r) derived from 
stepwise regression analysis with Pf and 
backward wave pressures (Pb; model 
1), Pf and reflected wave index (RI; 
model 2), Pi and augmentation index 
(AIx; model 3), or RI and AIx (model 
4)+confounders included in the same 
regression models. Potential confounders 
included in the model are age, sex, mean 
arterial pressure, body height, body 
weight, pulse rate, diabetes mellitus 
or a glycosylated hemoglobin>6.1%, 
regular smoking, and regular alcohol 
intake. Those factors not independently 
associated with PPc were forced into 
the model. Pi=Aortic pulse pressure-Pa. 
*P<0.0001 for comparisons of partial 
r values with Pf or AIx (z statistics). CI 
indicates confidence interval; and Pa, 
augmented pressures.
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not attributed to reflected wave effects. Indeed, Pb or RI-LVMI 
relations were similar in men and women (Table 3). Similar 
findings were also noted in participants <50 years of age not 
receiving antihypertensive therapy (Table S10). There were 
too few participants (n=151) ≥50 years of age not receiving 
antihypertensive therapy to compare relationships between 
aortic hemodynamics and LVMI. Stroke volume was corre-
lated with LVMI (r=0.64, P<0.0001). However, with further 
adjustments for stroke volume, relative differences in relations 
between reflected versus forward wave indexes and LVMI 
were retained (Table S11).
Discussion
The main findings of this study are as follows: In a large 
(n=1185), community-based sample of African ancestry, inde-
pendent of confounders including mean arterial pressure (dis-
tending pressures), reflected waves (RI or Pb) accounted for 
more of the variation in PPc and LVMI than did Pf, whereas Pi 
accounted for more of the variation in PPc and LVMI than did 
aortic systolic pressure augmentation (AIx or Pa). The marked 
contrasting contributions of indexes of reflected waves, RI or 
Pb and AIx or Pa, as compared with Pf and Pi toward varia-
tions in PPc and LVMI were noted below as well as above the 
age threshold (50 years) when Pf or Pi began to increase as 
well as in women and men considered separately.
Several previous studies have reported on a relatively 
greater contribution of Pa as compared with Pi to age-related 
increases in PPc.24–26 However, it is now recognized that Pa may 
be confounded by considerable overlap between forward and 
backward waves and that there is a poor relationship between 
the magnitude of the reflected wave and Pa.13–18 Indeed, Pa 
may be determined in large part by Pf.16 Nevertheless, studies 
which have used approaches to separate Pb from Pf, suggest 
that Pb contributes little to age-related increases in PPc.22,27 
These studies were nonetheless conducted either in a sample 
where BP values were largely well-controlled22 or in a sample 
with a narrow age range.27 In contrast, using wave separation 
analysis in this study conducted in a community sample with 
a wide age range and with a high prevalence of uncontrolled 
hypertension, we show that Pb has a far stronger relation-
ship with PPc than Pf, and that these associations occurred 
irrespective of age and independent of sex. Hence, this study 
provides the first direct evidence to show that across the adult 
lifespan of a community sample with poorly controlled hyper-
tension, in both women and men reflected waves account for 
more of the variation in PPc than do Pf and that indexes of 
aortic pressure augmentation underestimate the contribution 
of aortic wave reflection to variations in PPc.
A few previous studies have suggested that indexes of 
reflected waves derived from wave separation analysis (Pb 
or RI) are more closely associated with end-organ damage 
than Pa indexes (Pa and AIx).19,21 However, in neither study 
were these comparisons made with adjustments for confound-
ers. Hence, the differences reported on19 may be attributed to 
confounders including distending pressures and heart rate. 
Moreover, in neither study19,21 were comparisons of relations 
made in age-specific categories, despite increases in Pf occur-
ring only later in life. Furthermore, in 1 study21 no compari-
sons were made between correlation coefficients and similar 
relations were noted between reflected wave indexes derived 
from wave separation analysis and end-organ changes as com-
pared with relations between indexes of aortic systolic pres-
sure augmentation and end-organ changes.21 In this study, we 
provide clear evidence that relations between indexes of wave 
reflection and LVMI were markedly stronger than Pf effects, 
whereas indexes of aortic systolic pressure augmentation con-
siderably underestimated the contribution of reflected as com-
pared with Pf.
As age-related increases in AIx occurred in those less than, 
but not greater than 50 years of age, a lack of relationship 
between AIx and LVMI in those >50 years of age is not unex-
pected. However, Pa increased across the full adult age range, 
and yet, in those >50 years, reflected, but not augmented wave 
pressures accounted for variations in LVMI. Thus, without the 
use of wave separation analysis, even when indexes of pres-
sure augmentation that increase with age across the full adult 
lifespan are used, the effect of reflected wave function on end-
organ changes may be markedly underestimated.
As previously demonstrated,28 the assumptions intrinsic to the 
use of the triangulation method of aortic wave separation are not 
ideal. However, this approach produces correlations between 
reflected wave indexes derived from the triangulation method 
and actual aortic flow waveforms (r2=0.55) that are considerably 
stronger than between AIx and indexes derived from actual aortic 
Table 2. Independent Relationships Between Aortic 
Hemodynamics and PPc in Sex-Specific Categories in a Group 
of African Ancestry
PPc vs
Women (n=771) Men (n=414)
Partial r (CI)* P Value Partial r (CI)* P Value
Model with Pb and Pf included together
  Pb 0.97  
(0.90–1.04)†
<0.0001 0.92  
(0.82–1.02)†
<0.0001
  Pf 0.19  
(0.12–0.26)
<0.0001 0.10  
(0.02–0.20)
<0.0001
Model with RI and Pf included together
  RI 0.88  
(0.81–0.95)†
<0.0001 0.86  
(0.76–0.96)†
<0.0001
  Pf 0.39  
(0.32–0.46)
<0.0001 0.18  
(0.08–0.28)
<0.0001
Model with AIx and Pi included together
  AIx 0.41  
(0.34–0.48)
<0.0001 0.34  
(0.24–0.44)
<0.0001
  Pi 0.90  
(0.83–0.97)‡
<0.0001 0.93  
(0.83–1.03)‡
<0.0001
Model with RI and AIx included together
  RI 0.88 (0.81–0.95)‡ <0.0001 0.86 (0.76–
0.96)‡
<0.0001
  AIx 0.19 (0.12–0.26) <0.0001 0.18 (0.08–0.28) <0.0001
AIx indicates augmentation index; CI, confidence intervals; Pb, backward 
wave pressures; Pf, forward wave pressures; Pi, incident wave pressures; PPc, 
central aortic pulse pressure; and RI, reflected wave index.
*Adjustors are age, mean arterial pressure, body height, body weight, pulse 
rate, diabetes mellitus or a glycosylated hemoglobin >6.1%, regular smoking, 
and regular alcohol intake.
†P<0.0001 for comparisons of partial r values with Pf.
‡P<0.0001 for comparison of partial r values with AIx (z statistics).
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flow waveforms (r2=0.34).28 Thus, the triangulation method of 
wave separation is better than augmentation indexes at identify-
ing reflected wave effects. Despite using a relatively imprecise 
method of identifying reflected wave magnitude and index, we 
were still able to show that indexes of aortic wave reflection were 
more closely associated with PPc and LVMI than Pf, whereas 
indexes of aortic pressure augmentation showed weaker associa-
tions than Pf with PPc and LVMI. Hence, this study provides 
evidence that improved measures of wave reflection are indeed 
better than augmentation indexes at detecting relations between 
reflected wave effects and both PPc and LVMI.
Dobutamine, which enhances PPc through increases in 
myocardial contractility and stroke volume, largely increases 
Pf.29 In contrast, norepinephrine, which augments PPc through 
marked vasoconstriction, mainly increases Pb but does 
not produce as much of an increase in PPc.29 Furthermore, 
increases in Pf may account for more of the increment in PPc 
in hypertensives than reflected wave pressures.29 It has, there-
fore, been suggested that Pf, mediated by increases in stroke 
volume may be more important than reflected wave pressures 
in determining variations in PPc in hypertension.29 However, 
as in this and previous26,27 studies where no increase27 or only 
modest increases (this study) in stroke volume were noted 
with increasing age, or where stroke volume contributed little 
to variations in PPc,26 increases in stroke volume are unlikely 
to explain a significant proportion of age-related increases 
in PPc. Moreover, norepinephrine-induced effects on aortic 
reflected waves29 are more likely to represent the hypertensive 
state where a major effect on BP is through increases in vascu-
lar smooth muscle tone. Furthermore, in this study the greater 
effect of Pb as compared with Pf on variations in PPc and 
LVMI were replicated even when stroke volume was included 
in multivariate-adjusted analysis.
Previous studies have demonstrated that the effect of aortic 
pressure augmentation on end-organ changes12 or cardiovas-
cular outcomes19 is attenuated in women as compared with 
men. In this study, we similarly show that relations between 
Figure 2. Contribution of aortic 
hemodynamic variables to variations 
in left ventricular mass indexed (LVMI) 
to body surface area in age-specific 
categories in a group of African descent. 
Closed circles indicate indexes of wave 
reflection and open circles indicate 
indexes of forward (Pf) or incident (Pi) 
wave pressures. Potential confounders 
included in the model are age, sex, 
mean arterial pressure, pulse rate, body 
height, pulse rate, diabetes mellitus 
or a glycosylated hemoglobin>6.1%, 
regular smoking, and regular alcohol 
intake. Those factors not independently 
associated with LVMI were forced into 
the model. Pi=Aortic pulse pressure-Pa. 
*P<0.05 for comparisons of partial  
r values with Pf and augmentation index 
(AIx); †P<0.05 for comparison of partial  
r values with AIx; #P<0.05 for comparison 
of partial r values with Pa and AIx 
(z-statistics). CI indicates confidence 
interval; Pa, augmented pressures; 
Pb, backward wave pressures; and RI, 
reflected wave index.
Table 3. Independent Relationships Between Aortic 
Hemodynamics and LVMI-BSA in Women and Men of African 
Ancestry
LVMI-BSA 
vs
Women (n=515) Men (n=278)
Partial r (CI)* P Value Partial r (CI)* P Value
Pb 0.32  
(0.23 to 0.41)†
<0.0001 0.33  
(0.21 to 0.45)‡
<0.0001
Pf 0.08  
(−0.01 to 0.17)
0.07 0.13  
(0.01 to 0.25)
<0.05
Pa 0.04  
(−0.05 to 0.13)
0.40 0.31  
(0.19 to 0.43)
<0.0001
Pi 0.29  
(0.20 to 0.38)§
<0.0001 0.29  
(0.17 to 0.41)
<0.0001
RI 0.30  
(0.21 to 0.39)ǁ
<0.0001 0.34  
(0.22 to 0.46)¶
<0.0001
AIx −0.07  
(−0.16 to 0.02)
0.08 0.12  
(0.01 to 0.24)
=0.04
AIx indicates augmentation index; CI, confidence intervals; LVMI, left 
ventricular mass index; Pa, augmented pressures; Pb, backward wave 
pressures; Pf, forward wave pressures; Pi, incident wave pressure; and RI, 
reflected wave index.
*Adjustors are age, mean arterial pressure, body height, body weight, pulse rate, 
diabetes mellitus or an HbA1c >6.1%, regular smoking and regular alcohol intake.
†P<0.0005 for comparisons of partial r values with Pf.
‡P<0.02.
§P<0.0001 for comparisons of partial r values with Pa.
ǁP<0.0001 for comparisons of partial r values with AIx (z statistics).
¶P<0.01.
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Pa or AIx and LVMI were diminished in women as com-
pared with men. However, these differences were not 
attributed to disparities in reflected wave effects. Indeed, 
Pb or RI-LVMI relations were similar in men as compared 
with women. Hence, the weaker associations between aug-
mentation indexes and cardiovascular damage in women 
as compared with men12,19 are likely to be attributed to a 
greater degree of inaccuracy of pressure augmentation as 
an index of wave reflection in women as compared with 
men, effects which may be attributed to sex differences in 
the width of the forward wave peak and the slope of the 
backward wave upstroke.17
Additional limitations of this study are as follows: This 
study was a cross-sectional design. Therefore, we can-
not determine whether the age-related changes reported on 
are attributed to the long-term effect of age or a cumulative 
effect of alternative risk factors over time or whether rela-
tions between aortic hemodynamics and LVMI are indeed 
cause and effect. Further longitudinal studies are required to 
determine these effects. Moreover, in this study calibration of 
the radial waveform from brachial BP measurements ignores 
amplification of BP from brachial to radial arteries. Hence, 
aortic pressures are likely to have been underestimated using 
the current approach.
Perspectives
Although indexes of aortic systolic pressure augmentation 
(Pa and AIx) have been demonstrated in various populations 
to be independent predictors of outcomes,3–7 the use of these 
indexes as surrogate measures of aortic wave reflection has 
been challenged.13–18 However, the extent to which reflected 
waves derived from wave separation analysis are more 
strongly related to PPc and end-organ damage than indexes of 
aortic systolic pressure augmentation is unclear. In this study 
conducted in a community sample with a high prevalence of 
uncontrolled hypertension, we show that reflected waves are 
more closely associated with PPc and LVMI than forward 
waves, but that indexes of aortic systolic pressure augmenta-
tion markedly underestimate these effects. These data provide 
support for a role of reflected wave function in mediating the 
adverse effects of PPc, effects which nonetheless cannot be 
accurately detected using indexes of aortic systolic pressure 
augmentation. Moreover, given the high prevalence of hyper-
tension and related cardiovascular events in urban communi-
ties in Africa, this study suggests that approaches to decreasing 
age-related increases in aortic wave reflection may produce a 
major effect on the burden of disease in these communities.
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What Is New?
??The extent to which measures of aortic systolic pressure augmentation 
(augmented pressure or augmentation index) underestimate the effects 
of reflected waves on cardiovascular risk is uncertain.
What Is Relevant?
??As marked overlap between aortic forward and reflected waves may 
confound aortic augmented pressure and augmentation index, these 
measures may be poor indexes of wave reflection. Hence, recent studies 
have recommended the use of approaches to separate the forward and 
backward pressure waves.
Summary
In a community sample, with a high prevalence of uncontrolled 
hypertension, strikingly better relations were noted between aor-
tic wave reflection, derived from wave separation analysis, and 
aortic pulse pressure or left ventricular mass index as compared 
with relations between aortic systolic pressure augmentation 
and aortic pulse pressure or left ventricular mass index. Hence, 
indexes of aortic systolic pressure augmentation may markedly 
underestimate relationships between wave reflection and cardio-
vascular risk.
Novelty and Significance
 by guest on February 12, 2015http://hyper.ahajournals.org/Downloaded from 
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Independent relationships between aortic haemodynamics and central aortic pulse 
pressure (PPc) in age-specific categories in a group of African ancestry, with brachial form 
factor instead of mean arterial pressure as an adjustor. 
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Appendix 4. Independent relationships between aortic haemodynamics and central aortic 
pulse pressure (PPc) in age-specific categories in a group of African ancestry, with 
brachial form factor instead of mean arterial pressure as an adjustor. 
 
PPc vs              <50 years (n=703)       ≥50 years (n=482) 
  partial r (CI)*     p value  partial r (CI)*    p value 
___________________________________________________________________ 
Pb  0.87 (0.80 to 0.95)†    <0.0001  0.97 (0.88 to 1.10)†    <0.0001 
Pf  0.65 (0.58 to 0.72)     <0.0001  0.80 (0.71 to 0.89)     <0.0001 
Pa  0.80 (0.72 to 0.87)     <0.0001  0.88 (0.79 to 0.97)     <0.0001 
Pi  0.88 (0.81 to 0.96)‡‡  <0.0001  0.92 (0.83 to 1.01)‡    <0.0001 
RI  0.79 (0.71 to 0.86)§   <0.0001  0.86 (0.77 to 0.95)§    <0.0001 
AIx  0.38 (0.31 to 0.45)     <0.0001  0.31 (0.22 to 0.40)      <0.0001 
___________________________________________________________________ 
CI, confidence intervals; Pb, reflected wave pressure; Pf, forward wave pressure; Pa, 
aortic augmented pressure; Pi=Aortic pulse pressure-Pa; RI, reflected wave index; AIx, 
aortic augmentation index. *Adjustors are age, sex, brachial form factor, body height, body 
weight, pulse rate, diabetes mellitus or an HbA1c>6.1%, regular smoking and regular 
alcohol intake. †p<0.0001 for comparisons of partial r values with Pf, ‡p<0.05 ‡‡p<0.0001 
for comparisons of partial r values with Pa, §p<0.0001 for comparison of partial r values 
with AIx (z-statistics). 
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Independent relationships between aortic haemodynamics and central aortic pulse 
pressure (PPc) in age-specific categories in a group of African ancestry, with brachial form 
factor instead of mean arterial pressure as an adjustor. 
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Appendix 5. Independent relationships between aortic haemodynamics and central aortic 
pulse pressure (PPc) in age-specific categories in a group of African ancestry, with 
brachial form factor instead of mean arterial pressure as an adjustor. 
 
PPc vs        <50 years (n=703)   ≥50 years (n=482) 
  partial r (CI)*  p value partial r (CI)*  p value 
___________________________________________________________________ 
    Model with Pb and Pf included together 
Pb  0.87 (0.80-0.95)† <0.0001 0.97 (0.89-1.06)† <0.0001 
Pf  0.17 (0.09-0.24) <0.0001 0.19 (0.10-0.28) <0.0001 
    Model with RI and Pf included together 
RI  0.78 (0.71-0.86)† <0.0001 0.86 (0.77-0.95)† <0.0001 
Pf  0.33 (0.25-0.40) <0.0001 0.42 (0.34-0.52) <0.0001 
Model with AIx and Pi included together 
AIx  0.45 (0.38-0.52) <0.0001 0.37 (0.28-0.46) <0.0001 
Pi  0.88 (0.81-0.95) ‡ <0.0001 0.92 (0.83-1.01) ‡ <0.0001 
    Model with RI and AIx included together 
RI  0.78 (0.71-0.86) ‡ <0.0001 0.86 (0.77-0.95) ‡ <0.0001 
AIx  0.05 (0.01-0.13) =0.022  0.08 (0.01-0.15) <0.0001 
___________________________________________________________________ 
CI, confidence intervals; Pb, reflected wave pressure; Pf, forward wave pressure; Pa, 
aortic augmented pressure; Pi=Aortic pulse pressure-Pa; RI, reflected wave index; AIx, 
aortic augmentation index. *Adjustors are age, sex, brachial form factor, body height, body 
weight, pulse rate, diabetes mellitus or an HbA1c>6.1%, regular smoking and regular 
alcohol intake. †p<0.0001 for comparisons of partial r values with Pf, ‡p<0.0001 for 
comparison of partial r values with AIx (z-statistics). 
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Appendix 6 
 
 
Independent relationships between aortic haemodynamics and left ventricular mass 
indexed to body surface area (LVMI) in participants of African ancestry, with brachial form 
factor instead of mean arterial pressure as an adjustor. 
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Appendix 6. Independent relationships between aortic haemodynamics and left 
ventricular mass indexed to body surface area (LVMI) in participants of African ancestry, 
with brachial form factor instead of mean arterial pressure as an adjustor. 
 
    <50 years (n=468)     ≥50 years (n=325) 
LVMI vs        partial r (CI)*        p value          partial r (CI)*    p value 
__________________________________________________________________ 
Pb   0.28 (0.19 to 0.37)†   <0.0001      0.21 (0.10 to 0.32)†   =0.0001 
Pf   0.14 (0.05 to 0.23)    <0.001       0.05 (-0.06 to 0.13)    =0.25 
Pa   0.13 (0.04 to 0.22)     <0.005       0.11 (0.001 to 0.22)     <0.05 
Pi   0.22 (0.14 to 0.32)     <0.0001      0.23 (0.12 to 0.34)‡  <0.0001 
RI             0.29 (0.20 to 0.38)§    <0.0001      0.10 (-0.01 to 0.21)     =0.06 
AIx             0.08 (-0.01 to 0.17)     <0.05       0.05 (-0.06 to 0.16)    =0.35 
__________________________________________________________________ 
CI, confidence intervals; Pb, reflected wave pressure; Pf, forward wave pressure; Pa, 
aortic augmented pressure; Pi=Aortic pulse pressure-Pa; RI, reflected wave index; AIx, 
aortic augmentation index. *Adjustors are age, sex, brachial form factor, body weight, 
pulse rate, diabetes mellitus or an HbA1c>6.1%, regular smoking and regular alcohol 
intake. †p<0.05 for comparisons of partial r values with Pf, ‡p<0.05 for comparison of 
partial r values with Pa and AIx, §p<0.05 for comparison of partial r values with AIx (z-
statistics). 
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Appendix 7 
 
 
Independent relationships between aortic haemodynamics and left ventricular mass 
indexed to height1.7 (LVMI-ht1.7) in participants of African ancestry, with brachial form factor 
instead of mean arterial pressure as an adjustor. 
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Appendix 7. Independent relationships between aortic haemodynamics and left 
ventricular mass indexed to height1.7 (LVMI-ht1.7) in participants of African ancestry, with 
brachial form factor instead of mean arterial pressure as an adjustor. 
 
    <50 years (n=468)     ≥50 years (n=325) 
LVMI-ht1.7 vs        partial r (CI)*        p value          partial r (CI)*    p value 
__________________________________________________________________ 
Pb   0.20 (0.11 to 0.29)†   <0.0001      0.20 (0.09 to 0.31)†   <0.0005 
Pf   0.08 (-0.01 to 0.17)    =0.07       0.08 (-0.03 to 0.19)    =0.06 
Pa   0.17 (0.08 to 0.26)     =0.0001      0.12 (0.01 to 0.13)     <0.05 
Pi   0.15 (0.06 to 0.24)     =0.0005      0.25 (0.14 to 0.36)‡  <0.0001 
RI             0.19 (0.10 to 0.29)§    <0.0001      0.13 (0.02 to 0.24)     <0.02 
AIx             0.07 (-0.02 to 0.16)      =0.15       0.04 (-0.07 to 0.15)    =0.47 
__________________________________________________________________ 
CI, confidence intervals; Pb, reflected wave pressure; Pf, forward wave pressure; Pa, 
aortic augmented pressure; Pi=Aortic pulse pressure-Pa; RI, reflected wave index; AIx, 
aortic augmentation index. *Adjustors are age, sex, brachial form factor, body weight, 
pulse rate, diabetes mellitus or an HbA1c>6.1%, regular smoking and regular alcohol 
intake. †p<0.05 for comparisons of partial r values with Pf, ‡p<0.05 for comparison of 
partial r values with Pa, §p<0.05 for comparison of partial r values with AIx (z-statistics). 
 
196 
 
 
 
Appendix 8 
 
 
“Turnitin” plagiarism report 

198 
 
References 
Agabiti-Rosei, E., Mancia, G., O’Rourke, M. F., Roman, M. J., Safar, M. E., Smulyan, H., 
Wang J.G., Wilkinson, I.B., Williams, B., & Vlachopoulos, C. (2007). Central blood 
pressure measurements and antihypertensive therapy a consensus document. 
Hypertension, 50, 154-160. 
Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., Bray, 
G.A., Vogt, T.M., Cutler, J.A., Windhauser, M.M., Lin, P.H., & Karanja, N. (1997). A 
clinical trial of the effects of dietary patterns on blood pressure. New England Journal 
of Medicine, 336, 1117-1124. 
Avolio, A. P., Van Bortel, L. M., Boutouyrie, P., Cockcroft, J. R., McEniery, C. M., 
Protogerou, A. D., Roman, M.J., Safar, M.E., Segers, P., & Smulyan, H. (2009). Role 
of pulse pressure amplification in arterial hypertension experts’ opinion and review of 
the data. Hypertension, 54, 375-383. 
Bavikati, V. V., Sperling, L. S., Salmon, R. D., Faircloth, G. C., Gordon, T. L., Franklin, B. A., 
& Gordon, N. F. (2008). Effect of comprehensive therapeutic lifestyle changes on 
prehypertension. The American Journal of Cardiology, 102, 1677-1680. 
Benetos, A., Gautier, S., Labat, C., Salvi, P., Valbusa, F., Marino, F., Toulza, O., Agnoletti, 
D., Zamboni, M., Dubail, D., Manckoundia, P., Rolland, Y., Hanon, O., Perret-
Guillaume, C., Lacolley, P., Safar, M.E., & Guillemin, F. (2012). Mortality and 
cardiovascular events are best predicted by low central/peripheral pulse pressure 
amplification but not by high blood pressure levels in elderly nursing home subjects: 
the PARTAGE (Predictive Values of Blood Pressure and Arterial Stiffness in 
Institutionalized Very Aged Population) study. Journal of the American College of 
Cardiology, 60, 1503-1511. 
Benetos, A., Thomas, F., Joly, L., Blacher, J., Pannier, B., Labat, C., Salvi, P., Smulyan, H., 
& Safar, M. E. (2010). Pulse Pressure AmplificationA Mechanical Biomarker of 
Cardiovascular Risk. Journal of the American College of Cardiology, 55, 1032-1037. 
199 
 
Bennett, C. M., Guo, M., & Dharmage, S. C. (2007). HbA1c as a screening tool for detection 
of type 2 diabetes: a systematic review. Diabetic Medicine, 24, 333-343. 
Blake, G. J., Rifai, N., Buring, J. E., & Ridker, P. M. (2003). Blood pressure, C-reactive 
protein, and risk of future cardiovascular events. Circulation, 108, 2993-2999. 
Booysen, H.L., Woodiwiss, A. J., Moekanyi, J. S., Hodson, B., Raymond, A., Libhaber, E., 
Sareli, P., Norton, G. R. (2015) Indexes of aortic pressure augmentation markedly 
underestimates the contribution of reflected waves toward variations in aortic 
pressure and left ventricular mass. Hypertension, 65, 540-546. 
Booysen, H. L., Norton, G. R., Maseko, M. J., Libhaber, C. D., Majane, O. H., Sareli, P., & 
Woodiwiss, A. J. (2013). Aortic, but not brachial blood pressure category enhances 
the ability to identify target organ changes in normotensives. Journal of Hypertension, 
31, 1124-1130. 
Boutouyrie, P., Bussy, C., Lacolley, P., Girerd, X., Laloux, B., & Laurent, S. (1999). 
Association between local pulse pressure, mean blood pressure, and large-artery 
remodelling. Circulation, 100, 1387-1393. 
Burt, V. L., Cutler, J. A., Higgins, M., Horan, M. J., Labarthe, D., Whelton, P., Brown, C., & 
Roccella, E. J. (1995). Trends in the prevalence, awareness, treatment, and control 
of hypertension in the adult US population data from the health examination surveys, 
1960 to 1991. Hypertension, 26, 60-69. 
Butler, J., Kalogeropoulos, A. P., Georgiopoulou, V. V., Bibbins-Domingo, K., Najjar, S. S., 
Sutton-Tyrrell, K. C., Harris, T.B., Kritchevsky, S.B., Lloyd-Jones, D.M., Newman, 
A.B., & Psaty, B. M. (2011). Systolic blood pressure and incident heart failure in the 
elderly. The Cardiovascular Health Study and the Health, Ageing and Body 
Composition Study. Heart, hrt-2011. 
Camacho, F., Avolio, A., & Lovell, N. H. (2004). Estimation of pressure pulse amplification 
between aorta and brachial artery using stepwise multiple regression models. 
Physiological Measurement, 25, 879-889. 
200 
 
Cecelja, M., Jiang, B., McNeill, K., Kato, B., Ritter, J., Spector, T., & Chowienczyk, P. (2009). 
Increased Wave Reflection Rather Than Central Arterial Stiffness Is the Main 
Determinant of Raised Pulse Pressure in Women and Relates to Mismatch in Arterial 
Dimensions A Twin Study. Journal of the American College of Cardiology, 54, 695-
703. 
Cheng, K., Cameron, J. D., Tung, M., Mottram, P. M., Meredith, I. T., & Hope, S. A. (2012). 
Association of left ventricular motion and central augmentation index in healthy 
young men. Journal of Hypertension, 30, 2395-2402. 
Chirinos, J. A., Kips, J. G., Jacobs, D. R., Brumback, L., Duprez, D. A., Kronmal, R., 
Kronmal, R., Bluemke, D.A., Townsend, R.R., Vermeersch, S. & Segers, P. (2012). 
Arterial wave reflections and incident cardiovascular events and heart failure: MESA 
(Multi-ethnic Study of Atherosclerosis). Journal of the American College of 
Cardiology, 60, 2170-2177. 
Chirinos, J. A., Zambrano, J. P., Chakko, S., Veerani, A., Schob, A., Perez, G., & Mendez, 
A. J. (2005a). Relation between ascending aortic pressures and outcomes in patients 
with angiographically demonstrated coronary artery disease. The American Journal 
of Cardiology, 96, 645-648.  
Chirinos, J.A., Segers, P., De Buyzere, M.L., Kronmal, R.A., Raja, M.W., De Bacquer, D., 
Claessens, T., Gillebert, T.C., St John-Sutton, M., and Rietzschel, E.R. (2010). Left 
ventricular mass: allometric scaling, normative values, effect of obesity, and 
prognostic performance. Hypertension, 56, 91-98. 
Chirinos, J. A., Zambrano, J. P., Chakko, S., Veerani, A., Schob, A., Willens, H. J., Perez, 
G., & Mendez, A. J. (2005b). Aortic pressure augmentation predicts adverse 
cardiovascular events in patients with established coronary artery disease. 
Hypertension, 45, 980-985.  
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo Jr, J. L., 
Jones, D.W., Materson, B.J., Oparil, S., Wright, J.T. Jr, Roccella, E.J.; National 
Heart, Lung & Blood Institute Joint National Committee on Prevention, Detection, 
201 
 
Evaluation, and Treatment of High Blood Pressure & National High Blood Pressure 
Education Program Coordinating Committee. (2003). The seventh report of the joint 
national committee on prevention, detection, evaluation, and treatment of high blood 
pressure: the JNC 7 report. The Journal of the American Medical Association, 289, 
2560-2571. 
Chrysohoou, C., Pitsavos, C., Panagiotakos, D. B., Skoumas, J., & Stefanadis, C. (2004). 
Association between prehypertension status and inflammatory markers related to 
atherosclerotic disease* The ATTICA Study. American Journal of Hypertension, 17, 
568-573. 
Conen, D., Ridker, P. M., Buring, J. E., & Glynn, R. J. (2007). Risk of cardiovascular events 
among women with high normal blood pressure or blood pressure progression: 
prospective cohort study. British Medical Journal, 335, 432. 
Connor, M. D., Modi, G., & Warlow, C. P. (2009). Differences in the nature of stroke in a 
multiethnic urban South African population the Johannesburg hospital stroke register. 
Stroke, 40, 355-362. 
Cook, N. R., Cutler, J. A., Obarzanek, E., Buring, J. E., Rexrode, K. M., Kumanyika, S. K., 
Appel, L.J., & Whelton, P. K. (2007). Long term effects of dietary sodium reduction on 
cardiovascular disease outcomes: observational follow-up of the trials of 
hypertension prevention (TOHP). British Medical Journal, 334, 885. 
Cooper, L. L., Rong, J., Benjamin, E. J., Larson, M. G., Levy, D., Vita, J. A., Hamburg, N.M., 
Vasan, R.S., & Mitchell, G. F. (2014). Components of Hemodynamic Load and 
Cardiovascular Events: The Framingham Heart Study. Circulation, 
CIRCULATIONAHA-114. 
Cooper-DeHoff, R. M., Gong, Y., Handberg, E. M., Bavry, A. A., Denardo, S. J., Bakris, G. 
L., & Pepine, C. J. (2010). Tight blood pressure control and cardiovascular outcomes 
among hypertensive patients with diabetes and coronary artery disease. The Journal 
of the American Medical Association, 304, 61-68. 
202 
 
Covic, A., Goldsmith, D. J., Panaghiu, L., Covic, M., & Sedor, J. (2000). Analysis of the effect 
of hemodialysis on peripheral and central arterial pressure waveforms. Kidney 
International, 57, 2634-2643. 
Cushman, W. C., Evans, G. W., Byington, R. P., Goff Jr, D. C., Grimm Jr, R. H., Cutler, J. A., 
Cutler, J.A., Simons-Morton, D.G., Basile, J.N., Corson, M.A., Probstfield, J.L., Katz, 
L., Peterson, K.A., Friedewald, W.T., Buse, J.B., Bigger, J.T., Gerstein, H.C., Ismail-
Beigi, F., & ACCORD Study Group. (2010). Effects of intensive blood-pressure 
control in type 2 diabetes mellitus. The New England Journal of Medicine, 362, 1563-
1574. 
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, 
F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., Lindholm, L.H., Nieminen, 
M.S., Omvik, P., Oparil, S., & Wedel, H. (2002). Cardiovascular morbidity and 
mortality in the Losartan Intervention For Endpoint reduction in hypertension study 
(LIFE): a randomised trial against atenolol. The Lancet, 359, 995-1003. 
Dart, A. M., Gatzka, C. D., Kingwell, B. A., Willson, K., Cameron, J. D., Liang, Y. L., Berry, 
K.L., Wing, L.M., Reid, C.M., Ryan, P., Beilin, L.J., Jennings, G.L., Johnston, C.I., 
McNeil, J.J.,Macdonald, G.J., Morgan, T.O., & West, M. J. (2006). Brachial blood 
pressure but not carotid arterial waveforms predict cardiovascular events in elderly 
female hypertensives. Hypertension, 47, 785-790. 
Davies, J. E., Baksi, J., Francis, D. P., Hadjiloizou, N., Whinnett, Z. I., Manisty, C. H., 
Aguado-Sierra, J., Foale, R.A., Malik, I.S., Tyberg, J.V., Parker, K.H., Mayet, J. & 
Hughes, A. D. (2010). The arterial reservoir pressure increases with aging and is the 
major determinant of the aortic augmentation index. American Journal of Physiology-
Heart and Circulatory Physiology, 298, H580-H586. 
de Simone, G., Devereux, R. B., Ganau, A., Hahn, R. T., Saba, P. S., Mureddu, G. F., 
Roman, M.J., & Howard, B. V. (1996). Estimation of left ventricular chamber and 
stroke volume by limited M-mode echocardiography and validation by two-
203 
 
dimensional and Doppler echocardiography. The American Journal of Cardiology, 78, 
801-807. 
de Simone, G., Izzo, R., De Luca, N., & Gerdts, E. (2013). Left ventricular geometry in 
obesity: Is it what we expect? Nutrition, Metabolism and Cardiovascular Diseases, 
23, 905-912. 
Devereux, R. B., Alonso, D. R., Lutas, E. M., Gottlieb, G. J., Campo, E., Sachs, I., & 
Reichek, N. (1986). Echocardiographic assessment of left ventricular hypertrophy: 
comparison to necropsy findings. The American Journal of Cardiology, 57, 450-458. 
Djami-Tchatchou, A.T., Norton, G.R., Raymond, A., Booysen, H.L., Hodson, B., Libhaber, E., 
Sareli, P., and Woodiwiss, A.J. (2015). Intrafamilial Aggregation and Heritability of 
Aortic Reflected (Backward) Waves Derived From Wave Separation Analysis. 
American Journal of Hypertension, (Epub ahead of print). 
Dorjgochoo, T., Shu, X. O., Zhang, X., Li, H., Yang, G., Gao, L., Cai, H. Gao, Y.T., & Zheng, 
W. (2009). Relation of blood pressure components and categories and all-cause, 
stroke and coronary heart disease mortality in urban Chinese women: a population-
based prospective study. Journal of Hypertension, 27, 468-475. 
Drzewiecki, G.M., Melbin, J., Noordergraaf, A. (1983). Aarterial tonometry: review and 
analysis. Journal of Biomechanics, 16, 141-152. 
Fok, H., Guilcher, A., Li, Y., Brett, S., Shah, A., Clapp, B., & Chowienczyk, P. (2014). 
Augmentation Pressure Is Influenced by Ventricular Contractility/Relaxation 
Dynamics Novel Mechanism of Reduction of Pulse Pressure by Nitrates. 
Hypertension, 63, 1050-1055. 
Franklin, S. S., Gustin, W., Wong, N. D., Larson, M. G., Weber, M. A., Kannel, W. B., & 
Levy, D. (1997). Hemodynamic patterns of age-related changes in blood pressure 
The Framingham Heart Study. Circulation, 96, 308-315. 
Fukuhara, M., Arima, H., Ninomiya, T., Hata, J., Yonemoto, K., Doi, Y., Hirakawa, Y., 
Matsumura, K., Kitazono, T., & Kiyohara, Y. (2012). Impact of lower range of 
204 
 
prehypertension on cardiovascular events in a general population: the Hisayama 
Study. Journal of Hypertension, 30, 893-900. 
Greenlund, K. J., Croft, J. B., & Mensah, G. A. (2004). Prevalence of heart disease and 
stroke risk factors in persons with prehypertension in the United States, 1999-2000. 
Archives of Internal Medicine, 164, 2113-2118. 
Grotto, I., Grossman, E., Huerta, M., & Sharabi, Y. (2006). Prevalence of prehypertension 
and associated cardiovascular risk profiles among young Israeli adults. Hypertension, 
48, 254-259. 
Gu, D., Chen, J., Wu, X., Duan, X., Jones, D. W., Huang, J. F., Chen, C.S., Chen, J.C., 
Kelly, T.N., Whelton, P.K., & He, J. (2009). Prehypertension and risk of 
cardiovascular disease in Chinese adults. Journal of Hypertension, 27, 721-729. 
Hashimoto, J., Imai, Y., & O'Rourke, M. F. (2007). Indices of pulse wave analysis are better 
predictors of left ventricular mass reduction than cuff pressure. American Journal of 
Hypertension, 20, 378-384. 
Hashimoto, J., Watabe, D., Hatanaka, R., Hanasawa, T., Metoki, H., Asayama, K., Ohkubo, 
T., Totsune, K., & Imai, Y. (2006). Enhanced Radial Late Systolic Pressure 
Augmentation in Hypertensive Patients With Left Ventricular Hypertrophy*. American 
Journal of Hypertension, 19, 27-32. 
Hope, S. A., Meredith, I. T., & Cameron, J. D. (2008). Arterial transfer functions and the 
reconstruction of central aortic waveforms: myths, controversies and misconceptions. 
Journal of Hypertension, 26, 4-7. 
Hope, S. A., Tay, D. B., Meredith, I. T., & Cameron, J. D. (2002). Comparison of generalized 
and gender-specific transfer functions for the derivation of aortic waveforms. 
American Journal of Physiology-Heart and Circulatory Physiology, 283, H1150-
H1156. 
Hope, S. A., Tay, D. B., Meredith, I. T., & Cameron, J. D. (2004). Use of arterial transfer 
functions for the derivation of central aortic waveform characteristics in subjects with 
type 2 diabetes and cardiovascular disease. Diabetes care, 27, 746-751. 
205 
 
Hsia, J., Margolis, K. L., Eaton, C. B., Wenger, N. K., Allison, M., Wu, L., LaCroix A.Z., & 
Black, H. R. (2007). Prehypertension and cardiovascular disease risk in the Women’s 
Health Initiative. Circulation, 115, 855-860. 
Hughes, A. D., Park, C., Davies, J., Francis, D., Thom, S. A. M., Mayet, J., & Parker, K. H. 
(2013). Limitations of augmentation index in the assessment of wave reflection in 
normotensive healthy individuals. PloS one, 8, e59371. 
Jankowski, P., Kawecka-Jaszcz, K., Czarnecka, D., Brzozowska-Kiszka, M., Styczkiewicz, 
K., Loster, M., Kloch-Badełek, M., Wiliński, J., Curyło, A.M., & Dudek, D. (2008). 
Pulsatile but not steady component of blood pressure predicts cardiovascular events 
in coronary patients. Hypertension, 51, 848-855. 
Julius, S., Nesbitt, S. D., Egan, B. M., Weber, M. A., Michelson, E. L., Kaciroti, N., Black, 
H.R., Grimm, R.H. Jr, Messerli, F.H., Oparil, S., & Schork, M. A. (2006). Feasibility of 
treating prehypertension with an angiotensin-receptor blocker. New England Journal 
of Medicine, 354, 1685-1697. 
Kannel, W. B., Gordon, T., & Schwartz, M. J. (1971). Systolic versus diastolic blood pressure 
and risk of coronary heart disease: the Framingham study. The American Journal of 
Cardiology, 27, 335-346. 
Khoshdel, A. R. (2007). Time to end a doubt: is pulse wave analysis a valid measure for 
central arterial blood pressure and arterial stiffness? Journal of Hypertension, 25, 
724-725. 
Kim, B. J., Lee, H. A., Kim, N. H., Kim, M. W., Kim, B. S., & Kang, J. H. (2011). The 
association of albuminuria, arterial stiffness, and blood pressure status in 
nondiabetic, nonhypertensive individuals. Journal of Hypertension, 29, 2091-2098. 
King, D. E., Egan, B. M., Mainous, A. G., & Geesey, M. E. (2004). Elevation of C‐Reactive 
Protein in People With Prehypertension. The Journal of Clinical Hypertension, 6, 562-
568. 
Kips, J. G., Rietzschel, E. R., De Buyzere, M. L., Westerhof, B. E., Gillebert, T. C., Van 
Bortel, L. M., & Segers, P. (2009). Evaluation of noninvasive methods to assess 
206 
 
wave reflection and pulse transit time from the pressure waveform alone. 
Hypertension, 53, 142-149. 
Kjeldsen, S., Feldman, R. D., Lisheng, L., Mourad, J. J., Chiang, C. E., Zhang, W., Wu, Z., 
Li, W., & Williams, B. (2014). Updated National and International Hypertension 
Guidelines: A Review of Current Recommendations. Drugs, 74, 2033-2051. 
Kshirsagar, A. V., Carpenter, M., Bang, H., Wyatt, S. B., & Colindres, R. E. (2006). Blood 
pressure usually considered normal is associated with an elevated risk of 
cardiovascular disease. The American Journal of Medicine, 119, 133-141. 
Laurent, S., Cockcroft, J., Van Bortel, L., Boutouyrie, P., Giannattasio, C., Hayoz, D., 
Pannier, B., Vlachopoulos, C., Wilkinson, I., & Struijker-Boudier, H. (2006). Expert 
consensus document on arterial stiffness: methodological issues and clinical 
applications. European Heart Journal, 27, 2588-2605. 
Law, M. R., Morris, J. K., & Wald, N. J. (2009). Use of blood pressure lowering drugs in the 
prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the 
context of expectations from prospective epidemiological studies. British Medical 
Journal, 338: b1665. 
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., & Roth, D. (1999). A more 
accurate method to estimate glomerular filtration rate from serum creatinine: a new 
prediction equation. Annals of Internal Medicine, 130, 461-470. 
Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R.J., 
Perrone, R.D., Lau, J., & Eknoyan, G. (2003). National Kidney Foundation practice 
guidelines for chronic kidney disease: evaluation, classification, and stratification. 
Annals of Internal Medicine, 139, 137-147. 
Lewington, P. S. C. (2002). S. & Clarke, R. & Qizilbash, N. & Peto, R. & Collins, R.," Age-
specific relevance of usual blood pressure to vascular mortality: a meta-analysis of 
individual data for one million adults in 61 prospective studies. Lancet, 360, 1903-
1913. 
207 
 
Libhaber, E., Woodiwiss, A.J., Raymond, A., Gomes, M., Maseko, M.J., Sareli, P., and 
Norton, G.R. (2015). Independent associations of circulating galectin-3 
concentrations with aortic pulse wave velocity and wave reflection in a community 
sample. Hypertension, 65, 1356-1364. 
Liszka, H. A., Mainous, A. G., King, D. E., Everett, C. J., & Egan, B. M. (2005). 
Prehypertension and cardiovascular morbidity. The Annals of Family Medicine, 3, 
294-299. 
London, G. M., Blacher, J., Pannier, B., Guérin, A. P., Marchais, S. J., & Safar, M. E. (2001). 
Arterial wave reflections and survival in end-stage renal failure. Hypertension, 38, 
434-438. 
Lüders, S., Schrader, J., Berger, J., Unger, T., Zidek, W., Böhm, M., Middeke, M., Motz, W., 
Lübcke, C., Gansz, A., Brokamp, L., Schmieder, R.E., Trenkwalder, P., Haller, 
H.,Dominiak, P.,  & PHARAO Study Group. (2008). The PHARAO study: prevention 
of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients 
with high-normal blood pressure–a prospective, randomized, controlled prevention 
trial of the German Hypertension League. Journal of Hypertension, 26, 1487-1496. 
Mackenzie, J. (1902). The study of the pulse, arterial, venous, and hepatic, and of the 
movements of the heart. YJ Pentland. 
Mahieu, D., Kips, J., Rietzschel, E. R., De Buyzere, M. L., Verbeke, F., Gillebert, T. C., De 
Backer, G.G., De Bacquer, D., Verdonck, P., Van Bortel, L.M., & Segers, P. (2010). 
Noninvasive assessment of central and peripheral arterial pressure (waveforms): 
implications of calibration methods. Journal of Hypertension, 28, 300-305. 
Mainous III, A. G., Everett, C. J., Liszka, H., King, D. E., & Egan, B. M. (2004). 
Prehypertension and mortality in a nationally representative cohort. The American 
Journal of Cardiology, 94, 1496-1500. 
Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G.,  Grassi, 
G., Heagerty, A.M., Kjeldsen, S.E., Laurent, S., Narkiewicz, K., Ruilope, 
L.,Rynkiewicz, A., Schmieder, R.E., Struijker Boudier, H.A., Zanchetti, A., Vahanian, 
208 
 
A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-
Brentano, C.,Hellemans, I., Kristensen, S.D., McGregor, K., Sechtem, U., Silber, S., 
Tendera, M., Widimsky, P., Zamorano, J.L., Kjeldsen, S.E., Erdine, S., Narkiewicz, 
K., Kiowski, W., Agabiti-Rosei, E., Ambrosioni, E., Cifkova, R., Dominiczak, A., 
Fagard, R., Heagerty, A.M., Laurent, S., Lindholm, L.H., Mancia, G., Manolis, A., 
Nilsson, P.M., Redon, J., Schmieder, R.E., Struijker-Boudier, H.A., Viigimaa, M., 
Filippatos, G., Adamopoulos, S., Agabiti-Rosei, E., Ambrosioni, E., Bertomeu, V., 
Clement, D., Erdine, S., Farsang, C., Gaita, D., Kiowski, W., Lip, G., Mallion, J.M., 
Manolis, A.J., Nilsson, P.M., & O'Brien, E. (2007). 2007 Guidelines for the 
management of arterial hypertension The Task Force for the Management of Arterial 
Hypertension of the European Society of Hypertension (ESH) and of the European 
Society of Cardiology (ESC). European Heart Journal, 28, 1462-1536. 
Manios, E., Michas, F., Tsivgoulis, G., Stamatelopoulos, K., Tsagalis, G., Koroboki, E., 
Alexaki, E., Papamichael, C., Vemmos, K., & Zakopoulos, N. (2011). Impact of 
prehypertension on carotid artery intima–media thickening: Actual or masked? 
Atherosclerosis, 214, 215-219. 
Marey, E. J. (1863). Physiologie médicale de la circulation du sang. Delahaye. 
McEniery, C. M., Hall, I. R., Qasem, A., Wilkinson, I. B., & Cockcroft, J. R. (2005). Normal 
Vascular Aging: Differential Effects on Wave Reflection and Aortic Pulse Wave 
Velocity The Anglo-Cardiff Collaborative Trial (ACCT). Journal of the American 
College of Cardiology, 46, 1753-1760. 
McEniery, C. M., McDonnell, B., Munnery, M., Wallace, S. M., Rowe, C. V., Cockcroft, J. R., 
& Wilkinson, I. B. (2008). Central pressure: variability and impact of cardiovascular 
risk factors the Anglo-Cardiff Collaborative Trial II. Hypertension, 51, 1476-1482. 
McMurray, J.J., Holman, R.R., Haffner, S.M., Bethel, M.A., Holzhauer, B., Hua, T.A., 
Belenkov, Y., Boolell, M., Buse, J.B., Buckley, B.M., Chacra, A.R., Chiang, F.T., 
Charbonnel, B., Chow, C.C., Davies, M.J., Deedwania, P., Diem, P., Einhorn, D., 
Fonseca, V., Fulcher, G.R., Gaciong, Z., Gaztambide, S., Giles, T., Horton, E., 
209 
 
Ilkova, H., Jenssen, T., Kahn, S.E., Krum, H., Laakso, M., Leiter, L.A., Levitt, N.S., 
Mareev, V., Martinez, F., Masson, C., Mazzone, T., Meaney, E., Nesto, R., Pan, C., 
Prager, R., Raptis, S.A.,Rutten, G.E., Sandstroem, H., Schaper, F., Scheen, A., 
Schmitz, O., Sinay, I., Soska, V., Stender, S., Tamás, G., Tognoni, G., Tuomilehto, 
J., Villamil, A.S., Vozár, J., Califf, R.M. (2010). Effect of valsartan on the incidence of 
diabetes and cardiovascular events. New England Journal of Medicine, 362, 1477-
1490. 
Mendis, S., Lindholm, L. H., Mancia, G., Whitworth, J., Alderman, M., Lim, S., & Heagerty, T. 
(2007). World Health Organization (WHO) and International Society of Hypertension 
(ISH) risk prediction charts: assessment of cardiovascular risk for prevention and 
control of cardiovascular disease in low and middle-income countries. Journal of 
Hypertension, 25, 1578-1582. 
Mitchell, G. F. (2006). Triangulating the peaks of arterial pressure. Hypertension, 48, 543-
545. 
Mitchell, G. F., Hwang, S. J., Vasan, R. S., Larson, M. G., Pencina, M. J., Hamburg, N. M., 
Vita, J.A., Levy, D., & Benjamin, E. J. (2010a). Arterial stiffness and cardiovascular 
events the Framingham Heart Study. Circulation, 121, 505-511.  
Mitchell, G. F., Lacourcière, Y., Ouellet, J. P., Izzo, J. L., Neutel, J., Kerwin, L. J., Block, A.J., 
& Pfeffer, M. A. (2003). Determinants of elevated pulse pressure in middle-aged and 
older subjects with uncomplicated systolic hypertension the role of proximal aortic 
diameter and the aortic pressure-flow relationship. Circulation, 108, 1592-1598. 
Mitchell, G. F., Wang, N., Palmisano, J. N., Larson, M. G., Hamburg, N. M., Vita, J. A., Levy, 
D., Benjamin, E.J., & Vasan, R. S. (2010b). Hemodynamic correlates of blood 
pressure across the adult age spectrum noninvasive evaluation in the Framingham 
Heart Study. Circulation, 122, 1379-1386.  
Moreira, L. B., Fuchs, S. C., Wiehe, M., Gus, M., Moraes, R. S., & Fuchs, F. D. (2008). 
Incidence of hypertension in Porto Alegre, Brazil: a population-based study. Journal 
of Human Hypertension, 22, 48-50. 
210 
 
Namasivayam, M., McDonnell, B. J., McEniery, C. M., & O'Rourke, M. F. (2009). Does wave 
reflection dominate age-related change in aortic blood pressure across the human 
life span?. Hypertension, 53, 979-985. 
Neisius, U., Bilo, G., Taurino, C., McClure, J. D., Schneider, M. P., Kawecka-Jaszcz, K., 
Stolarz-Skrzypek, K., Klima, Ł., Staessen, J.A., Kuznetsova, T., Redon, J., Martinez, 
F., Rosei, E.A., Muiesan, M.L., Melander, O., Zannad, F., Rossignol, P., Laurent, S., 
Collin, C., Lonati, L., Zanchetti, A., Dominiczak, A.F., & Delles, C. (2012). Association 
of central and peripheral pulse pressure with intermediate cardiovascular 
phenotypes. Journal of Hypertension, 30, 67-74. 
Nichols, W., O'Rourke, M., & Vlachopoulos, C. (Eds.). (2011). McDonald's blood flow in 
arteries: theoretical, experimental and clinical principles. CRC Press. 
Nissen, S. E., Tuzcu, E. M., Libby, P., Thompson, P. D., Ghali, M., Garza, D., Berman, L., 
Shi, H., Buebendorf, E., Topol, E.J., & Camelot Investigators. (2004). Effect of 
antihypertensive agents on cardiovascular events in patients with coronary disease 
and normal blood pressure: the CAMELOT study: a randomized controlled trial. The 
Journal of the American Medical Association, 292, 2217-2225. 
Norton, G. R., Majane, O. H., Maseko, M. J., Libhaber, C., Redelinghuys, M., Kruger, D., 
Veller, M., Sareli, P., & Woodiwiss, A. J. (2012). Brachial Blood Pressure–
Independent Relations Between Radial Late Systolic Shoulder-Derived Aortic 
Pressures and Target Organ Changes. Hypertension, 59, 885-892. 
Norton, G. R., Maseko, M., Libhaber, E., Libhaber, C. D., Majane, O. H., Dessein, P., Sareli, 
P., & Woodiwiss, A. J. (2008). Is prehypertension an independent predictor of target 
organ changes in young-to-middle-aged persons of African descent? Journal of 
Hypertension, 26, 2279-2287. 
O'Donnell, M. J., Xavier, D., Liu, L., Zhang, H., Chin, S. L., Rao-Melacini, P., Rangarajan, S., 
Islam, S., Pais, P., McQueen, M.J., Mondo, C., Damasceno, A., Lopez-Jaramillo, P., 
Hankey, G.J., Dans, A.L., Yusoff, K., Truelsen, T., Diener, H.C., Sacco, R.L., 
Ryglewicz, D., Czlonkowska, A., Weimar, C., Wang, X., & Yusuf, S. (2010). Risk 
211 
 
factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the 
INTERSTROKE study): a case-control study. The Lancet, 376, 112-123.  
O'Rourke, M. F. (1970). Arterial hemodynamics in hypertension. Circulation Research, 27, 
Suppl-2:123-133. 
O’Rourke, M.F., Safar, M.E., & Roman, M.J. (2010). Letter by O’Rourke et regarding article, 
‘’Arterial stiffness and cardiovascular events: the Framingham Heart Study’’. 
Circulation, 122, e512. 
Osler, W. (1898). The Principles and Practice of Medicine. 1197 pp. New York: D. Appleton 
& Company, 490. 
Patel, A. (2007). Effects of a fixed combination of perindopril and indapamide on 
macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus 
(the ADVANCE trial): a randomised controlled trial. The Lancet, 370, 829-840. 
Pednekar, M. S., Gupta, R., & Gupta, P. C. (2009). Association of blood pressure and 
cardiovascular mortality in India: Mumbai cohort study. American Journal of 
Hypertension, 22, 1076-1084. 
Pini, R., Cavallini, M. C., Palmieri, V., Marchionni, N., Di Bari, M., Devereux, R. B., Masotti, 
G., & Roman, M. J. (2008). Central But Not Brachial Blood Pressure Predicts 
Cardiovascular Events in an Unselected Geriatric Population The ICARe Dicomano 
Study. Journal of the American College of Cardiology, 51, 2432-2439. 
Qureshi, A. I., Suri, M. F. K., Kirmani, J. F., Divani, A. A., & Mohammad, Y. (2005). Is 
prehypertension a risk factor for cardiovascular diseases? Stroke, 36, 1859-1863. 
Rayner, B. (2010). Hypertension: detection and management in South Africa. Nephron 
Clinical Practice, 116, c269-c273. 
Redelinghuys, M., Norton, G. R., Scott, L., Maseko, M. J., Brooksbank, R., Majane, O. H., 
Sareli, P., & Woodiwiss, A. J. (2010). Relationship between urinary salt excretion and 
pulse pressure and central aortic hemodynamics independent of steady state 
pressure in the general population. Hypertension, 56, 584-590. 
212 
 
Regnault, V., Thomas, F., Safar, M. E., Osborne-Pellegrin, M., Khalil, R. A., Pannier, B., & 
Lacolley, P. (2012). Sex Difference in Cardiovascular Risk Role of Pulse Pressure 
Amplification. Journal of the American College of Cardiology, 59, 1771-1777. 
Remme, W. J., Deckers, J. W., Fox, K. M., Ferrari, R., Bertrand, M., & Simoons, M. L. 
(2009). Secondary Prevention of Coronary Disease with ACE Inhibition-does Blood 
Pressure Reduction with Perindopril Explain the Benefits in EUROPA? 
Cardiovascular Drugs and Therapy, 23, 161-170. 
Roman, M. J., & Devereux, R. B. (2014). Association of Central and Peripheral Blood 
Pressures With Intermediate Cardiovascular Phenotypes. Hypertension, 63, 1148-
1153. 
Roman, M. J., Devereux, R. B., Kizer, J. R., Lee, E. T., Galloway, J. M., Ali, T., Umans, J.G., 
& Howard, B. V. (2007). Central pressure more strongly relates to vascular disease 
and outcome than does brachial pressure the strong heart study. Hypertension, 50, 
197-203. 
Roman, M. J., Devereux, R. B., Kizer, J. R., Okin, P. M., Lee, E. T., Wang, W., Umans, J.G., 
Calhound, D., & Howard, B. V. (2009). High Central Pulse Pressure Is Independently 
Associated With Adverse Cardiovascular Outcome The Strong Heart Study. Journal 
of the American College of Cardiology, 54, 1730-1734. 
Roman, M. J., Okin, P. M., Kizer, J. R., Lee, E. T., Howard, B. V., & Devereux, R. B. (2010). 
Relations of central and brachial blood pressure to left ventricular hypertrophy and 
geometry: the Strong Heart Study. Journal of Hypertension, 28, 384-388. 
Safar, M. E., Blacher, J., Pannier, B., Guerin, A. P., Marchais, S. J., Guyonvarc’h, P. M., & 
London, G. M. (2002). Central pulse pressure and mortality in end-stage renal 
disease. Hypertension, 39, 735-738. 
Sahn, D. J. (1978). The Committee on M-mode standardization of the American Society of 
Echocardiography. Recommendations regarding quantitation in M-mode 
echocardiography: results of a survey of echocardiographic measurements. 
Circulation, 58, 1072-1083. 
213 
 
Schrier, R. W., Estacio, R. O., Esler, A., & Mehler, P. (2002). Effects of aggressive blood 
pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy 
and strokes. Kidney International, 61, 1086-1097. 
Schultz, M. G., Davies, J. E., Roberts-Thomson, P., Black, J. A., Hughes, A. D., & Sharman, 
J. E. (2013). Exercise central (aortic) blood pressure is predominantly driven by 
forward traveling waves, not wave reflection. Hypertension, 62, 175-182. 
Segers, P., Rietzschel, E. R., De Buyzere, M. L., Vermeersch, S. J., De Bacquer, D., Van 
Bortel, L. M., De Backer, G., Gillebert, T.C., & Verdonck, P. R. (2007). Noninvasive 
(input) impedance, pulse wave velocity, and wave reflection in healthy middle-aged 
men and women. Hypertension, 49, 1248-1255. 
Segers, P., Taelman, L., Degroote, J., Bols, J., & Vierendeels, J. (2015). The aortic 
reservoir-wave as a paradigm for arterial haemodynamics: insights from three-
dimensional fluid-structure interaction simulations in a model of aortic coarctation. 
Journal of Hypertension, 33, 554-563. 
Sehestedt, T., Jeppesen, J., Hansen, T. W., Rasmussen, S., Wachtell, K., Ibsen, H., Torp-
Pedersen, C., & Olsen, M. H. (2009). Risk stratification with the risk chart from the 
European Society of Hypertension compared with SCORE in the general population. 
Journal of Hypertension, 27, 2351-2357. 
Sehestedt, T., Jeppesen, J., Hansen, T. W., Wachtell, K., Ibsen, H., Torp-Petersen, C., 
Hildebrandt, P., & Olsen, M. H. (2010). Risk prediction is improved by adding 
markers of subclinical organ damage to SCORE. European Heart Journal, 31, 883-
891. 
Shiburi, C. P., Staessen, J. A., Maseko, M., Wojciechowska, W., Thijs, L., Van Bortel, L. M., 
Woodiwiss, A.J., & Norton, G. R. (2006). Reference Values for SphygmoCor 
Measurements in South Africans of African Ancestry. American Journal of 
Hypertension, 19, 40-46. 
214 
 
Shimbo, D., Newman, J. D., & Schwartz, J. E. (2012). Masked hypertension and 
prehypertension: diagnostic overlap and interrelationships with left ventricular mass: 
the Masked Hypertension Study. American Journal of Hypertension, 25, 664-671. 
Sibiya, M. J., Norton, G. R., Hodson, B., Redelinghuys, M., Maseko, M. J., Majane, O. H. I., 
Libhaber, E., & Woodiwiss, A. J. (2014). Gender-specific contribution of aortic 
augmentation index to variations in left ventricular mass index in a community 
sample of African ancestry. Hypertension Research, 37, 1021-1027. 
Simkus, G. J., & Fitchett, D. H. (1990). Radial arterial pressure measurements may be a 
poor guide to the beneficial effects of nitroprusside on left ventricular systolic 
pressure in congestive heart failure. The American Journal of Cardiology, 66, 323-
326. 
Staessen, J. A., & Jiguang, W. (2001). Randomised trial of a perindopril-based blood-
pressure-lowering regimen among 6105 individuals with previous stroke or transient 
ischaemic attack. Commentary. Lancet, 358, 1033-1041. 
Stewart, S., Wilkinson, D., Hansen, C., Vaghela, V., Mvungi, R., McMurray, J., & Sliwa, K. 
(2008). Predominance of Heart Failure in the Heart of Soweto Study Cohort 
Emerging Challenges for Urban African Communities. Circulation, 118, 2360-2367. 
Steyn, K., Sliwa, K., Hawken, S., Commerford, P., Onen, C., Damasceno, A., Ounpuu, S., & 
Yusuf, S. (2005). Risk Factors Associated With Myocardial Infarction in Africa The 
INTERHEART Africa Study. Circulation, 112, 3554-3561. 
Takazawa, K., Tanaka, N., Takeda, K., Kurosu, F., & Ibukiyama, C. (1995). Underestimation 
of vasodilator effects of nitroglycerin by upper limb blood pressure. Hypertension, 26, 
520-523. 
Tollman, S. M., Kahn, K., Sartorius, B., Collinson, M. A., Clark, S. J., & Garenne, M. L. 
(2008). Implications of mortality transition for primary health care in rural South 
Africa: a population-based surveillance study. The Lancet, 372, 893-901. 
Torjesen, A. A., Wang, N., Larson, M. G., Hamburg, N. M., Vita, J. A., Levy, D., Benjamin, 
E.J., Vasan, R.S., & Mitchell, G. F. (2014). Forward and Backward Wave Morphology 
215 
 
and Central Pressure Augmentation in Men and Women in the Framingham Heart 
Study. Hypertension, HYPERTENSIONAHA-114. 
Trialists’ Collaboration, B. P. L. T. (2003). Effects of different blood-pressure-lowering 
regimens on major cardiovascular events: results of prospectively-designed 
overviews of randomised trials. Lancet, 362, 1527-1535. 
Ueda, H., Hayashi, T., Tsumura, K., Yoshimaru, K., Nakayama, Y., & Yoshikawa, J. (2004). 
The timing of the reflected wave in the ascending aortic pressure predicts restenosis 
after coronary stent placement. Hypertension Research: Official Journal of the 
Japanese Society of Hypertension, 27, 535-540. 
US National Health Survey 1977: US National Health Survey. Washington, DC: Public 
Health Services, National Institutes of Health, US Department of Health and Human 
Services. 
Van Bortel, L. M., Laurent, S., Boutouyrie, P., Chowienczyk, P., Cruickshank, J. K., De 
Backer, T., Filipovsky, J., Huybrechts, S., Mattace-Raso, F.U., Protogerou, A.D., 
Schillaci, G., Segers, P., Vermeersch, S., & Weber, T. (2012). Expert consensus 
document on the measurement of aortic stiffness in daily practice using carotid-
femoral pulse wave velocity. Journal of Hypertension, 30, 445-448. 
Vasan, R. S., Larson, M. G., Leip, E. P., Evans, J. C., O'Donnell, C. J., Kannel, W. B., & 
Levy, D. (2001). Impact of high-normal blood pressure on the risk of cardiovascular 
disease. New England Journal of Medicine, 345, 1291-1297. 
Ventura, H. O., Mehra, M. R., & Messerli, F. H. (2001). Desperate diseases, desperate 
measures: tackling malignant hypertension in the 1950s. American Heart Journal, 
142, 197-203. 
Verbeke, F., Segers, P., Heireman, S., Vanholder, R., Verdonck, P., & Van Bortel, L.M. 
(2005). Noninvasive assessment of local pulse pressure: importance of brachial-to-
radial pressure amplification. Hypertension, 46, 244-248. 
Vlachopoulos, C., & O’Rourke, M. (2000). Diastolic pressure, systolic pressure, or pulse 
pressure? Current hypertension reports, 2, 271-279. 
216 
 
Vlachopoulos, C., Aznaouridis, K., O'Rourke, M. F., Safar, M. E., Baou, K., & Stefanadis, C. 
(2010). Prediction of cardiovascular events and all-cause mortality with central 
haemodynamics: a systematic review and meta-analysis. European Heart Journal, 
31, 1865-1871. 
Vlachopoulos, C., Dima, I., Aznaouridis, K., Vasiliadou, C., Ioakeimidis, N., Aggeli, C., 
Toutouza, M., & Stefanadis, C. (2005). Acute systemic inflammation increases 
arterial stiffness and decreases wave reflections in healthy individuals. Circulation, 
112, 2193-2200. 
Wang, K. L., Cheng, H. M., Chuang, S. Y., Spurgeon, H. A., Ting, C. T., Lakatta, E. G., Yin, 
F.C., Chou, P., & Chen, C. H. (2009). Central or peripheral systolic or pulse pressure: 
which best relates to target-organs and future mortality? Journal of Hypertension, 27, 
461-467. 
Wang, K. L., Cheng, H. M., Sung, S. H., Chuang, S. Y., Li, C. H., Spurgeon, H. A., Ting, 
C.T., Najjar, S.S., Lakatta, E.G., Yin, F.C., Chou, P., & Chen, C. H. (2010). Wave 
Reflection and Arterial Stiffness in the Prediction of 15-Year All-Cause and 
Cardiovascular Mortalities A Community-Based Study. Hypertension, 55, 799-805. 
Weber, T., Auer, J., O’Rourke, M. F., Punzengruber, C., Kvas, E., & Eber, B. (2006). 
Prolonged mechanical systole and increased arterial wave reflections in diastolic 
dysfunction. Heart, 92, 1616-1622. 
Weber, T., Auer, J., O'Rourke, M. F., Kvas, E., Lassnig, E., Lamm, G., Stark, N., Rammer, 
M., & Eber, B. (2005). Increased arterial wave reflections predict severe 
cardiovascular events in patients undergoing percutaneous coronary interventions. 
European Heart Journal, 26, 2657-2663. 
Weber, T., Wassertheurer, S., Rammer, M., Haiden, A., Hametner, B., & Eber, B. (2012). 
Wave reflections, assessed with a novel method for pulse wave separation, are 
associated with end-organ damage and clinical outcomes. Hypertension, 60, 534-
541. 
217 
 
Westerbacka, J., Leinonen, E., Salonen, J. T., Salonen, R., Hiukka, A., Yki-Järvinen, H., & 
Taskinen, M. R. (2005). Increased augmentation of central blood pressure is 
associated with increases in carotid intima–media thickness in type 2 diabetic 
patients. Diabetologia, 48, 1654-1662. 
Westerhof, B. E., Guelen, I., Westerhof, N., Karemaker, J. M., & Avolio, A. (2006). 
Quantification of Wave Reflection in the Human Aorta From Pressure Alone A Proof 
of Principle. Hypertension, 48, 595-601. 
Wilkinson, I. B., MacCallum, H., Flint, L., Cockcroft, J. R., Newby, D. E., & Webb, D. J. 
(2000). The influence of heart rate on augmentation index and central arterial 
pressure in humans. The Journal of Physiology, 525, 263-270. 
Wilkinson, I. B., MacCallum, H., Hupperetz, P. C., van Thoor, C. J., Cockcroft, J. R., & 
Webb, D. J. (2001). Changes in the derived central pressure waveform and pulse 
pressure in response to angiotensin II and noradrenaline in man. The Journal of 
Physiology, 530, 541-550. 
Williams, B., & Lacy, P. S. (2009). Impact of Heart Rate on Central Aortic Pressures and 
HemodynamicsAnalysis From the CAFE (Conduit Artery Function Evaluation) Study: 
CAFE-Heart Rate. Journal of the American College of Cardiology, 54, 705-713. 
Williams, B., Lacy, P. S., Thom, S. M., Cruickshank, K., Stanton, A., Collier, D., Hughes, 
A.D., Thurston, H., & O’Rourke, M. (2006). Differential impact of blood pressure–
lowering drugs on central aortic pressure and clinical outcomes principal results of 
the Conduit Artery Function Evaluation (CAFE) Study. Circulation, 113, 1213-1225. 
Wohlfahrt, P., Wichterle, D., Seidlerová, J., Filipovský, J., Bruthans, J., Adámková, V., & 
Cífková, R. (2011). Relation of central and brachial blood pressure to left ventricular 
hypertrophy. The Czech Post-MONICA Study. Journal of Human Hypertension, 26, 
14-19. 
Woodiwiss, A. J., Molebatsi, N., Maseko, M. J., Libhaber, E., Libhaber, C., Majane, O. H., 
Paiker, J., Dessein, P., Brooksbank, R., Sareli, P., & Norton, G. R. (2009). Nurse-
218 
 
recorded auscultatory blood pressure at a single visit predicts target organ changes 
as well as ambulatory blood pressure. Journal of Hypertension, 27, 287-297. 
Woodiwiss, A.J., and Norton, G.R. (2015). Obesity and left ventricular hypertrophy: the 
hypertension connection. Current Hypertension Reports, 17, 28. 
Yaginuma, T., Koda. T., Tsuchiya, M., Takazawa, K., Tananka, H., Kotoda, K., Hosoda, S., 
Arai, T., & Nagashima, H. (1985). Interaction of left ventricular contraction and aortic 
input impedance in experimental and clinical studies. Japanese Circulation 
Journal 49, 206-214. 
Yusuf, S., Diener, H. C., Sacco, R. L., Cotton, D., Ôunpuu, S., Lawton, W. A., Palesch, Y., 
Martin, R.H., Albers, G.W., Bath, P., Bornstein, N., Chan, B.P., Chen, S.T., Cunha, 
L., Dahlöf, B., De Keyser, J., Donnan, G.A., Estol, C., Gorelick, P., Gu, V., 
Hermansson, K., Hilbrich, L., Kaste, M., Lu, C., Machnig, T., Pais, P., Roberts, R., 
Skvortsova, V., Teal, P., Toni, D., VanderMaelen, C., Voigt, T., Weber, M., & Yoon, 
B. W. (2008). Telmisartan to prevent recurrent stroke and cardiovascular events. 
New England Journal of Medicine, 359, 1225-1237. 
Yusuf, S., Reddy, S., Ôunpuu, S., & Anand, S. (2001). Global burden of cardiovascular 
diseases part I: general considerations, the epidemiologic transition, risk factors, and 
impact of urbanization. Circulation, 104, 2746-2753. 
Zamani, P., Jacobs, D. R., Segers, P., Duprez, D. A., Brumback, L., Kronmal, R. A., Lilly, 
S.M., Townsend, R.R., Budoff, M., Lima, J.A., Hannan, P., & Chirinos, J. A. (2014). 
Reflection Magnitude as a Predictor of Mortality The Multi-Ethnic Study of 
Atherosclerosis. Hypertension, 64, 958-964. 
Zhang, Y., Lee, E. T., Devereux, R. B., Yeh, J., Best, L. G., Fabsitz, R. R., & Howard, B. V. 
(2006). Prehypertension, Diabetes, and Cardiovascular Disease Risk in a Population-
Based Sample The Strong Heart Study. Hypertension, 47, 410-414. 
